METHODS IN ENZYMOLOGY EDITORS-IN-CHIEF
John N. Abelson
Melvin I. Simon
DIVISION OF BIOLOGY CALIFORNIA INSTITUTE OF TE...
39 downloads
1543 Views
6MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
METHODS IN ENZYMOLOGY EDITORS-IN-CHIEF
John N. Abelson
Melvin I. Simon
DIVISION OF BIOLOGY CALIFORNIA INSTITUTE OF TECHNOLOGY PASADENA, CALIFORNIA
FOUNDING EDITORS
Sidney P. Colowick and Nathan O. Kaplan
Contributors to Volume 380 Article numbers are in parentheses and following the names of contributors. Affiliations listed are current.
Vahe Bandarian (7), Department of Biochemistry, University of Arizona, Tucson, Arizona 85721
Carl Frieden (18), Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110
James G. Bann (18), Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110
D. Travis Gallagher (4), Biotech Division, Chemical Science and Technology Lab, National Institute of Standards and Technology, Gaithersburg, Maryland 20899
George Barany (17), Department of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455
Bertrand Garci´a-Moreno E. (2), Department of Biophysics, Johns Hopkins University, Baltimore, Maryland 21218
Elisar Barbar (11), Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio 45701
Robert A. Goldbeck (14), Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064
Michael Carey (10), Department of Biological Chemistry, UCLA School of Medicine, Los Angeles, California 90095 Nata`lia Carulla (17), Department of Chemistry, Cambridge University, Cambridge CB2 1EW, England
Gregory A. Grant (5), Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110
Hue Sun Chan (16), Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Michael Hare (11), Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio 45701
Eefie Chen (14), Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064
Sydney D. Hoeltzli (18), Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110
Diana Chinchilla (4), CARB/University of Maryland Biotechnology Institute, Rockville, Maryland 20850 Edward Eisenstein (4), CARB/University of Maryland Biotechnology Institute, Rockville, Maryland 20850
Vasanthi Jayaraman (8), Department of Integrative Biology and Pharmacology, University of Texas Health Sciences Center, Houston, Texas 77030
Carolyn A. Fitch (2), Department of Biophysics, Johns Hopkins University, Baltimore, Maryland 21218
Kristina M. Johnson (10), Department of Biological Chemistry, UCLA School of Medicine, Los Angeles, California 90095
ix
x
contributors to volume 380
Hu¨ seyin Kaya (16), Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada
David L. Smith (13), Department of Chemistry, University of Nebraska, Lincoln, Nebraska 68588
David S. Kliger (14), Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064
Elaine Stephens (1), Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, England
Heidi Lau (4), CARB/University of Maryland Biotechnology Institute, Rockville, Maryland 20850 Susan Marqusee (15), Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720 Rowena G. Matthews (7), Biophysics Research Division, University of Michigan, Ann Arbor, Michigan 48109
Marek Sˇ trajbl (3), Department of Chemistry, University of Southern California, Los Angeles, California 90089 Jin Wang (10), Department of Biochemistry, Ninjing University, Ninjing, People’s Republic of China Arieh Warshel (3), Department of Chemistry, University of Southern California, Los Angeles, California 90089
Hai Pan (13), Amgen Inc., Thousand Oaks, California 91320
Joachim Weber (6), Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas 79430
Gregory D. Reinhart (9), Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843
David Wildes (15), Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720
Claudia N. Schutz (3), Department of Chemistry, University of Southern California, Los Angeles, California 90089
Dudley H. Williams (1), Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, England
Alan Senior (6), Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York 14642
Clare Woodward (17), Department of Biochemistry, Biophysics and Molecular Biology, University of Minnesota, St. Paul, Minnesota 55108
Seishi Shimizu (16), Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Robert W. Woody (12), Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado 80525
Avital Shurki (3), Department of Chemistry, University of Southern California, Los Angeles, California 90089 Andrea Smallwood (10), Department of Biological Chemistry, UCLA School of Medicine, Los Angeles, California 90095
Rosa Zerella (1), Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, England Min Zhou (1), Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, England
Preface
One of the most intriguing problems in biological energetics is that of cooperativity. From the discovery of cooperativity and allostery in hemoglobin 100 years ago (Bohr et al., 1904)1 to the characterization of cooperativity in a myriad of processes in modern times (i.e., transport, catalysis, signaling, assembly, folding), the molecular mechanisms by which energy is transferred from one part of a macromolecule to another continues to challenge us. Of course, the problem has many layers, as a molecule as ‘‘simple’’ and familiar as hemoglobin can simultaneously sense the chemical potential of each physiological ligand and adjust its interactions with the others accordingly. Ironically, the very allosteric intermediates that hold the structural and energetic secrets of cooperativity are the same whose populations are suppressed and, in many instances, largely obscured by the nature of cooperativity itself. Thus, innovative methodologies and techniques have been developed to address cooperative systems, many of which are presented in this volume Energetics of Biological Macromolecules Part E and its companion volume, Part D. The reader will observe remarkable similarities among the wide range of experimental strategies employed, attesting to fundamental issues inherent in all cooperative systems. Jo M. Holt Michael L. Johnson Gary K. Ackers
1
C. Bohr, K. A. Hasselbach, and A. Krogh, Skand. Arch. Physiol. 16, 402 (1904).
xi
METHODS IN ENZYMOLOGY Volume I. Preparation and Assay of Enzymes Edited by Sidney P. Colowick and Nathan O. Kaplan Volume II. Preparation and Assay of Enzymes Edited by Sidney P. Colowick and Nathan O. Kaplan Volume III. Preparation and Assay of Substrates Edited by Sidney P. Colowick and Nathan O. Kaplan Volume IV. Special Techniques for the Enzymologist Edited by Sidney P. Colowick and Nathan O. Kaplan Volume V. Preparation and Assay of Enzymes Edited by Sidney P. Colowick and Nathan O. Kaplan Volume VI. Preparation and Assay of Enzymes (Continued) Preparation and Assay of Substrates Special Techniques Edited by Sidney P. Colowick and Nathan O. Kaplan Volume VII. Cumulative Subject Index Edited by Sidney P. Colowick and Nathan O. Kaplan Volume VIII. Complex Carbohydrates Edited by Elizabeth F. Neufeld and Victor Ginsburg Volume IX. Carbohydrate Metabolism Edited by Willis A. Wood Volume X. Oxidation and Phosphorylation Edited by Ronald W. Estabrook and Maynard E. Pullman Volume XI. Enzyme Structure Edited by C. H. W. Hirs Volume XII. Nucleic Acids (Parts A and B) Edited by Lawrence Grossman and Kivie Moldave Volume XIII. Citric Acid Cycle Edited by J. M. Lowenstein Volume XIV. Lipids Edited by J. M. Lowenstein Volume XV. Steroids and Terpenoids Edited by Raymond B. Clayton
xiii
xiv
methods in enzymology
Volume XVI. Fast Reactions Edited by Kenneth Kustin Volume XVII. Metabolism of Amino Acids and Amines (Parts A and B) Edited by Herbert Tabor and Celia White Tabor Volume XVIII. Vitamins and Coenzymes (Parts A, B, and C) Edited by Donald B. McCormick and Lemuel D. Wright Volume XIX. Proteolytic Enzymes Edited by Gertrude E. Perlmann and Laszlo Lorand Volume XX. Nucleic Acids and Protein Synthesis (Part C) Edited by Kivie Moldave and Lawrence Grossman Volume XXI. Nucleic Acids (Part D) Edited by Lawrence Grossman and Kivie Moldave Volume XXII. Enzyme Purification and Related Techniques Edited by William B. Jakoby Volume XXIII. Photosynthesis (Part A) Edited by Anthony San Pietro Volume XXIV. Photosynthesis and Nitrogen Fixation (Part B) Edited by Anthony San Pietro Volume XXV. Enzyme Structure (Part B) Edited by C. H. W. Hirs and Serge N. Timasheff Volume XXVI. Enzyme Structure (Part C) Edited by C. H. W. Hirs and Serge N. Timasheff Volume XXVII. Enzyme Structure (Part D) Edited by C. H. W. Hirs and Serge N. Timasheff Volume XXVIII. Complex Carbohydrates (Part B) Edited by Victor Ginsburg Volume XXIX. Nucleic Acids and Protein Synthesis (Part E) Edited by Lawrence Grossman and Kivie Moldave Volume XXX. Nucleic Acids and Protein Synthesis (Part F) Edited by Kivie Moldave and Lawrence Grossman Volume XXXI. Biomembranes (Part A) Edited by Sidney Fleischer and Lester Packer Volume XXXII. Biomembranes (Part B) Edited by Sidney Fleischer and Lester Packer Volume XXXIII. Cumulative Subject Index Volumes I-XXX Edited by Martha G. Dennis and Edward A. Dennis Volume XXXIV. Affinity Techniques (Enzyme Purification: Part B) Edited by William B. Jakoby and Meir Wilchek
methods in enzymology
xv
Volume XXXV. Lipids (Part B) Edited by John M. Lowenstein Volume XXXVI. Hormone Action (Part A: Steroid Hormones) Edited by Bert W. O’Malley and Joel G. Hardman Volume XXXVII. Hormone Action (Part B: Peptide Hormones) Edited by Bert W. O’Malley and Joel G. Hardman Volume XXXVIII. Hormone Action (Part C: Cyclic Nucleotides) Edited by Joel G. Hardman and Bert W. O’Malley Volume XXXIX. Hormone Action (Part D: Isolated Cells, Tissues, and Organ Systems) Edited by Joel G. Hardman and Bert W. O’Malley Volume XL. Hormone Action (Part E: Nuclear Structure and Function) Edited by Bert W. O’Malley and Joel G. Hardman Volume XLI. Carbohydrate Metabolism (Part B) Edited by W. A. Wood Volume XLII. Carbohydrate Metabolism (Part C) Edited by W. A. Wood Volume XLIII. Antibiotics Edited by John H. Hash Volume XLIV. Immobilized Enzymes Edited by Klaus Mosbach Volume XLV. Proteolytic Enzymes (Part B) Edited by Laszlo Lorand Volume XLVI. Affinity Labeling Edited by William B. Jakoby and Meir Wilchek Volume XLVII. Enzyme Structure (Part E) Edited by C. H. W. Hirs and Serge N. Timasheff Volume XLVIII. Enzyme Structure (Part F) Edited by C. H. W. Hirs and Serge N. Timasheff Volume XLIX. Enzyme Structure (Part G) Edited by C. H. W. Hirs and Serge N. Timasheff Volume L. Complex Carbohydrates (Part C) Edited by Victor Ginsburg Volume LI. Purine and Pyrimidine Nucleotide Metabolism Edited by Patricia A. Hoffee and Mary Ellen Jones Volume LII. Biomembranes (Part C: Biological Oxidations) Edited by Sidney Fleischer and Lester Packer Volume LIII. Biomembranes (Part D: Biological Oxidations) Edited by Sidney Fleischer and Lester Packer
xvi
methods in enzymology
Volume LIV. Biomembranes (Part E: Biological Oxidations) Edited by Sidney Fleischer and Lester Packer Volume LV. Biomembranes (Part F: Bioenergetics) Edited by Sidney Fleischer and Lester Packer Volume LVI. Biomembranes (Part G: Bioenergetics) Edited by Sidney Fleischer and Lester Packer Volume LVII. Bioluminescence and Chemiluminescence Edited by Marlene A. DeLuca Volume LVIII. Cell Culture Edited by William B. Jakoby and Ira Pastan Volume LIX. Nucleic Acids and Protein Synthesis (Part G) Edited by Kivie Moldave and Lawrence Grossman Volume LX. Nucleic Acids and Protein Synthesis (Part H) Edited by Kivie Moldave and Lawrence Grossman Volume 61. Enzyme Structure (Part H) Edited by C. H. W. Hirs and Serge N. Timasheff Volume 62. Vitamins and Coenzymes (Part D) Edited by Donald B. McCormick and Lemuel D. Wright Volume 63. Enzyme Kinetics and Mechanism (Part A: Initial Rate and Inhibitor Methods) Edited by Daniel L. Purich Volume 64. Enzyme Kinetics and Mechanism (Part B: Isotopic Probes and Complex Enzyme Systems) Edited by Daniel L. Purich Volume 65. Nucleic Acids (Part I) Edited by Lawrence Grossman and Kivie Moldave Volume 66. Vitamins and Coenzymes (Part E) Edited by Donald B. McCormick and Lemuel D. Wright Volume 67. Vitamins and Coenzymes (Part F) Edited by Donald B. McCormick and Lemuel D. Wright Volume 68. Recombinant DNA Edited by Ray Wu Volume 69. Photosynthesis and Nitrogen Fixation (Part C) Edited by Anthony San Pietro Volume 70. Immunochemical Techniques (Part A) Edited by Helen Van Vunakis and John J. Langone Volume 71. Lipids (Part C) Edited by John M. Lowenstein
methods in enzymology
xvii
Volume 72. Lipids (Part D) Edited by John M. Lowenstein Volume 73. Immunochemical Techniques (Part B) Edited by John J. Langone and Helen Van Vunakis Volume 74. Immunochemical Techniques (Part C) Edited by John J. Langone and Helen Van Vunakis Volume 75. Cumulative Subject Index Volumes XXXI, XXXII, XXXIV–LX Edited by Edward A. Dennis and Martha G. Dennis Volume 76. Hemoglobins Edited by Eraldo Antonini, Luigi Rossi-Bernardi, and Emilia Chiancone Volume 77. Detoxication and Drug Metabolism Edited by William B. Jakoby Volume 78. Interferons (Part A) Edited by Sidney Pestka Volume 79. Interferons (Part B) Edited by Sidney Pestka Volume 80. Proteolytic Enzymes (Part C) Edited by Laszlo Lorand Volume 81. Biomembranes (Part H: Visual Pigments and Purple Membranes, I) Edited by Lester Packer Volume 82. Structural and Contractile Proteins (Part A: Extracellular Matrix) Edited by Leon W. Cunningham and Dixie W. Frederiksen Volume 83. Complex Carbohydrates (Part D) Edited by Victor Ginsburg Volume 84. Immunochemical Techniques (Part D: Selected Immunoassays) Edited by John J. Langone and Helen Van Vunakis Volume 85. Structural and Contractile Proteins (Part B: The Contractile Apparatus and the Cytoskeleton) Edited by Dixie W. Frederiksen and Leon W. Cunningham Volume 86. Prostaglandins and Arachidonate Metabolites Edited by William E. M. Lands and William L. Smith Volume 87. Enzyme Kinetics and Mechanism (Part C: Intermediates, Stereo-chemistry, and Rate Studies) Edited by Daniel L. Purich Volume 88. Biomembranes (Part I: Visual Pigments and Purple Membranes, II) Edited by Lester Packer Volume 89. Carbohydrate Metabolism (Part D) Edited by Willis A. Wood
xviii
methods in enzymology
Volume 90. Carbohydrate Metabolism (Part E) Edited by Willis A. Wood Volume 91. Enzyme Structure (Part I) Edited by C. H. W. Hirs and Serge N. Timasheff Volume 92. Immunochemical Techniques (Part E: Monoclonal Antibodies and General Immunoassay Methods) Edited by John J. Langone and Helen Van Vunakis Volume 93. Immunochemical Techniques (Part F: Conventional Antibodies, Fc Receptors, and Cytotoxicity) Edited by John J. Langone and Helen Van Vunakis Volume 94. Polyamines Edited by Herbert Tabor and Celia White Tabor Volume 95. Cumulative Subject Index Volumes 61–74, 76–80 Edited by Edward A. Dennis and Martha G. Dennis Volume 96. Biomembranes [Part J: Membrane Biogenesis: Assembly and Targeting (General Methods; Eukaryotes)] Edited by Sidney Fleischer and Becca Fleischer Volume 97. Biomembranes [Part K: Membrane Biogenesis: Assembly and Targeting (Prokaryotes, Mitochondria, and Chloroplasts)] Edited by Sidney Fleischer and Becca Fleischer Volume 98. Biomembranes (Part L: Membrane Biogenesis: Processing and Recycling) Edited by Sidney Fleischer and Becca Fleischer Volume 99. Hormone Action (Part F: Protein Kinases) Edited by Jackie D. Corbin and Joel G. Hardman Volume 100. Recombinant DNA (Part B) Edited by Ray Wu, Lawrence Grossman, and Kivie Moldave Volume 101. Recombinant DNA (Part C) Edited by Ray Wu, Lawrence Grossman, and Kivie Moldave Volume 102. Hormone Action (Part G: Calmodulin and Calcium-Binding Proteins) Edited by Anthony R. Means and Bert W. O’Malley Volume 103. Hormone Action (Part H: Neuroendocrine Peptides) Edited by P. Michael Conn Volume 104. Enzyme Purification and Related Techniques (Part C) Edited by William B. Jakoby Volume 105. Oxygen Radicals in Biological Systems Edited by Lester Packer Volume 106. Posttranslational Modifications (Part A) Edited by Finn Wold and Kivie Moldave
methods in enzymology
xix
Volume 107. Posttranslational Modifications (Part B) Edited by Finn Wold and Kivie Moldave Volume 108. Immunochemical Techniques (Part G: Separation and Characterization of Lymphoid Cells) Edited by Giovanni Di Sabato, John J. Langone, and Helen Van Vunakis Volume 109. Hormone Action (Part I: Peptide Hormones) Edited by Lutz Birnbaumer and Bert W. O’Malley Volume 110. Steroids and Isoprenoids (Part A) Edited by John H. Law and Hans C. Rilling Volume 111. Steroids and Isoprenoids (Part B) Edited by John H. Law and Hans C. Rilling Volume 112. Drug and Enzyme Targeting (Part A) Edited by Kenneth J. Widder and Ralph Green Volume 113. Glutamate, Glutamine, Glutathione, and Related Compounds Edited by Alton Meister Volume 114. Diffraction Methods for Biological Macromolecules (Part A) Edited by Harold W. Wyckoff, C. H. W. Hirs, and Serge N. Timasheff Volume 115. Diffraction Methods for Biological Macromolecules (Part B) Edited by Harold W. Wyckoff, C. H. W. Hirs, and Serge N. Timasheff Volume 116. Immunochemical Techniques (Part H: Effectors and Mediators of Lymphoid Cell Functions) Edited by Giovanni Di Sabato, John J. Langone, and Helen Van Vunakis Volume 117. Enzyme Structure (Part J) Edited by C. H. W. Hirs and Serge N. Timasheff Volume 118. Plant Molecular Biology Edited by Arthur Weissbach and Herbert Weissbach Volume 119. Interferons (Part C) Edited by Sidney Pestka Volume 120. Cumulative Subject Index Volumes 81–94, 96–101 Volume 121. Immunochemical Techniques (Part I: Hybridoma Technology and Monoclonal Antibodies) Edited by John J. Langone and Helen Van Vunakis Volume 122. Vitamins and Coenzymes (Part G) Edited by Frank Chytil and Donald B. McCormick Volume 123. Vitamins and Coenzymes (Part H) Edited by Frank Chytil and Donald B. McCormick Volume 124. Hormone Action (Part J: Neuroendocrine Peptides) Edited by P. Michael Conn
xx
methods in enzymology
Volume 125. Biomembranes (Part M: Transport in Bacteria, Mitochondria, and Chloroplasts: General Approaches and Transport Systems) Edited by Sidney Fleischer and Becca Fleischer Volume 126. Biomembranes (Part N: Transport in Bacteria, Mitochondria, and Chloroplasts: Protonmotive Force) Edited by Sidney Fleischer and Becca Fleischer Volume 127. Biomembranes (Part O: Protons and Water: Structure and Translocation) Edited by Lester Packer Volume 128. Plasma Lipoproteins (Part A: Preparation, Structure, and Molecular Biology) Edited by Jere P. Segrest and John J. Albers Volume 129. Plasma Lipoproteins (Part B: Characterization, Cell Biology, and Metabolism) Edited by John J. Albers and Jere P. Segrest Volume 130. Enzyme Structure (Part K) Edited by C. H. W. Hirs and Serge N. Timasheff Volume 131. Enzyme Structure (Part L) Edited by C. H. W. Hirs and Serge N. Timasheff Volume 132. Immunochemical Techniques (Part J: Phagocytosis and Cell-Mediated Cytotoxicity) Edited by Giovanni Di Sabato and Johannes Everse Volume 133. Bioluminescence and Chemiluminescence (Part B) Edited by Marlene DeLuca and William D. McElroy Volume 134. Structural and Contractile Proteins (Part C: The Contractile Apparatus and the Cytoskeleton) Edited by Richard B. Vallee Volume 135. Immobilized Enzymes and Cells (Part B) Edited by Klaus Mosbach Volume 136. Immobilized Enzymes and Cells (Part C) Edited by Klaus Mosbach Volume 137. Immobilized Enzymes and Cells (Part D) Edited by Klaus Mosbach Volume 138. Complex Carbohydrates (Part E) Edited by Victor Ginsburg Volume 139. Cellular Regulators (Part A: Calcium- and Calmodulin-Binding Proteins) Edited by Anthony R. Means and P. Michael Conn Volume 140. Cumulative Subject Index Volumes 102–119, 121–134
methods in enzymology
xxi
Volume 141. Cellular Regulators (Part B: Calcium and Lipids) Edited by P. Michael Conn and Anthony R. Means Volume 142. Metabolism of Aromatic Amino Acids and Amines Edited by Seymour Kaufman Volume 143. Sulfur and Sulfur Amino Acids Edited by William B. Jakoby and Owen Griffith Volume 144. Structural and Contractile Proteins (Part D: Extracellular Matrix) Edited by Leon W. Cunningham Volume 145. Structural and Contractile Proteins (Part E: Extracellular Matrix) Edited by Leon W. Cunningham Volume 146. Peptide Growth Factors (Part A) Edited by David Barnes and David A. Sirbasku Volume 147. Peptide Growth Factors (Part B) Edited by David Barnes and David A. Sirbasku Volume 148. Plant Cell Membranes Edited by Lester Packer and Roland Douce Volume 149. Drug and Enzyme Targeting (Part B) Edited by Ralph Green and Kenneth J. Widder Volume 150. Immunochemical Techniques (Part K: In Vitro Models of B and T Cell Functions and Lymphoid Cell Receptors) Edited by Giovanni Di Sabato Volume 151. Molecular Genetics of Mammalian Cells Edited by Michael M. Gottesman Volume 152. Guide to Molecular Cloning Techniques Edited by Shelby L. Berger and Alan R. Kimmel Volume 153. Recombinant DNA (Part D) Edited by Ray Wu and Lawrence Grossman Volume 154. Recombinant DNA (Part E) Edited by Ray Wu and Lawrence Grossman Volume 155. Recombinant DNA (Part F) Edited by Ray Wu Volume 156. Biomembranes (Part P: ATP-Driven Pumps and Related Transport: The Na, K-Pump) Edited by Sidney Fleischer and Becca Fleischer Volume 157. Biomembranes (Part Q: ATP-Driven Pumps and Related Transport: Calcium, Proton, and Potassium Pumps) Edited by Sidney Fleischer and Becca Fleischer Volume 158. Metalloproteins (Part A) Edited by James F. Riordan and Bert L. Vallee
xxii
methods in enzymology
Volume 159. Initiation and Termination of Cyclic Nucleotide Action Edited by Jackie D. Corbin and Roger A. Johnson Volume 160. Biomass (Part A: Cellulose and Hemicellulose) Edited by Willis A. Wood and Scott T. Kellogg Volume 161. Biomass (Part B: Lignin, Pectin, and Chitin) Edited by Willis A. Wood and Scott T. Kellogg Volume 162. Immunochemical Techniques (Part L: Chemotaxis and Inflammation) Edited by Giovanni Di Sabato Volume 163. Immunochemical Techniques (Part M: Chemotaxis and Inflammation) Edited by Giovanni Di Sabato Volume 164. Ribosomes Edited by Harry F. Noller, Jr., and Kivie Moldave Volume 165. Microbial Toxins: Tools for Enzymology Edited by Sidney Harshman Volume 166. Branched-Chain Amino Acids Edited by Robert Harris and John R. Sokatch Volume 167. Cyanobacteria Edited by Lester Packer and Alexander N. Glazer Volume 168. Hormone Action (Part K: Neuroendocrine Peptides) Edited by P. Michael Conn Volume 169. Platelets: Receptors, Adhesion, Secretion (Part A) Edited by Jacek Hawiger Volume 170. Nucleosomes Edited by Paul M. Wassarman and Roger D. Kornberg Volume 171. Biomembranes (Part R: Transport Theory: Cells and Model Membranes) Edited by Sidney Fleischer and Becca Fleischer Volume 172. Biomembranes (Part S: Transport: Membrane Isolation and Characterization) Edited by Sidney Fleischer and Becca Fleischer Volume 173. Biomembranes [Part T: Cellular and Subcellular Transport: Eukaryotic (Nonepithelial) Cells] Edited by Sidney Fleischer and Becca Fleischer Volume 174. Biomembranes [Part U: Cellular and Subcellular Transport: Eukaryotic (Nonepithelial) Cells] Edited by Sidney Fleischer and Becca Fleischer Volume 175. Cumulative Subject Index Volumes 135–139, 141–167
methods in enzymology
xxiii
Volume 176. Nuclear Magnetic Resonance (Part A: Spectral Techniques and Dynamics) Edited by Norman J. Oppenheimer and Thomas L. James Volume 177. Nuclear Magnetic Resonance (Part B: Structure and Mechanism) Edited by Norman J. Oppenheimer and Thomas L. James Volume 178. Antibodies, Antigens, and Molecular Mimicry Edited by John J. Langone Volume 179. Complex Carbohydrates (Part F) Edited by Victor Ginsburg Volume 180. RNA Processing (Part A: General Methods) Edited by James E. Dahlberg and John N. Abelson Volume 181. RNA Processing (Part B: Specific Methods) Edited by James E. Dahlberg and John N. Abelson Volume 182. Guide to Protein Purification Edited by Murray P. Deutscher Volume 183. Molecular Evolution: Computer Analysis of Protein and Nucleic Acid Sequences Edited by Russell F. Doolittle Volume 184. Avidin-Biotin Technology Edited by Meir Wilchek and Edward A. Bayer Volume 185. Gene Expression Technology Edited by David V. Goeddel Volume 186. Oxygen Radicals in Biological Systems (Part B: Oxygen Radicals and Antioxidants) Edited by Lester Packer and Alexander N. Glazer Volume 187. Arachidonate Related Lipid Mediators Edited by Robert C. Murphy and Frank A. Fitzpatrick Volume 188. Hydrocarbons and Methylotrophy Edited by Mary E. Lidstrom Volume 189. Retinoids (Part A: Molecular and Metabolic Aspects) Edited by Lester Packer Volume 190. Retinoids (Part B: Cell Differentiation and Clinical Applications) Edited by Lester Packer Volume 191. Biomembranes (Part V: Cellular and Subcellular Transport: Epithelial Cells) Edited by Sidney Fleischer and Becca Fleischer Volume 192. Biomembranes (Part W: Cellular and Subcellular Transport: Epithelial Cells) Edited by Sidney Fleischer and Becca Fleischer
xxiv
methods in enzymology
Volume 193. Mass Spectrometry Edited by James A. McCloskey Volume 194. Guide to Yeast Genetics and Molecular Biology Edited by Christine Guthrie and Gerald R. Fink Volume 195. Adenylyl Cyclase, G Proteins, and Guanylyl Cyclase Edited by Roger A. Johnson and Jackie D. Corbin Volume 196. Molecular Motors and the Cytoskeleton Edited by Richard B. Vallee Volume 197. Phospholipases Edited by Edward A. Dennis Volume 198. Peptide Growth Factors (Part C) Edited by David Barnes, J. P. Mather, and Gordon H. Sato Volume 199. Cumulative Subject Index Volumes 168–174, 176–194 Volume 200. Protein Phosphorylation (Part A: Protein Kinases: Assays, Purification, Antibodies, Functional Analysis, Cloning, and Expression) Edited by Tony Hunter and Bartholomew M. Sefton Volume 201. Protein Phosphorylation (Part B: Analysis of Protein Phosphorylation, Protein Kinase Inhibitors, and Protein Phosphatases) Edited by Tony Hunter and Bartholomew M. Sefton Volume 202. Molecular Design and Modeling: Concepts and Applications (Part A: Proteins, Peptides, and Enzymes) Edited by John J. Langone Volume 203. Molecular Design and Modeling: Concepts and Applications (Part B: Antibodies and Antigens, Nucleic Acids, Polysaccharides, and Drugs) Edited by John J. Langone Volume 204. Bacterial Genetic Systems Edited by Jeffrey H. Miller Volume 205. Metallobiochemistry (Part B: Metallothionein and Related Molecules) Edited by James F. Riordan and Bert L. Vallee Volume 206. Cytochrome P450 Edited by Michael R. Waterman and Eric F. Johnson Volume 207. Ion Channels Edited by Bernardo Rudy and Linda E. Iverson Volume 208. Protein–DNA Interactions Edited by Robert T. Sauer Volume 209. Phospholipid Biosynthesis Edited by Edward A. Dennis and Dennis E. Vance
methods in enzymology
xxv
Volume 210. Numerical Computer Methods Edited by Ludwig Brand and Michael L. Johnson Volume 211. DNA Structures (Part A: Synthesis and Physical Analysis of DNA) Edited by David M. J. Lilley and James E. Dahlberg Volume 212. DNA Structures (Part B: Chemical and Electrophoretic Analysis of DNA) Edited by David M. J. Lilley and James E. Dahlberg Volume 213. Carotenoids (Part A: Chemistry, Separation, Quantitation, and Antioxidation) Edited by Lester Packer Volume 214. Carotenoids (Part B: Metabolism, Genetics, and Biosynthesis) Edited by Lester Packer Volume 215. Platelets: Receptors, Adhesion, Secretion (Part B) Edited by Jacek J. Hawiger Volume 216. Recombinant DNA (Part G) Edited by Ray Wu Volume 217. Recombinant DNA (Part H) Edited by Ray Wu Volume 218. Recombinant DNA (Part I) Edited by Ray Wu Volume 219. Reconstitution of Intracellular Transport Edited by James E. Rothman Volume 220. Membrane Fusion Techniques (Part A) Edited by Nejat Du¨ zgu¨ nes, Volume 221. Membrane Fusion Techniques (Part B) Edited by Nejat Du¨ zgu¨ nes, Volume 222. Proteolytic Enzymes in Coagulation, Fibrinolysis, and Complement Activation (Part A: Mammalian Blood Coagulation Factors and Inhibitors) Edited by Laszlo Lorand and Kenneth G. Mann Volume 223. Proteolytic Enzymes in Coagulation, Fibrinolysis, and Complement Activation (Part B: Complement Activation, Fibrinolysis, and Nonmammalian Blood Coagulation Factors) Edited by Laszlo Lorand and Kenneth G. Mann Volume 224. Molecular Evolution: Producing the Biochemical Data Edited by Elizabeth Anne Zimmer, Thomas J. White, Rebecca L. Cann, and Allan C. Wilson Volume 225. Guide to Techniques in Mouse Development Edited by Paul M. Wassarman and Melvin L. DePamphilis
xxvi
methods in enzymology
Volume 226. Metallobiochemistry (Part C: Spectroscopic and Physical Methods for Probing Metal Ion Environments in Metalloenzymes and Metalloproteins) Edited by James F. Riordan and Bert L. Vallee Volume 227. Metallobiochemistry (Part D: Physical and Spectroscopic Methods for Probing Metal Ion Environments in Metalloproteins) Edited by James F. Riordan and Bert L. Vallee Volume 228. Aqueous Two-Phase Systems Edited by Harry Walter and Go¨ te Johansson Volume 229. Cumulative Subject Index Volumes 195–198, 200–227 Volume 230. Guide to Techniques in Glycobiology Edited by William J. Lennarz and Gerald W. Hart Volume 231. Hemoglobins (Part B: Biochemical and Analytical Methods) Edited by Johannes Everse, Kim D. Vandegriff, and Robert M. Winslow Volume 232. Hemoglobins (Part C: Biophysical Methods) Edited by Johannes Everse, Kim D. Vandegriff, and Robert M. Winslow Volume 233. Oxygen Radicals in Biological Systems (Part C) Edited by Lester Packer Volume 234. Oxygen Radicals in Biological Systems (Part D) Edited by Lester Packer Volume 235. Bacterial Pathogenesis (Part A: Identification and Regulation of Virulence Factors) Edited by Virginia L. Clark and Patrik M. Bavoil Volume 236. Bacterial Pathogenesis (Part B: Integration of Pathogenic Bacteria with Host Cells) Edited by Virginia L. Clark and Patrik M. Bavoil Volume 237. Heterotrimeric G Proteins Edited by Ravi Iyengar Volume 238. Heterotrimeric G-Protein Effectors Edited by Ravi Iyengar Volume 239. Nuclear Magnetic Resonance (Part C) Edited by Thomas L. James and Norman J. Oppenheimer Volume 240. Numerical Computer Methods (Part B) Edited by Michael L. Johnson and Ludwig Brand Volume 241. Retroviral Proteases Edited by Lawrence C. Kuo and Jules A. Shafer Volume 242. Neoglycoconjugates (Part A) Edited by Y. C. Lee and Reiko T. Lee Volume 243. Inorganic Microbial Sulfur Metabolism Edited by Harry D. Peck, Jr., and Jean LeGall
methods in enzymology
xxvii
Volume 244. Proteolytic Enzymes: Serine and Cysteine Peptidases Edited by Alan J. Barrett Volume 245. Extracellular Matrix Components Edited by E. Ruoslahti and E. Engvall Volume 246. Biochemical Spectroscopy Edited by Kenneth Sauer Volume 247. Neoglycoconjugates (Part B: Biomedical Applications) Edited by Y. C. Lee and Reiko T. Lee Volume 248. Proteolytic Enzymes: Aspartic and Metallo Peptidases Edited by Alan J. Barrett Volume 249. Enzyme Kinetics and Mechanism (Part D: Developments in Enzyme Dynamics) Edited by Daniel L. Purich Volume 250. Lipid Modifications of Proteins Edited by Patrick J. Casey and Janice E. Buss Volume 251. Biothiols (Part A: Monothiols and Dithiols, Protein Thiols, and Thiyl Radicals) Edited by Lester Packer Volume 252. Biothiols (Part B: Glutathione and Thioredoxin; Thiols in Signal Transduction and Gene Regulation) Edited by Lester Packer Volume 253. Adhesion of Microbial Pathogens Edited by Ron J. Doyle and Itzhak Ofek Volume 254. Oncogene Techniques Edited by Peter K. Vogt and Inder M. Verma Volume 255. Small GTPases and Their Regulators (Part A: Ras Family) Edited by W. E. Balch, Channing J. Der, and Alan Hall Volume 256. Small GTPases and Their Regulators (Part B: Rho Family) Edited by W. E. Balch, Channing J. Der, and Alan Hall Volume 257. Small GTPases and Their Regulators (Part C: Proteins Involved in Transport) Edited by W. E. Balch, Channing J. Der, and Alan Hall Volume 258. Redox-Active Amino Acids in Biology Edited by Judith P. Klinman Volume 259. Energetics of Biological Macromolecules Edited by Michael L. Johnson and Gary K. Ackers Volume 260. Mitochondrial Biogenesis and Genetics (Part A) Edited by Giuseppe M. Attardi and Anne Chomyn Volume 261. Nuclear Magnetic Resonance and Nucleic Acids Edited by Thomas L. James
xxviii
methods in enzymology
Volume 262. DNA Replication Edited by Judith L. Campbell Volume 263. Plasma Lipoproteins (Part C: Quantitation) Edited by William A. Bradley, Sandra H. Gianturco, and Jere P. Segrest Volume 264. Mitochondrial Biogenesis and Genetics (Part B) Edited by Giuseppe M. Attardi and Anne Chomyn Volume 265. Cumulative Subject Index Volumes 228, 230–262 Volume 266. Computer Methods for Macromolecular Sequence Analysis Edited by Russell F. Doolittle Volume 267. Combinatorial Chemistry Edited by John N. Abelson Volume 268. Nitric Oxide (Part A: Sources and Detection of NO; NO Synthase) Edited by Lester Packer Volume 269. Nitric Oxide (Part B: Physiological and Pathological Processes) Edited by Lester Packer Volume 270. High Resolution Separation and Analysis of Biological Macromolecules (Part A: Fundamentals) Edited by Barry L. Karger and William S. Hancock Volume 271. High Resolution Separation and Analysis of Biological Macromolecules (Part B: Applications) Edited by Barry L. Karger and William S. Hancock Volume 272. Cytochrome P450 (Part B) Edited by Eric F. Johnson and Michael R. Waterman Volume 273. RNA Polymerase and Associated Factors (Part A) Edited by Sankar Adhya Volume 274. RNA Polymerase and Associated Factors (Part B) Edited by Sankar Adhya Volume 275. Viral Polymerases and Related Proteins Edited by Lawrence C. Kuo, David B. Olsen, and Steven S. Carroll Volume 276. Macromolecular Crystallography (Part A) Edited by Charles W. Carter, Jr., and Robert M. Sweet Volume 277. Macromolecular Crystallography (Part B) Edited by Charles W. Carter, Jr., and Robert M. Sweet Volume 278. Fluorescence Spectroscopy Edited by Ludwig Brand and Michael L. Johnson Volume 279. Vitamins and Coenzymes (Part I) Edited by Donald B. McCormick, John W. Suttie, and Conrad Wagner
methods in enzymology
xxix
Volume 280. Vitamins and Coenzymes (Part J) Edited by Donald B. McCormick, John W. Suttie, and Conrad Wagner Volume 281. Vitamins and Coenzymes (Part K) Edited by Donald B. McCormick, John W. Suttie, and Conrad Wagner Volume 282. Vitamins and Coenzymes (Part L) Edited by Donald B. McCormick, John W. Suttie, and Conrad Wagner Volume 283. Cell Cycle Control Edited by William G. Dunphy Volume 284. Lipases (Part A: Biotechnology) Edited by Byron Rubin and Edward A. Dennis Volume 285. Cumulative Subject Index Volumes 263, 264, 266–284, 286–289 Volume 286. Lipases (Part B: Enzyme Characterization and Utilization) Edited by Byron Rubin and Edward A. Dennis Volume 287. Chemokines Edited by Richard Horuk Volume 288. Chemokine Receptors Edited by Richard Horuk Volume 289. Solid Phase Peptide Synthesis Edited by Gregg B. Fields Volume 290. Molecular Chaperones Edited by George H. Lorimer and Thomas Baldwin Volume 291. Caged Compounds Edited by Gerard Marriott Volume 292. ABC Transporters: Biochemical, Cellular, and Molecular Aspects Edited by Suresh V. Ambudkar and Michael M. Gottesman Volume 293. Ion Channels (Part B) Edited by P. Michael Conn Volume 294. Ion Channels (Part C) Edited by P. Michael Conn Volume 295. Energetics of Biological Macromolecules (Part B) Edited by Gary K. Ackers and Michael L. Johnson Volume 296. Neurotransmitter Transporters Edited by Susan G. Amara Volume 297. Photosynthesis: Molecular Biology of Energy Capture Edited by Lee McIntosh Volume 298. Molecular Motors and the Cytoskeleton (Part B) Edited by Richard B. Vallee
xxx
methods in enzymology
Volume 299. Oxidants and Antioxidants (Part A) Edited by Lester Packer Volume 300. Oxidants and Antioxidants (Part B) Edited by Lester Packer Volume 301. Nitric Oxide: Biological and Antioxidant Activities (Part C) Edited by Lester Packer Volume 302. Green Fluorescent Protein Edited by P. Michael Conn Volume 303. cDNA Preparation and Display Edited by Sherman M. Weissman Volume 304. Chromatin Edited by Paul M. Wassarman and Alan P. Wolffe Volume 305. Bioluminescence and Chemiluminescence (Part C) Edited by Thomas O. Baldwin and Miriam M. Ziegler Volume 306. Expression of Recombinant Genes in Eukaryotic Systems Edited by Joseph C. Glorioso and Martin C. Schmidt Volume 307. Confocal Microscopy Edited by P. Michael Conn Volume 308. Enzyme Kinetics and Mechanism (Part E: Energetics of Enzyme Catalysis) Edited by Daniel L. Purich and Vern L. Schramm Volume 309. Amyloid, Prions, and Other Protein Aggregates Edited by Ronald Wetzel Volume 310. Biofilms Edited by Ron J. Doyle Volume 311. Sphingolipid Metabolism and Cell Signaling (Part A) Edited by Alfred H. Merrill, Jr., and Yusuf A. Hannun Volume 312. Sphingolipid Metabolism and Cell Signaling (Part B) Edited by Alfred H. Merrill, Jr., and Yusuf A. Hannun Volume 313. Antisense Technology (Part A: General Methods, Methods of Delivery, and RNA Studies) Edited by M. Ian Phillips Volume 314. Antisense Technology (Part B: Applications) Edited by M. Ian Phillips Volume 315. Vertebrate Phototransduction and the Visual Cycle (Part A) Edited by Krzysztof Palczewski Volume 316. Vertebrate Phototransduction and the Visual Cycle (Part B) Edited by Krzysztof Palczewski
methods in enzymology
xxxi
Volume 317. RNA–Ligand Interactions (Part A: Structural Biology Methods) Edited by Daniel W. Celander and John N. Abelson Volume 318. RNA–Ligand Interactions (Part B: Molecular Biology Methods) Edited by Daniel W. Celander and John N. Abelson Volume 319. Singlet Oxygen, UV-A, and Ozone Edited by Lester Packer and Helmut Sies Volume 320. Cumulative Subject Index Volumes 290–319 Volume 321. Numerical Computer Methods (Part C) Edited by Michael L. Johnson and Ludwig Brand Volume 322. Apoptosis Edited by John C. Reed Volume 323. Energetics of Biological Macromolecules (Part C) Edited by Michael L. Johnson and Gary K. Ackers Volume 324. Branched-Chain Amino Acids (Part B) Edited by Robert A. Harris and John R. Sokatch Volume 325. Regulators and Effectors of Small GTPases (Part D: Rho Family) Edited by W. E. Balch, Channing J. Der, and Alan Hall Volume 326. Applications of Chimeric Genes and Hybrid Proteins (Part A: Gene Expression and Protein Purification) Edited by Jeremy Thorner, Scott D. Emr, and John N. Abelson Volume 327. Applications of Chimeric Genes and Hybrid Proteins (Part B: Cell Biology and Physiology) Edited by Jeremy Thorner, Scott D. Emr, and John N. Abelson Volume 328. Applications of Chimeric Genes and Hybrid Proteins (Part C: Protein–Protein Interactions and Genomics) Edited by Jeremy Thorner, Scott D. Emr, and John N. Abelson Volume 329. Regulators and Effectors of Small GTPases (Part E: GTPases Involved in Vesicular Traffic) Edited by W. E. Balch, Channing J. Der, and Alan Hall Volume 330. Hyperthermophilic Enzymes (Part A) Edited by Michael W. W. Adams and Robert M. Kelly Volume 331. Hyperthermophilic Enzymes (Part B) Edited by Michael W. W. Adams and Robert M. Kelly Volume 332. Regulators and Effectors of Small GTPases (Part F: Ras Family I) Edited by W. E. Balch, Channing J. Der, and Alan Hall Volume 333. Regulators and Effectors of Small GTPases (Part G: Ras Family II) Edited by W. E. Balch, Channing J. Der, and Alan Hall Volume 334. Hyperthermophilic Enzymes (Part C) Edited by Michael W. W. Adams and Robert M. Kelly
xxxii
methods in enzymology
Volume 335. Flavonoids and Other Polyphenols Edited by Lester Packer Volume 336. Microbial Growth in Biofilms (Part A: Developmental and Molecular Biological Aspects) Edited by Ron J. Doyle Volume 337. Microbial Growth in Biofilms (Part B: Special Environments and Physicochemical Aspects) Edited by Ron J. Doyle Volume 338. Nuclear Magnetic Resonance of Biological Macromolecules (Part A) Edited by Thomas L. James, Volker Do¨ tsch, and Uli Schmitz Volume 339. Nuclear Magnetic Resonance of Biological Macromolecules (Part B) Edited by Thomas L. James, Volker Do¨ tsch, and Uli Schmitz Volume 340. Drug–Nucleic Acid Interactions Edited by Jonathan B. Chaires and Michael J. Waring Volume 341. Ribonucleases (Part A) Edited by Allen W. Nicholson Volume 342. Ribonucleases (Part B) Edited by Allen W. Nicholson Volume 343. G Protein Pathways (Part A: Receptors) Edited by Ravi Iyengar and John D. Hildebrandt Volume 344. G Protein Pathways (Part B: G Proteins and Their Regulators) Edited by Ravi Iyengar and John D. Hildebrandt Volume 345. G Protein Pathways (Part C: Effector Mechanisms) Edited by Ravi Iyengar and John D. Hildebrandt Volume 346. Gene Therapy Methods Edited by M. Ian Phillips Volume 347. Protein Sensors and Reactive Oxygen Species (Part A: Selenoproteins and Thioredoxin) Edited by Helmut Sies and Lester Packer Volume 348. Protein Sensors and Reactive Oxygen Species (Part B: Thiol Enzymes and Proteins) Edited by Helmut Sies and Lester Packer Volume 349. Superoxide Dismutase Edited by Lester Packer Volume 350. Guide to Yeast Genetics and Molecular and Cell Biology (Part B) Edited by Christine Guthrie and Gerald R. Fink Volume 351. Guide to Yeast Genetics and Molecular and Cell Biology (Part C) Edited by Christine Guthrie and Gerald R. Fink
methods in enzymology
xxxiii
Volume 352. Redox Cell Biology and Genetics (Part A) Edited by Chandan K. Sen and Lester Packer Volume 353. Redox Cell Biology and Genetics (Part B) Edited by Chandan K. Sen and Lester Packer Volume 354. Enzyme Kinetics and Mechanisms (Part F: Detection and Characterization of Enzyme Reaction Intermediates) Edited by Daniel L. Purich Volume 355. Cumulative Subject Index Volumes 321–354 Volume 356. Laser Capture Microscopy and Microdissection Edited by P. Michael Conn Volume 357. Cytochrome P450, Part C Edited by Eric F. Johnson and Michael R. Waterman Volume 358. Bacterial Pathogenesis (Part C: Identification, Regulation, and Function of Virulence Factors) Edited by Virginia L. Clark and Patrik M. Bavoil Volume 359. Nitric Oxide (Part D) Edited by Enrique Cadenas and Lester Packer Volume 360. Biophotonics (Part A) Edited by Gerard Marriott and Ian Parker Volume 361. Biophotonics (Part B) Edited by Gerard Marriott and Ian Parker Volume 362. Recognition of Carbohydrates in Biological Systems (Part A) Edited by Yuan C. Lee and Reiko T. Lee Volume 363. Recognition of Carbohydrates in Biological Systems (Part B) Edited by Yuan C. Lee and Reiko T. Lee Volume 364. Nuclear Receptors Edited by David W. Russell and David J. Mangelsdorf Volume 365. Differentiation of Embryonic Stem Cells Edited by Paul M. Wassauman and Gordon M. Keller Volume 366. Protein Phosphatases Edited by Susanne Klumpp and Josef Krieglstein Volume 367. Liposomes (Part A) Edited by Nejat Du¨ zgu¨ nes, Volume 368. Macromolecular Crystallography (Part C) Edited by Charles W. Carter, Jr., and Robert M. Sweet Volume 369. Combinational Chemistry (Part B) Edited by Guillermo A. Morales and Barry A. Bunin Volume 370. RNA Polymerases and Associated Factors (Part C) Edited by Sankar L. Adhya and Susan Garges
xxxiv
methods in enzymology
Volume 371. RNA Polymerases and Associated Factors (Part D) Edited by Sankar L. Adhya and Susan Garges Volume 372. Liposomes (Part B) Edited by Negat Du¨ zgu¨ nes, Volume 373. Liposomes (Part C) Edited by Negat Du¨ zgu¨ nes, Volume 374. Macromolecular Crystallography (Part D) Edited by Charles W. Carter, Jr., and Robert W. Sweet Volume 375. Chromatin and Chromatin Remodeling Enzymes (Part A) Edited by C. David Allis and Carl Wu Volume 376. Chromatin and Chromatin Remodeling Enzymes (Part B) Edited by C. David Allis and Carl Wu Volume 377. Chromatin and Chromatin Remodeling Enzymes (Part C) Edited by C. David Allis and Carl Wu Volume 378. Quinones and Quinone Enzymes (Part A) Edited by Helmut Sies and Lester Packer Volume 379. Energetics of Biological Macromolecules (Part D) Edited by Jo M. Holt, Michael L. Johnson, and Gary K. Ackers Volume 380. Energetics of Biological Macromolecules (Part E) Edited by Jo M. Holt, Michael L. Johnson, and Gary K. Ackers Volume 381. Oxygen Sensing (in preparation) Edited by Chandan K. Sen and Gregg L. Semenza Volume 382. Quinones and Quinone Enzymes (Part B) (in preparation) Edited by Helmut Sies and Lester Packer Volume 383. Numerical Computer Methods (Part D) (in preparation) Edited by Ludwig Brand and Michael L. Johnson Volume 384. Numerical Computer Methods (Part E) (in preparation) Edited by Ludwig Brand and Michael L. Johnson Volume 385. Imaging in Biological Research (Part A) (in preparation) Edited by P. Michael Conn Volume 386. Imaging in Biological Research (Part B) (in preparation) Edited by P. Michael Conn
[1]
packing improvements within enzymes and receptors
3
[1] Contributions to the Catalytic Efficiency of Enzymes, and the Binding of Ligands to Receptors, from Improvements in Packing within Enzymes and Receptors By Dudley H. Williams, Elaine Stephens, Min Zhou, and Rosa Zerella Introduction
One of the great challenges to twenty-first-century science is to further our understanding of the noncovalent interactions that are responsible for the molecule-to-molecule binding that is the key to biological function. Suppose we were given a picture of a set of noncovalent interactions involved in the association of two entities (e.g., from X-ray crystallography). If we were then able to predict successfully the binding constant (say, to within a factor of 10), we could claim a relatively good understanding of noncovalent interactions. Among such attempts, the approach known as LUDI1a is—given its simplicity—moderately successful. LUDI builds on an equation developed in our own laboratory.2 Its modified version1a is Eq. (1). G ¼ Gtþr þ Gr þ AreaðGh Þ þ Ghb þ Gionic
(1)
In this equation, G is the observed free energy of a bimolecular association. Since G ¼ RT ln K, G determines the binding constant K. Five common parameters (right-hand side of the equation) that are known to be important in binding are considered. It is assumed that their sum will give a useful approximation of G, and hence of K. The first two terms oppose binding. Gtþr is the free energy cost of restricting the overall motion of a ligand when it binds to its receptor. Gr is the free energy cost of restricting an internal rotation of the ligand that is restrained upon binding (summed over all such rotations). Both these terms are essentially adverse entropy terms. The remaining three terms promote binding. Gh is the free energy bene˚ 2 of hydrocarbon surface area from water fit due to the removal of 1 A upon binding (the hydrophobic effect). Gh is therefore multiplied by the 1
(a) H.-J. Bo¨hm, J. Comp. Aided Mol. Des. 8, 243 (1994). (b) H.-J. Bo¨hm, personal communication (2001). 2 D. H. Williams, J. P. L. Cox, A. J. Doig, M. Gardner, U. Gerhard, P. T. Kaye, A. R. Lal, I. A. Nicholls, C. J. Salter, and R. C. Mitchell, J. Am. Chem. Soc. 113, 7020 (1991).
METHODS IN ENZYMOLOGY, VOL. 380
Copyright 2004, Elsevier Inc. All rights reserved. 0076-6879/04 $35.00
4
allosteric enzymes and receptors
[1]
buried surface area for each specified case. Ghb is the free energy benefit of a hydrogen bond in the binding (summed over all such hydrogen bonds). Gionic is the free energy benefit of an ionic bond in the binding site (summed over all such ionic bonds). To ‘‘train’’ the equation, a set of 45 complexes with experimentally known binding constants was used. In these complexes, ligands of relatively small molecular weight (66 to 1047) interact with proteins through sets of known interactions (determined by X-ray crystallography). Since Eq. (1) has only five types of G contributions, and the 45 binding sites involve different combinations of these five types of G contributions, average values for them can be obtained. Using these average values, the equation can then be used to estimate binding constants where ‘‘pictures’’ of binding sites are available. The equation is remarkably successful, for in a limited data set (but one that includes compounds outside the training set) it is able to predict binding constants with a standard deviation of only log10 1.7.1a However, in a wider data set, it performs less well.1b Estimated binding constants can be in error by a factor of 1000, or more. Partly this is because other important terms (e.g., other favorable terms such as – stacking) are neglected. Partly, it is because cooperativity is neglected. Some physical consequences of cooperative binding are the subject of this chapter. Cooperativity
Cooperativity is the phenomenon through which one set of binding interactions can change the binding energy of another. Equation (1) ignores such cooperativity. However, Eq. (1) shows that sets of interactions acting simultaneously can give more binding energy than the sum of the sets when occurring separately. This point can be understood by reference to Fig. 1A and B. Suppose that Z can make interactions to its receptor cup that promote binding by a factor of 103 M1. Let the cost of restricting the motion of Z into its receptor cup (Gtþr) oppose binding by a factor of 102 M1. The binding constant of Z to the receptor would therefore be 101 M1. Let Y, when bound alone, interact with the same parameters into its (central) receptor cup. The binding constant of Y to its receptor cup would therefore also be 101 M1. Equation (1) tells us that it would be false to conclude that X–Y (Fig. 1B, where X and Y are connected with a strain-free connection, allowing both groups to bind in the geometry as when binding separately) would exhibit a binding constant of 101 101 ¼ 102 M1 (the sum of the parts). Equation (1) assumes that the cost of a bimolecular association (Gtþr) has to be paid only once.2 Therefore, the estimated binding constant of X–Y to the receptor is 103 103/102 M1 ¼ 104 M1 (greater than the sum of the parts).
[1]
packing improvements within enzymes and receptors
5
Fig. 1. Schematic representation of a receptor that binds ligands X, Y, and Z. (A) Binding of Z results in a structure with intermolecular distance d0. (B) When Y and Z are connected by a rigid, strain-free linker (Y–Z), if they bind the receptor without positive cooperativity, then d0 ¼ d1. If they bind with positive cooperativity, there is structural tightening (d1 < d0). (C) If X is connected to Y–Z by a rigid, strain-free linker to form X–Y–Z then positively cooperative will cause further structural tightening (d2 < d1). (D) The shorter linker between Y and Z does not allow both these binding interactions to occur with optimal geometries. Y–Z binds the receptor with negative cooperativity, and there is structural loosening (d3 > d0).
The assumption of a useful average Gtþr term in Eq. (1) is an Achilles heel of the approach. It implies that all ligands are restricted in motion to the same, or similar, extents. That is, that the degree to which Z is restrained in Fig. 1A is essentially the same as the degree to which Z is restrained in Fig. 1B, i.e., d0 ¼ d1. However, the free energy cost Gtþr is not a standard cost that is paid for any bimolecular association. Rather, the cost becomes greater as the motions of a ligand relative to its receptor become more restricted by stronger bonds (bonds that are formed with a greater exothermicity).3 Awareness of the above fact points to a problem for any approach to the estimation of binding constants that treats individual interactions as though (when formed with the same geometry) they have usefully constant 3
M. S. Westwell, M. S. Searle, J. Klein, and D. H. Williams, J. Phys. Chem. 100, 16000 (1996).
6
allosteric enzymes and receptors
[1]
free energy benefits [e.g., for terms 4 and 5 in Eq. (1)]. It is motion that opposes bonding. In light of this observation, reconsider cases where a number of noncovalent interactions can be simultaneously made in a strain-free manner to promote the ligand/receptor binding (Fig. 1). The motions about a specified noncovalent interaction (Fig. 1A) will typically become more restricted as the ligand is held in place by more adjacent noncovalent bonds (Fig. 1A ! Fig. 1B ! Fig. 1C). The specified interaction (Fig. 1A) then forms with a more favorable enthalpy (i.e., it is associated with better bonding), but with an increased cost in entropy (a greater restriction in motion). Each of the three noncovalent interactions made by X, Y, and Z to a receptor give rise to better bonding when they are made simultaneously rather than separately. Evidence for the effects modeled in Fig. 1A–C is available from proton nuclear magnetic resonance (NMR) experiments carried out on the binding of ligands to glycopeptide antibiotics,4 and is detailed in the following section. Positively Cooperative Binding Probed by NMR Spectroscopy Several peptide ligands, all containing the carboxyl group depicted at the lower right in Fig. 2, were separately bound to the antibiotics. In all cases, a downfield chemical shift of the antibiotic amide NH proton w2 was observed upon ligand binding. A larger limiting downfield shift of w2 indicates a shorter carboxylate to NH hydrogen bond. This hydrogen bond was found to decrease in length as the number of the adjacent hydrogen bonds that aid ligand binding was increased. The motional restriction of the carboxylate group afforded by these additional hydrogen bonds shortens the hydrogen bonds directly made to the carboxylate.4 Analogous effects have been observed at other interfaces.5 Although the above experiments establish the shortening of noncovalent bonds as a consequence of positive cooperativity, they do not prove that the noncovalent bonds are thereby improved in terms of their free energy benefit. The proof that the benefit in improved bonding (increased exothermicity) outweighs the cost in entropy (more restricted motion) is seen in cases in which two interfaces made simultaneously give a larger free energy of association than the sum of their parts. Dimers of glycopeptide antibiotics of the vancomycin group are further stabilized when they bind two molecules of the bacterial cell wall analogues (Fig. 3). The dimeric system is stabilized by the ligand binding, with attendant distance 4
M. S. Searle, G. J. Sharman, P. Groves, B. Benhamu, D. A. Beauregard, M. S. Westwell, R. J. Dancer, A. J. Maguire, A. C. Try, and D. H. Williams, J. Chem. Soc. Perkin Trans. 1 2781 (1996). 5 C. T. Calderone and D. H. Williams, J. Am. Chem. Soc. 123, 6262 (2001).
[1]
packing improvements within enzymes and receptors
7
Fig. 2. Exploded view of the binding interaction between the glycopeptide antibiotics (in this case vancomycin) and the peptide ligand N--acetyl-Lys-(N-e-acetyl)-d-Ala-d-Ala. Hydrogen bonds between the two are indicated by dotted lines. The binding is also promoted by hydrophobic interactions, notably of the Ala methyl groups to the aromatic rings of the antibiotic. The amide NH proton W2, mentioned in the text, is labeled.
reductions at the dimer interface.6 In nine of nine cases, the positive cooperativity is associated with a benefit in enthalpy; in eight of nine cases, it is associated with a cost in entropy.7,8 There are large numbers of papers9–12 that report changes in receptor structures upon ligand binding, and clear indications that the receptor can in some cases be stabilized. The antibiotic work indicates some specific correlations that increase our understanding: 6
D. H. Williams, A. J. Maguire, W. Tsuzuki, and M. S. Westwell, Science 280, 711 (1998). D. McPhail and A. Cooper, J. Chem. Soc. Faraday Trans. 93, 2283 (1997). 8 D. H. Williams, C. T. Calderone, and D. P. O’Brien, J. Chem. Soc. Chem. Commun. 1266 (2002). 7
8
allosteric enzymes and receptors
[1]
Fig. 3. Peptide backbone of a glycopeptide antibiotic dimer, simultaneously bound to two molecules of a bacterial cell peptide precursor analogue (N-Ac-d-Ala-d-Ala). The binding of the N-Ac-d-Ala-d-Ala occurs with positive cooperativity, such that the dimer system is stabilized and shortens some of the distances at the central (dimer) interface, with an overall benefit in enthalpy and a cost in entropy.
9
M. Gonzalez, L. A. Bagatolli, I. Echabe, J. L. R. Arrondo, C. E. Argarana, C. R. Cantor, and G. D. Fidelio, J. Biol. Chem. 272, 11288 (1997). 10 D. C. Williams, D. C. Benjamin, R. J. Poljak, and G. S. Rule, J. Mol. Biol. 257, 866 (1996). 11 E. Freire, Proc. Natl. Acad. Sci. USA 96, 10118 (1999). 12 B. A. Johnson, E. M. Wilson, Y. Li, D. E. Moller, R. G. Smith, and G. Zhou, J. Mol. Biol. 298, 187 (2000).
[1]
packing improvements within enzymes and receptors
9
1. The dimeric nature of the receptor system allows the conclusion that tightening (shorter interfacial distances without geometric distortion) of an internal interface of the receptor induces increased stability of the receptor system. 2. The increased stability associated with the positive cooperativity is characterized by increased exothermicity and a cost in entropy. 3. A thermodynamic cycle establishes that increased stability of the receptor system when the ligand is bound necessarily leads to increased ligand-binding energy.13 Binding to Protein Receptors and the Use of Mass Spectrometry
From the above experiments, we can conclude that where the structure of a receptor undergoes tightening (reduced internal noncovalent distances) upon ligand binding, ligand binding is thereby enhanced. The properties of positively cooperative binding found above for a receptor dimer interface (Fig. 3) are equally applicable when the dimer interface is replaced by an interface that is within a monomeric receptor (Fig. 4). In each panel of Fig. 4, the ligand is represented as the upper molecule (a dipeptide) and the receptor as the lower structure (with illustration of only one set of its internal noncovalent interactions, in the form of two amide–amide hydrogen bonds). The tightening of noncovalent interactions (with exaggerated changes in bond lengths to illustrate the principle) occurs in Fig. 4B, where there is positively cooperative binding of ligand that is absent in Fig. 4A. Thus, in Fig. 4A and B, the proven reductions in dimer interfacial bond distances upon ligand binding with positive cooperativity are extrapolated to the monomeric receptor case. The physical basis for the tightening is that the matching fit of the ligand to the exposed binding site of the receptor causes, through the formation of the ligand/ receptor noncovalent bonds, a reduction on the motions of the exposed part of the receptor (here a peptide backbone). Since it is motion that opposes bonding, such reductions in motion will be accompanied by bond shortening within the receptor (Fig. 4A ! B). Since the internal tightening of receptor structures upon positively cooperative ligand binding reduces their dynamic behavior, the extent to which such tightened receptor structures undergo NH ! ND exchange of their backbone amide NHs upon exposure to D2O will be decreased. Such changes in exchange behavior can be conveniently monitored by mass spectrometry.14–16 A typical protocol, used to monitor H/D exchange in our laboratory, follows. 13
B. Bardsley and D. H. Williams, J. Chem. Soc. Chem. Commun. 2305 (1998).
10
allosteric enzymes and receptors
[1]
Fig. 4. Schematic representation of a ligand (upper peptide backbone) binding to a receptor (below) (A) in the absence of cooperativity, (B) with positive cooperativity, (C) with negative cooperativity prior to enthalpy/entropy compensation, and (D) with negative
[1]
packing improvements within enzymes and receptors
11
An H/D Exchange Protocol H/D exchange is typically initiated by dilution of 10 l of a 3 mM solution of a receptor protein in 100 mM ammonium acetate buffer (pH 8.0) into 90 l of 99.9 atom% excess D2O. The complex of the receptor protein with the appropriate ligand is formed by incubation of 0.3–3 mM receptor with a 10–20% molar excess of ligand at room temperature for greater than 1 h prior to dilution into D2O. Solutions are maintained at room temperature for H/D exchange and allowed to exchange for the desired times. At appropriate intervals, 5-l aliquots of the receptor solution are adjusted to pH 2.5 by the addition of 30 l of chilled acidic quench solution. These aliquots are immediately cooled to 0 . The use of relatively acidic conditions and low temperatures at this stage minimizes the extent of ND ! NH back exchange. A-10 l aliquot is then loop injected for electrospray ionization mass spectrometry (ESI-MS) to determine the deuterium content of the receptor system, both in the presence and absence of ligand. Locating the Regions of Structural Tightening in Receptors The above procedure may indicate the tightening of a receptor system upon ligand binding and therefore indicates that the ligand-binding energy can be enhanced in this way. This was the case found in our laboratory for the binding of biotin to streptavidin.17 Specifically, 22 backbone amide NH protons per streptavidin are protected from H/D exchange upon biotin binding. Thus, tightening of the streptavidin structure upon the binding of biotin contributes to the binding affinity of biotin. Since the binding of biotin occurs to a streptavidin tetramer (which accommodates four molecules of biotin), it is important to determine where the tightening of the streptavidin tetramer occurs. To determine where in the receptor system the structural tightening occurs, enzymatic digestion of the receptor is carried out. This can be achieved by two experiments involving pepsin digestion—of both the ligand-free and ligand-bound receptor. Pepsin 14
V. Katta and B. T. Chait, J. Am. Chem. Soc. 115, 6317 (1993). (a) Z. Zhang and D. L. Smith, Protein Sci. 2, 522 (1993). (b) D. L. Smith, Y. Deng, and Z. Zhang, J. Mass Spectrom. 32, 135 (1997). 16 F. Wang, R. W. Miles, G. Kicsa, E. Nieves, V. L. Schramm, and R. H. Angeletti, Protein Sci. 9, 1660 (2000). 17 D. H. Williams, E. Stephens, and M. Zhou, J. Mol. Biol. 329, 389 (2003). 15
cooperativity after enthalpy/entropy compensation. Where the tightened (B), or loosened (D), interactions are coupled to other interactions within the receptor system, they will be similarly affected.
12
allosteric enzymes and receptors
[1]
digestion is used because this enzyme can function at pH 2.5—the pH at which back exchange of amide backbone ND ! NH is minimized. The peptide fragments derived from the receptor in both experiments are then analyzed by liquid chromatography (LC)-ESI-MS. The relative deuterium contents of each set are determined from their molecular weights (in comparison with those of the corresponding peptides obtained in the absence of H/D exchange). The amino acid sequence of the receptor is of course typically known. Therefore, the structures of the peptides produced by pepsin digestion can be determined from their molecular weights, in combination with some sequence information derived from their collision-induced fragmentation. A protocol for achieving such digestion, and analyzing the products, follows. Previously published protocols are available.15,16 The following protocol was used to show that the peptide backbone NHs that are protected upon the binding of biotin to streptavidin are widely distributed through the streptavidin.17 Thus the binding energy for biotin to streptavidin is widely delocalized. A Protocol for Pepsin Digestion and Analysis of the Digest (Used in the Case of Streptavidin as the Receptor) Pepsin digestions can be performed on-line by linking a digestion cartridge made by packing a microbore guard column (1 20 mm) (Upchurch Scientific) with pepsin Porozyme media (Applied Biosystems) to a Rheodyne 7010 injector coupled with LC-MS. The protein solution, quenched to pH 2.5, is injected into the pepsin cartridge and the protein is digested for 3 min at 0 . The resulting peptide mixture is then infused at 100 l 1 min through a C18 reverse-phase peptide trap for 2 min, using ice-cold buffer (10 mM ammonium acetate, 2% acetic acid, pH 2.9). When the injector is switched to inject mode, the peptide trap is subsequently placed in-line with the LC column (PepMap C18, 300 m 5 cm; LC-Packings, Dionex) and peptides are eluted with increasing organic concentration. An LC-Packings Ultimate capillary high-performance liquid chromatography (HPLC) (Dionex) can be used to generate the gradient (flow rate 4 l min1), e.g., solvent A 0.1% formic acid in H2O and solvent B 90% acetonitrile containing 9.95% H2O and 0.05% formic acid. The peptic peptides eluted between 3.5 and 9 min with a 5-min 20–50% B gradient, at which time the gradient is held at 50% B for 10 min. The column effluent is delivered directly to a nanoflow ESI probe held at 3 kV. For all experiments, the solvents, Rheodyne injectors, peptide trap, and HPLC column are all immersed in an ice bath (0 ) to minimize back exchange with solvents. To account for deuterium gain or loss under quenched conditions,
[1]
packing improvements within enzymes and receptors
13
two control samples are prepared. A ‘‘zero deuteration’’ control is prepared by diluting the protein solution directly into a 1:1 (v:v) mixture of deuterated buffer and quench buffer. A ‘‘full-deuteration’’ control is pre pared by incubating streptavidin in 8 M urea-d4 in D2O at 55 for 2 h. Using the above protocol, the extent of deuterium loss in the peptic peptides was ca. 30–50%, consistent with previous reports.16 The deuterium content of each peptide can be calculated after correction for back exchange, as described previously.15 Identification of Peptides from Pepsin Digestion Peptides can be sequenced by LC-MS/MS following pepsin proteolysis under conditions identical to those used for the deuterium exchange experiments, except that D2O is omitted. Switching between MS and MS/MS can be achieved with automatic switching triggered by the detection of specific peptide ions entered into Masslynx software as a peak list. Argon is used as the collision gas and collision energies from 32 to 35 eV are typically applied. Evidence that Enzymes Derive Catalytic Efficiency by Tightening Their Structures to the Greatest Degree in the Transition State
The concept that when a small molecule (L) binds to a protein (P), binding energy of L to P is derived by tightening (contracting) the structure of P, has potential implications for enzyme catalysis. If enzymes exploit this effect to derive binding energy of the substrate and product, then the enzyme structure should be contracted when substrate and product are bound. However, if enzymes exploit this effect to increase catalytic efficiency, then enzyme structures should be contracted to the greatest extent in the transition state for reaction. This last point follows since, for efficient catalysis, the free energy of the substrate transition state–enzyme system must be lowered to the greatest degree. Thermodynamic Evidence for Better Packing of Enzymes in the Transition States A reaction [S ! P, Eq. (2)] catalyzed by an enzyme (E) benefits, relative to the reaction in free solution, because the adverse entropy of the reaction in free solution is reduced by the preorganization of the catalytic groups in relation to the substrate (S).18 Catalysis will also be promoted 18
A. Fersht, ‘‘Structure and Mechanism in Protein Science,’’ p. 362. W. H. Freeman and Co., New York, 1999.
14
allosteric enzymes and receptors
[1]
if the enzyme binds the transition state (S#) for reaction with positive cooperativity. According to the model presented here, such positively cooperative binding will give a benefit in enthalpy and a cost in entropy due to better packing within the enzyme structure in the transition state [E S#, Eq. (2)]. The prediction is therefore that this latter cost in entropy will offset the advantage of the preorganization, but that a large benefit in enthalpy should be apparent in enzyme catalysis. E þ S ! E S ! E S# ! E P ! E þ P
(2)
The extent to which enzyme catalysis is provided by any overall improvement in bonding (H#) is available from the difference between the enthalpy of activation for the enzyme-catalyzed reaction (H#cat) and for the spontaneous reaction in the absence of enzyme (H#non). The cost or benefit to catalysis in terms of an overall change in order (TS#) is available from the difference of the parameters TS#cat and TS#non for the same two processes. These differences are available for the reaction catalyzed by cytidine deaminase.19 The effect of enzyme catalysis is to increase the reaction rate by 1016 M1, due to a benefit in enthalpy (H#) of 84 kJ mol1, and a benefit in entropy (TS#) of only 7 kJ mol1. From the Boltzmann equation, 5.7 kJ mol1 benefits a reaction rate at room temperature by a factor of 101. Thus, the benefit of improved bonding to the enzyme-catalyzed reaction is a factor of ca. 1015, whereas the benefit due to improved order is only a factor of ca. 101. The very large overall improvement in bonding in the transition state of the enzymecatalyzed reaction is consistent with catalysis being derived to a major extent by a tightening of the enzyme structure, induced by the transition state of the substrate. The above data are therefore interpreted to reflect to an important degree the increased bonding within the enzyme on passing from its free to transition-state–bound form. The expectation is that much of this increased bonding within the enzyme will be derived on passing from the enzyme/substrate complex to the form that is bound by the transition state of the substrate. This is because enzymes have evolved to bind the transition states (S#) of substrates more strongly than the substrates themselves. One way to effect this is through a greater degree of tightening of the enzyme upon binding the substrate transition state than upon binding the substrate. The enthalpic (bonding) component of this difference for cytidine deaminase19 is 30 kJ mol1, which establishes that there is an overall increase in bonding as the reaction proceeds from the enzyme-bound 19
M. J. Snider, S. Gaunitz, C. Ridgeway, S. A. Short, and R. Wolfenden, Biochemistry 39, 9746 (2000).
[1]
packing improvements within enzymes and receptors
15
ground state to the transition state. The data are consistent with an improvement in bonding within the enzyme during this transformation. The efficiency of enzyme catalysis can be measure in terms of the rate ratio of the enzyme-catalyzed and non-catalyzed reactions (kcat/knon). The enthalpic (bonding) component of this difference has been measured by Wolfenden and co-workers20,21 for reactions catalyzed by six enzymes. The work establishes that these reactions are accelerated largely as a result of a more favorable enthalpy of activation (in comparison to the reaction in free solution). These contributions are 33 (chorismate dismutase), 66 (chymotrypsin), 63 (staphylococcal nuclease), 80 (bacterial -glucosidase), 93 (urease), and 143 (yeast OMP decarboxylase) kJ mol1. Since these differences are derived by comparison of reactions that both involve the transition state of the substrate, they must largely reflect bonding changes in the surroundings of this transition state structure. They give rise, when considered in isolation from other variables, to rate enhancements of ca. 106, 1012, 1011, 1014, 1016, and 1025 s1, respectively. These enthalpy changes are so large that widespread improvements in bonding in the enzyme structures, induced by the transition state of the substrate, offer a probable explanation. Evidence for Better Packing and Reduced Dynamic Behavior from Backbone Amide NH ! ND Exchange Although there is evidence in the literature that some enzymes become better packed in the transition state for reaction, the point that this must improve catalytic efficiency has not been made clear. The key data come from experiments carried out by Wang et al.16,22 Hydrogen/deuterium (H/D) exchange into backbone amide bonds in hypoxanthine-guanine phosphoribosyltransferase (HGPRT)22 and purine nucleoside phosphorylase16 was used to compare the dynamic properties of the enzymes alone, in forms with bound reactant/product, and in forms with bound transition-state analogues. For both enzymes, it was found that the rate and extent of deuterium incorporation decreased when the reactant/product was bound, and decreased to an even greater extent when the transition state analogue was bound. Thus, the greatest reduction in dynamic motion of the enzymes is caused by the transition state analogue. The effects are large: the binding of the transition state analogue protects 34 peptide backbone NHs from exchange in the case of HGPRT, and 27 peptide backbone 20
A. Radzicka and R. Wolfenden, Science 267, 90 (1995). R. Wolfenden, M. Snider, C. Ridgway, and B. Miller, J. Am. Chem. Soc. 121, 7419 (1999). 22 F. Wang, W. Shi, E. Nieves, R. H. Angeletti, V. L. Schramm, and C. Grubmeyer, Biochemistry 40, 8043 (2001). 21
16
allosteric enzymes and receptors
[1]
NHs are similarly protected in the case of purine nucleoside phosphorylase. The reduced dynamic behavior of the enzymes goes hand in hand with improved noncovalent bonding within them. Our proposals indicate that for both enzymes binding energy is provided for the reactant/product through the enzymes becoming better packed. More importantly, even greater binding energy is provided for the transition state analogue when the enzyme packing is further improved. Negatively Cooperative Binding of Ligands and Structural Loosening in Receptors
So far, we have presented the case that positively cooperative binding can cause the tightening of noncovalently bonded structures. Negatively cooperative binding is the converse of positively cooperative binding. Therefore, it should be associated with converse properties, i.e., a reduction of the noncovalent bonding efficiency within the receptor system, and an increase in its dynamic behavior. These consequences of negatively cooperative binding should occur with a cost in enthalpy and a benefit in entropy. The physical model for an increase in receptor dynamics upon the exercise of negative cooperativity involves arguing via two hypothetically separated steps. The first step is that the ligand binds by making noncovalent bonds to the receptor whose formation demands distortion of the noncovalent bonds that previously existed within the receptor. That is, making simultaneously the two sets of bonds in the preferred geometry that would occur if each set were made alone is not possible. Thus, the making of the ligand/receptor bonds decreases the bonding efficiency of the noncovalent bonds within the receptor (Fig. 4C)—there has been a cost in enthalpy. In the second step, we consider the dynamic consequence of this cost in enthalpy. The decrease in bonding within the receptor will result in an increase in its dynamic behavior, which will in turn cause a further cost in enthalpy (Fig. 4C ! D). We were encouraged that the model might have general applicability by a study of changes in the properties of tetrameric recombinant human tyrosine hydroxylase isoform 1 upon binding the natural cofactor (6R)-l-erythro5,6,7,8-tetrahydrobioptrin.23 The binding of the cofactor occurs with negative cooperativity, and this cofactor-bound form of the enzyme then shows a decreased resistance to limited tryptic proteolysis—as would be expected from a loosening of the enzyme structure. 23
T. Flatmark, B. Almas, P. M. Knappskog, S. V. Berge, R. M. Svebak, R. Chehin, A. Muga, and A. Martinez, Eur. J. Biochem. 262, 840 (1999).
[1]
packing improvements within enzymes and receptors
17
Test of the Model for Negatively Cooperative Binding The classic work of Monod, Wyman, and Changeux (MWC) showed that the binding of O2 to a ‘‘tense’’ form (T, populated before O2 binding) of the hemoglobin tetramer could force the T form toward a ‘‘relaxed’’ (R) form (Fig. 5).24 We note that in the MWC model, the O2 binding is defined as positively cooperative because much of the work required for the T ! R conversion is effected by the first O2 to bind. Therefore, subsequently binding O2 molecules have the advantage of accessing a relatively high population of the R state, and bind with greater affinity.25 In summary, the behavior is described as positively cooperative because the later-filled sites have affinities greater than the site that is preferentially filled first. However, in terms of the definition used here, there is negatively cooperative binding between the interface that O2 can most favorably form to hemoglobin and the one that is presented by the available T state. The optimal binding of O2 is incompatible with the geometry existing in the T state. The receptor is therefore forced to a modified geometry
Fig. 5. MWC model for the binding of the first molecule of ligand (L) to a tetrameric protein existing in tense (T) and relaxed (R) forms.
24 25
J. Monod, J. Wyman, and J.-P. Changeux, J. Mol. Biol. 12, 88 (1965). See, for example, A. Fersht, ‘‘Structure and Mechanism in Protein Science,’’ p. 292. W. H. Freeman and Co., New York, 1999.
18
allosteric enzymes and receptors
[1]
when O2 is bound, and this modified geometry is that existing in the R state. The negatively cooperative binding does indeed force a loosening of the T state of the tetramer, through the breaking of intersubunit salt bridges.26 However, and more importantly, widespread structural changes in the T to R transition seem possible. All noncovalent interactions within a receptor system that are coupled with negative cooperativity to ligand binding should loosen. To test this conclusion we determined27 by ESI-MS the change in dynamic behavior of the hemoglobin tetramer polypeptide backbone when it binds O2. Through the binding of oxygen, a further seven or eight exchangeable amide hydrogens per -chain (5.2–6% of the total number) and a further 16 per -chain (11.4% of the total number) were exposed to solvent exchange. Thus, since there are two -chains and two -chains per hemoglobin tetramer, complete saturation of the hemoglobin tetramer by O2 binding results in an increase of 46–48 in the number of backbone NHs undergoing exchange. The dramatic increase in amide NH exchange is in agreement with the predictions regarding the changes associated with negatively cooperative binding. These increases in dynamic behavior of the amide backbones of the hemoglobin subunits are not evident from previous X-ray studies.26 Presumably, the changes in dynamic behavior, which are important for an understanding of binding interactions, are masked by crystal packing forces. The requirement that negative cooperativity, as exercised in this system, should be accompanied by enthalpy/entropy compensation (in the sense of a benefit in entropy, and a cost in enthalpy—see earlier) is also satisfied. Thus, as O2 binding promotes the T to R transition, there should be an uptake of heat by, and increase in disorder within, the hemoglobin tetramer. In the case of trout hemoglobin,28 starting from the T state, O2 binding occurs with an exothermicity very near to zero, and a favorable TS term of þ21 kJ mol1. In contrast, O2 binding to the R state is exothermic (H ¼ 32 kJ mol1) and slightly unfavorable in entropy (TS ¼ 3 kJ mol1). The difference in the two sets of thermodynamic data reflects the way in which O2 binding promotes the disordering of the T state tetramer toward the R state tetramer. All the properties demanded by the model for negatively cooperative binding are fulfilled.
26
M. F. Perutz, A. J. Wilkinson, M. Paoli, and G. G. Dodson, Annu. Rev. Biophys. Biomol. Struc. 27, 1 (1998). 27 M. Zhou, Certificate of Post Graduate Study, University of Cambridge, June 2002. 28 A. Colosimo, M. Coletta, G. Falcioni, B. Giardina, S. J. Gill, and M. Brunori, J. Mol. Biol. 160, 531 (1982).
[1]
packing improvements within enzymes and receptors
19
Conclusion
Furthering our understanding of the noncovalent interactions that provide the binding energies involved in protein folding, the binding of ligands to receptors, and the binding of transition states to enzymes, is an important goal. In simple systems (glycopeptide antibiotics), NMR chemical shift changes (in conjunction with thermodynamic cycles) show that a receptor system provides ligand binding energy when the receptor system becomes more compact upon ligand binding. This ‘‘tightening’’ of the receptor system is a manifestation of positively cooperative binding. It is accompanied by a favorable contribution to the change in enthalpy, and an unfavorable contribution to the change in entropy. Electrospray mass spectrometry (ESI-MS) shows that a high-affinity receptor (streptavidin) tightens its structure upon binding biotin; the binding affinity of biotin is thereby increased. Where investigated, enzymes show analogous marked tightening of their structures (manifested by reduced dynamic behavior) in the transition state for reaction. This tightening of the enzyme structure therefore improves the catalytic efficiency of the enzymes. Where data are available, thermodynamic parameters for catalysis are consistent with this conclusion. Thus, it appears that catalysis is promoted through marked (and relatively widespread) improvements in noncovalent bonding in the transition state system. In this conclusion (the delocalization of binding energy), we can see why enzymes are relatively large. Negatively cooperative binding should exhibit the converse properties of structural loosening, more dynamic behavior, an unfavorable contribution to the change in enthalpy, and a favorable contribution to the change in entropy. These properties are exhibited when O2 binds with negative cooperativity to the T form of hemoglobin. Acknowledgments We thank EPSRC (R.Z.), BBSRC (E.S.), and Churchill College, Cambridge (M.Z.) for financial support.
20
[2]
allosteric enzymes and receptors
[2] Structural Interpretation of pH and Salt-Dependent Processes in Proteins with Computational Methods By Bertrand Garcı´a-Moreno E. and Carolyn A. Fitch Introduction
It is widely recognized that electrostatics plays a significant role in modulating the structure, the stability, and the function of proteins. The study of protein electrostatics continues to be of interest because they are of paramount biological importance—most biochemical processes are governed by electrostatics. One unique and particularly attractive feature of the problem of protein electrostatics is the dual possibility of measuring electrostatic contributions to an equilibrium process experimentally, and of calculating these contributions with structure-based computational methods based on realistic physical models. Another unique feature is that it is possible to dissect global electrostatic contributions experimentally into contributions by individual ionizable groups. This ability to interpret physical and structural origins of measured electrostatic energies in microscopic detail is inaccessible to any other type of noncovalent contribution to function. The most direct and exact connection that can be established between structure, function, and energy of proteins is through structure-based calculations of electrostatic energy.1 Electrostatic energies are central to the correlation of structure and function of proteins. Key biochemical processes of living systems are governed by electrostatics. Examples include the following: 1. The capture of photons (e.g., reaction centers) and their transduction into proton (Hþ) gradients (e.g., bacteriorhodopsin) or mechanical energy (e.g., photoactive yellow protein). 2. The conversion of Hþ gradients into high-energy bonds (e.g., ATPase) or into mechanical energy (e.g., flagellar motors). 3. The establishment and maintenance of ion gradients (e.g., Kþ and Cl channels). 4. e conduction (e.g., light harvesting complexes) and redox chemistry (e.g., all redox centers). 5. Role of Ca2þ as a secondary messenger (e.g., calmodulin). 6. Catalysis (e.g., all enzymes).
1
A. Warshel and M. Levitt, J. Mol. Biol. 103, 227 (1976).
METHODS IN ENZYMOLOGY, VOL. 380
Copyright 2004, Elsevier Inc. All rights reserved. 0076-6879/04 $35.00
[2]
electrostatic calculations with proteins
21
7. Recognition (e.g., proteins in their interactions with nucleic acids) and binding (e.g., most associating systems). Electrostatics also modulates important physicochemical properties of proteins, such as solubility, stability, and dynamics. It governs conformational transitions of proteins that are triggered physiologically by changes in pH and in the ionic composition. This includes (1) the allosteric transitions that regulate the affinity of human hemoglobin for oxygen, (2) the assembly, disassembly, and activation of viruses, (3) the activation of bacterial toxins such as the diphtheria toxin, and (4) the energetics of aggregation in many systems, including amyloidogenesis. In all of these cases it is impossible to understand the structural basis of function without quantitative understanding of the contributions made by electrostatics. Although high-resolution structures are available for many examples of proteins involved in the processes listed above, the electrostatic contributions to function and energetics remain poorly understood. The gap between structure and function cannot be bridged without quantitative understanding of the reciprocal relationship between structure and energy. This is possible for processes governed by electrostatics, and it involves the interplay between experimental measurement of electrostatic energies and structure-based calculations to understand their microscopic, physical origins. Specifically, to connect structure with function in depth in processes governed by electrostatics, it is necessary to know the pKa values or the redox potentials that describe the affinities for Hþ and e, respectively. pKa values and redox potentials can be measured experimentally with very high accuracy and precision in some proteins. They can also be calculated from structure with models based on physical principles. The ultimate goal of a study of electrostatic contributions to protein structure and function is to determine the pKa values or redox potentials, to understand their molecular determinants, and to understand how the values are linked to the conformation and dynamics of a protein. Computational methods for structure-based calculation of electrostatic energies are necessary in the analysis of structure–function relationship for other reasons. Experiments can carry the dissection of the electrostatic contributions to an equilibrium process only so far. Beyond a certain point, structure-based calculations are needed to interpret the structural origins of the measured energetics in detail. Calculations also provide specific, testable hypotheses. An even more important role of computational methods is to provide structural insight in cases in which experimental measurements are not possible. This is the situation, for example, with the integral membrane proteins that are involved in energy transduction modulated by electrostatics, such as bacteriorhodopsin, the photoreaction center,
22
allosteric enzymes and receptors
[2]
ATPase, cytochrome oxidase, etc. The experimental methods for measurement of pKa values or stability in water-soluble proteins cannot be applied to these membrane proteins. In these cases, a theory that has been calibrated carefully against experimental data with other simpler proteins can be used to elucidate relationships between structure, energy, and function. This chapter reviews some aspects of the theory and models available for calculation of electrostatic energies and pKa values in proteins. The emphasis is on the calculation of pKa values and Hþ binding/release reactions because it is a more general and common problem than the calculation of redox potentials and e affinities (the calculations of pKa values and of redox potentials are analogous). We emphasize from the outset that despite the widespread dissemination and popularity of several sophisticated algorithms for structure-based electrostatic calculations, the calculation of thermodynamic parameters from structure remains a difficult and daunting proposition. The accuracy of the available methods is sufficient to allow calculation of some thermodynamic quantities, but not all. In this chapter we describe the types of analyses of electrostatic effects in proteins that are possible with judicious application of structure-based calculations in concert with experimental studies. Examples are given of the type of insight about the character of electrostatic effects in proteins that has emerged recently from the joint application of calculations and experiments. Problems that currently limit the reliability of these computational methods are also discussed. Experimental Measurement of Hþ and Salt-Linked Thermodynamics
An excellent and extensive monograph on the thermodynamic concepts germane to the analysis of pH and salt-dependent equilibria of proteins is available.2 Here we provide a brief outline of the nature of thermodynamic information that must be obtained to elucidate electrostatic contributions to stability and function. The experimental dissection of electrostatic contributions to an equilibrium process begins with the study of salt and pH effects. The macromolecular equilibrium reaction A $ B will be pH dependent if protons (Hþ) are bound or released upon conversion of A to B. If, for example, Hþ are bound preferentially by B, then the conversion of A to B will be promoted by low pH. Preferential Hþ binding by one of the states is determined by the pKa values of ionizable residues. The pKa values are influenced by a large variety of molecular factors, including interactions with other 2
M. Schaefer, H. W. van Vlijmen, and M. Karplus, Adv. Protein Chem. 51, 1 (1998).
[2]
electrostatic calculations with proteins
23
charges, with polar atoms, with polarizable atoms, and with water molecules. In the structural analysis of pH and salt-dependent processes of proteins it is necessary to understand the molecular determinants of pKa values. It is virtually impossible to isolate these factors experimentally. This can be done only with structure-based pKa calculations. Electrolyte ions can interact with the charged and polar atoms of proteins; therefore they also modulate electrostatic effects and pKa values. For example, the energy of coulombic interactions between pairs of charges will decrease with increasing salt concentration because ions can screen charges effectively. Thus the salt dependence of the equilibrium can be used as a diagnostic, to identify certain types of electrostatic contributions to pKa values and to equilibrium processes in general. However, as discussed later, it has become increasingly clear that some of the early ideas about the origins of the salt sensitivity of equilibrium constants and their utility as a diagnostic for identifying electrostatic contributions to an equilibrium process must be revised. Effects of Salts and pH on Phenomenological Equilibrium Constants The analysis of the effects of pH on experimental equilibrium constants is performed with Wyman’s linkage relationships. The number of Hþ that are bound or released during an equilibrium process, Hþ, can be obtained from the slope of the pH dependence of the equilibrium constant3,4: d ln Keq ¼ Hþ d ln Hþ
(1)
Another way of obtaining the net differential Hþ binding is by direct measurements with potentiometric methods.5 For example, in the case of protein folding, Hþ refers to the moles of Hþ bound preferentially to either the native (N) or the unfolded (U) states. Hþ can also be obtained by using Eq. (1) to analyze the pH dependence of stability measured by chemical denaturation data assuming a two-state model N $ U. Hþ can also be obtained as the difference between Hþ binding curves measured separately for the N and for the U states with potentiometric methods.5 The effects of salt on equilibrium processes are considerably more difficult to interpret. Note that in the case of pH effects, the Hþ obtained 3
J. Wyman and S. J. Gill, ‘‘Binding and Linkage.’’ University Science Books, Mill Valley, CA, 1990. 4 C. Tanford, J. Mol. Biol. 39, 539 (1969). 5 S. T. Whitten and B. Garcı´a-Moreno E., Biochemistry 39, 14292 (2000).
24
allosteric enzymes and receptors
[2]
with Eq. (1) can be interpreted unequivocally in terms of preferential Hþ binding because Hþ interact only with proteins through site-specific binding interactions. Considerable care is required in the application of equivalent expressions to analyze the dependence of equilibrium constants on salt concentration. There are different modes of interaction between ions and proteins,6 thus the slope of the salt dependence of the equilibrium constant represents a complex mixture of ionic effects on the thermodynamics of the process. Site-specific ion binding, aspecific screening of coulombic interactions, and even effects of ions on solvation properties of macromolecules are all reflected in the measured equilibrium constants and in their salt dependence, and it is virtually impossible to deconvolute these different types of contributions experimentally. For this reason the structural interpretation of the meaning of ions must proceed with great care.6 Structure-based calculations can be useful to identify the component that is related to the ionic strength effect. Microscopic Origins of pH Effects: pKa Values Hþ is a global or macroscopic descriptor of the effects of pH on equilibrium constants. It can be dissected into microscopic components reflecting contributions by individual ionizable residues. Toward this end, it is necessary to know the pKa values of individual ionizable sites. pKa values can be measured experimentally for histidines with one-dimensional nuclear magnetic resonance (NMR) spectroscopy methods,7 and with multidimensional methods for other ionizable residues.8 The pKa of an acid describes the process AH $ A þ Hþ, and for a base it describes BHþ $ B þ Hþ. The most notable difference between the dissociation of acids and bases is that for acids the dissociated form is charged and for bases it is neutral. Another difference is that the dissociation of the acid results in separation of charge and the dissociation of a base does not. For macromolecular equilibria to be pH sensitive, the pKa values of some of the ionizable residues must be different in the different macromolecular states in equilibrium. This is shown graphically in Fig. 1 for the process A $ B. The Hþ titration curves of an ionizable residue that titrates with a pKa ¼ 3 in state A of the macromolecule and with pKa ¼ 8 in state B are shown in Fig. 1. The difference in the pKa values in states A and B determines the pH dependence of the equilibrium between these two states.
6
B. Garcı´a-Moreno E., Methods Enzymol. 240, 645 (1994). S. P. Edgecomb and K. P. Murphy, Proteins Struct. Funct. Genet. 49, 1 (2002). 8 W. R. Forsyth, J. J. Antosiewicz, and A. D. Robertson, Proteins Struct. Funct. Genet. 48, 388 (2002). 7
[2]
electrostatic calculations with proteins
25
Fig. 1. Simulation of the Hþ titration curves of an ionizable residue that titrates with pKa ¼ 3 when the macromolecule is in state A and with pKa ¼ 8 when the macromolecule is in state B. The pH dependence of the free energy difference between states A and B, plotted with reference to the right ordinate, was calculated by integration of the area between the two titration curves with Eq. (2).
The effects of pH on the equilibrium can be obtained exactly by numerical integration of the area between the two titration curves with Eq. (2). The Go vs. pH curve calculated with Eq. (2) is also shown in Fig. 1. Z high pH A o B G ¼ 2:303RT H þ H (2) þ d pH low pH
The pH-dependent Go
describes, in a completely model-independent way, the manner in which the free energy difference between states A and B is dependent on pH. The total area between the two titration curves in Fig. 1 represents the maximal Go . It can be calculated by converting pKa values into Go using Go ¼ RT ln Keq, then taking a difference. At 25 , Go ¼ pKa 1.36 kcal/mol. Continuum Methods for Structure-Based Electrostatic Calculations
Several computational methods for structure-based calculation of electrostatic energies and pKa values in proteins are available, differing primarily in the amount of microscopic detail that is treated explicitly in the calculation, and in the accuracy and precision of the thermodynamic quantities that can be calculated. Atomistic models in which all atoms of both protein and water are represented explicitly represent one end of
26
allosteric enzymes and receptors
[2]
the spectrum. All-atom models can provide clear physical insight into the origins of electrostatic energies. However, in general, they are not yet useful for pKa calculations owing to problems with convergence and with inaccurate handling of long-range electrostatic interactions.9 The more useful models for structure-based pKa calculations in proteins are based on the continuum approximation, where the concept of a dielectric constant (e) is invoked to account implicitly for the polarizability of protein and water. In general, the ability of continuum models to obtain reliable electrostatic energies increases as microscopic detail is replaced by dielectric constants. However, this is achieved at the expense of a rigorous description of the physical origins of the energies. One example of a continuum model is the popular method based on the numerical solution of the Poisson–Boltzmann equation by the method of finite differences (FDPB).10 This is a continuum method in which a considerable amount of microscopic detail is retained. The protein dipole–Langevin dipole model (PDLD) by Warshel and coworkers11 is another example of a model in which dielectric-like constants are invoked to account for some forms of polarizability. However, the PDLD model has considerable microscopic character, and in its most useful version, treats explicitly the contributions by dynamics to the protein dielectric effect. The PDLD model is discussed in detail elsewhere in this volume. The recent review by Schutz and Warshel has an excellent critical discussion of the physical basis, shortcomings, and unique features of different models for electrostatic calculations in proteins.12 Thermodynamic Cycle Used to Calculate pKa Values The calculation of pKa values is a problem in electrostatics because it involves calculation of the difference in energy between charged and neutral forms of ionizable groups.13 The actual thermodynamic cycle that is used in pKa calculations is shown in Fig. 2. The horizontal arrows in this figure represent ionization reactions. The free energy of the reaction at the bottom of the cycle is determined by the pKa value of the ionizable prot group in the protein (pKa;i ). The free energy of the reaction at the top of the cycle is determined by the pKa value measured experimentally in 9
G. S. Del Buono, F. E. Figueirido, and R. M. Levy, Proteins Struct. Funct. Genet. 20, 85 (1994). 10 I. Klapper, R. Hagstrom, R. Fine, K. Sharp, and B. Honig, Proteins Struct. Funct. Genet. 1, 47 (1986). 11 A. Warshel and S. T. Russell, Q. Rev. Biophys. 17, 283 (1984). 12 C. N. Schutz and A. Warshel, Proteins Struct. Funct. Genet. 44, 400 (2001). 13 A. Warshel, Biochemistry 20, 3167 (1981).
[2]
electrostatic calculations with proteins
27
Fig. 2. Thermodynamic cycle used in the structure-based calculation of pKa values. The largest circles in the bottom side of this cycle represent the protein. The ionizable species are represented as large circles. The smaller circles represent polar atoms. The horizontal reactions represent the ionization of a model compound in water (top) or of an ionizable group in the protein (bottom). The vertical reactions represent the transfer of an ionizable group from water to protein in the neutral state (q ¼ 0, left) and in the charged state (q ¼ 1, right).
model ). The vertical axes describe the free energies to model compound (pKa;i transfer the model compound, either in the neutral (q ¼ 0) or ionized (q ¼ 1) states, from water into the protein environment. The largest spheres in this figure represent the protein. The large circles represent the ionizable groups. They can bear positive or negative charges. The smallest circles represent the background polar atoms. These are treated as point partial charges in some of the models. In most models the surface of the protein represents a boundary between regions with different polarizabilities— water, which has a dielectric constant eH2O ¼ 78.5, and protein, which has a lower dielectric constant ein. The calculation of pKa values consists of calculating correction factors to account for the effects of the macromolecular milieu on the pKa value measured experimentally in the model compounds used as reference. The transfer free energies that are calculated correspond to the electrostatic contributions to the ionization process in the protein: prot
tr model Gelec;i ¼ Gtr i;q¼1 Gi;q¼0 ¼ Ga;i Ga;i model : Equation (4) shows how these terms are used to modify the pKa;i
(3)
28
allosteric enzymes and receptors
prot
model pKa;i ¼ pKa;i þ
tr Gtr i;q¼1 Gi;q¼0
2:303RT
model ¼ pKa;i
[2]
zi Gelec;i 2:303RT (4)
Energy Terms Included in pKa Calculations In the continuum method for pKa calculations with the FDPB model, two different energy terms are included in the calculation of the transfer free energies shown in Fig. 2.14 One is the free energy of pairwise coulombic interactions between titratable sites in the protein, Gij, which in kcal/mol can be expressed as Gij ¼
332zi zj rij e
(5)
The other term is the self-energy, Gii. The self-energy in turn has two components. The first is the Born or reaction field energy, GBorn, which describes the differences in the self-energy of each charge in water and in the protein owing to their different polarizabilities. The general Born expression in Eq. (6) illustrates the overall magnitude of Born energies (kcal/mol) and their dependence on the dielectric properties of the system. This expression describes the difference in the self-energy of an ion of approximate radius rcav in water with electrolyte ions and in a material of polarizability equivalent to ein. 332z2i 1 1 (6) GBorn ¼ 2rcav ein eH2 O erij In this expression the term erij captures the effects of the ionic double layer about the charged group on the electrostatic potential. The second component of the self-energy is referred to as the background energy, Gbg. The background energy represents the free energy of interaction between the charge of interest and the background partial charges used to describe polar atoms in the protein. The background energies are calculated with expressions similar to Eq. (5). Together these three free energy terms are used to modify the pKa values measured in model compounds: z i prot model pKa;i ¼ pKa;i Gij þ Gii 2:303RT (7) z i model ¼ pKa;i Gij þ Gbg þ GBorn 2:303RT 14
D. Bashford and M. Karplus, Biochemistry 29, 10219 (1990).
[2]
electrostatic calculations with proteins
29
The calculation of the G terms in the thermodynamic cycle and in Eq. (7) is not trivial. In general, for an electrostatic system, G are calculated as the product of charge, z, times potential, : G ¼ z . An example of one of the expressions used in the FDPB algorithm to calculate energy terms for a simple ionizable residue is prot
Ga;i
n n X X 1 1 2 o;pr pr pr o;pr ¼ q2i ii qoi ii þ qi qj ij qoj qoj ij 2 2 j¼1 j¼1 m m X X pr o o o;pr þ qi qj ij qi qj ij j¼nþ1
j¼nþ1
ð8Þ
In this expression ij is the potential at site j due to a unit positive test charge at i, q is the charge at site i, o designates the neutral state of charge q, n is the number of partial charges in residue i, and m is the number of ionizable sites. The first two terms correspond to the Born energy, the other terms correspond to the background, and coulombic energy. A second similar expression, but without the rightmost two terms, would be necessary to calculate Gmodel . The actual calculation of pKa values is usua;i ally broken down into two steps. The intrinsic contributions to the pKa is calculated first, followed by the calculation of the energy of charge–charge interactions. The intrinsic pKa is defined to be the pKa value that an ionizable group has in the protein when all other titratable sites are neutral (i.e., the intrinsic pKa values reflect the pH-independent shifts to pKa values relative to the value in the model compound). The Born and the background energies are included in the calculation of the intrinsic pKa values. The actual protocols used in the calculations vary significantly depending on the specific implementation of the FDPB procedure that is being used.14–17 Calculation of Electrostatic Potentials with the FDPB Method The most difficult step in the structure-based calculation of electrostatic G is the calculation of the electrostatic potential () in the macromolecular milieu. This is difficult for two reasons. First, the electrostatic potential is a complex function of the charges of the system, of its polarizability, dynamics, composition, and shape. Second, proteins exist in electrolyte solutions, thus it is necessary to account for the effects of mobile counterions
15
D. Bashford and K. Gerwert, J. Mol. Biol. 224, 473 (1992). A.-S. Yang, M. R. Gunner, R. Sampogna, K. Sharp, and B. Honig, Proteins Struct. Funct. Genet. 15, 252 (1993). 17 J. Antosiewicz, A. J. McCammon, and M. K. Gilson, Biochemistry 35, 7819 (1996). 16
30
allosteric enzymes and receptors
[2]
on , which in turn requires knowledge of the organization of ions around proteins. In the FDPB method these issues are addressed by using the linear Poisson–Boltzmann equation to calculate the electrostatic potential. This equation relates the electrostatic potential, , the effects of the ionic double layer, , the charge density of the protein, , and the dielectric constants of the system, e: r ½eðrÞ rðrÞ 2 eðrÞ ðrÞ ¼ 4ðrÞ
(9)
In this expression is the Debye–Hu¨ ckel parameter, proportional to the ionic strength. It is through this parameter that the effects of electrolyte ions on the electrostatic potential are captured. The best known solution of this second-order differential equation is the model-dependent solution by Debye–Hu¨ ckel for the case of a spherical ion. The Tanford–Kirkwood model is another model-dependent solution of this equation, for the case of spherical proteins. The numerical solution of Eq. (9) by the FDPB method is the basis for the most popular continuum method for pKa calculation.10 In the finite difference solution of the linearized Poisson–Boltzmann equation the protein surface represents an interface between two regions of different polarizability. Water is treated with one dielectric constant, and the protein is treated with a lower dielectric constant. The dielectric constants of water are known over a wide range of physical conditions (temperature, pressure, and ionic strength). In contrast, quantitative treatment of the polarizability of the protein is difficult. It is not obvious that the inherently macroscopic concept of the dielectric constant is useful to describe the polarizability of proteins, which are chemically and dynamically heterogeneous and anisotropic. This is the problem that limits the accuracy and utility of all continuum models. Calculations with the PDLD Method The protein dipole–Langevin dipole model by Warshel is described elsewhere in this volume.11,18 In this semimicroscopic method some parts of the protein and solvent are treated as point-inducible dipoles on a lattice, some are approximated by a Langevin-type function, and a continuum dielectric constant is applied to treat the polarizability of the bulk solvent. Ionic strength effects were not treated explicitly in the original version of this algorithm. However, this is not a serious problem. A simple term proportional to 1/erij can be used to capture these effects nearly quantitatively. The unique features and advantages of the PDLD method for calculation of electrostatic energies are discussed later. 18
F. S. Lee, Z. T. Chu, and A. Warshel, J. Comput. Chem. 14, 161 (1993).
[2]
electrostatic calculations with proteins
31
Parameters Used in FDPB Calculations The pKa calculations with the FDPB method require the following set of inputs. 1. Coordinates of structures with H atoms added computationally. 2. Ionic strength, which in principle should not be higher than the physiological value. 3. Temperature, which is not a particularly important variable in these calculations. 4. A set of partial charges. The exact set will depend on the nature of the implementation that is used, as discussed later. 5. A set of pKa values of model compounds to describe the reaction in the top horizontal side of the thermodynamic cycle in Fig. 2. The values that are most commonly used are 3.8 for the C terminus, 4.0 for Asp, 4.4 for Glu, 6.3 for His, 7.5 for the N terminus, 9.6 for Tyr, 10.4 for Lys, and 12.0 for Arg. 6. A set of dielectric constants. Water is treated with eH2O ¼ 78.5 (25 ). The assignment of a dielectric constant to the protein interior, ein, is highly controversial for reasons discussed later. The dielectric constant of dry protein powders is close to 4; thus in many of the calculations ein ¼ 4 is used.19 However, in general this value exaggerates the magnitude of electrostatic effects. For this reason the empirical use of ein ¼ 20 has become popular in pKa calculations with static structures. This improves the agreement between calculated and measured pKa values for surface ionizable residues.20 Experimentally Measurable Thermodynamic Quantities That Can Be Calculated There is a wide range of thermodynamic quantities that can be measured experimentally in solution that can also be calculated from structure. Indeed, one important aspect of structure-based electrostatic calculations is that they can be tested rigorously against experimental data. pKa values are the single most important thermodynamic quantity that can be calculated. Since in the models the pKa values are pH-dependent quantities, the calculated pKa values that are compared against the pKa values measured by NMR spectroscopy are termed pKa,app. These represent the midpoint of the calculated Hþ titration curve for each titratable site. They
19 20
M. K. Gilson and B. H. Honig, Biopolymers 25, 2097 (1986). J. Antosiewicz, J. A. McCammon, and M. K. Gilson, J. Mol. Biol. 238, 415 (1994).
32
allosteric enzymes and receptors
[2]
can be used with the Hendersohn–Hasselbalch equation to calculate the Hþ titration curves of individual sites. The overall Hþ titration of the protein, which can be measured by potentiometric methods, can in turn be calculated as a sum of individual site Hþ isotherms. As shown by the simulated data in Fig. 1, the pKa values of ionizable residues in two states of a macromolecule can be used to determine the pH dependence of the equilibrium between the two states. For example, independent pKa calculations with the liganded and unliganded forms of hemoglobin can be used to calculate the pH dependence of the ligandbinding reactions (i.e., the Bohr effect). Similarly, using pKa values calculated with the native state of a protein, and assuming that the ionizable residues of an unfolded protein are well represented by the pKa values of model compounds, the FDPB method can be used to calculate the pH dependence of stability of any protein. In all of these calculations it is possible to vary the ionic strength in order to gauge the salt dependence of the calculated electrostatic contributions. It is also possible to dissect the calculated data into contributions by individual groups or by specific types of interactions. For example, the calculated contributions to stability or to the pH dependence of a process can be dissected into contributions from short-range ion pairing interactions and from medium-range interactions and long-range coulombic interactions. As shown later, this type of analysis can be very productive in the elucidation of the structural and physical origins of measured energetics. The most interesting recent applications of the calculations are in the analysis and interpretation of the determinants of pKa values, and in analysis of the effects of mutations that affect properties of ionizable residues. For example, the effects of removal of an ionizable residue on stability or on pKa values can be measured experimentally and compared against the calculated contributions. Equation (7) shows how FDPB-calculated electrostatic effects can be dissected into three types of contributions. In cases in which there is good agreement between calculated and measured pKa values, this dissection can be used to analyze experimental data in greater detail. The line of investigation also enables detailed tests of the accuracy and validity of the calculated energies by direct comparison with the experimental data. Use of experimental data to challenge structure-based pKa calculations has guided modifications to the algorithms that have greatly increased their accuracy and reliability. In the process our understanding of the physical character of electrostatic interactions in proteins has also been refined considerably.
[2]
electrostatic calculations with proteins
33
Problems with Existing Continuum Methods and Strategies to Address Them
The major problems with all models for calculation of pKa values and electrostatic energies in proteins stem from the difficulty of capturing quantitatively the dielectric properties of proteins. The protein surface represents an artificial boundary between media of different dielectric properties. The nature of dielectric relaxation and the properties of water or protein at this interface are not well understood. What is known with certainty is that the pKa values of surface ionizable residues measured by NMR spectroscopy are in general very similar to the values of model compounds in water.7,8 This suggests that the presence of the protein does not interfere significantly with the hydration of surface ionizable residues, or that the loss of hydration is compensated by favorable interactions with protein polar atoms. It also suggests that surface coulombic interactions are weak, or that strong attractive interactions are always balanced by repulsive interactions of the same magnitude. The notion that surface electrostatic effects are weak originated with the calculations with the Tanford–Kirkwood algorithm (SATK) modified empirically by inclusion of a normalized solvent accessibility parameter to attenuate all electrostatic effects. This algorithm is capable of reproducing the pKa values of surface residues.21 In the standard implementation of this method the lowest dielectric constant that is ever sampled between pairs of interacting charges is approximately 40, because even though the protein itself is treated with ein ¼ 4, the dielectric constant of water is weighted heavily. In SATK calculations the small deviations of pKa values relative to model compound values are the result of weak perturbations by coulombic interactions (no self-energies are included in the standard SATK method). In contrast, in early calculations with the FDPB method that treated the protein with ein ¼ 4, the magnitude of electrostatic effects was exaggerated, and the calculations failed to reproduce the experimental pKa values. This can be appreciated in some of the data included in Fig. 3. Today it is widely acknowledged that any model that treats the protein surface with high dielectric constants can capture pKa values of surface residues.20–23 Modifications to the Standard Implementation of the FDPB Method There are two trends among the strategies to improve the performance of pKa calculations with the FDPB method. One is to increase the amount of microscopic detail in the calculations. For example, in the simplest 21
J. B. Matthew, F. R. N. Gurd, B. Garcı´a-Moreno E., M. A. Flanagan, K. L. March, and S. J. Shire, CRC Crit. Rev. Biochem. 18, 91 (1985). 22 B. Svensson and B. Jo¨ nsson, J. Comput. Chem. 16, 370 (1995).
34
allosteric enzymes and receptors
[2]
implementation of the FDPB method using static structures, the charge of an ionizable residue is considered to reside in only one atom.20 In this single-site mode the calculations with ein ¼ 4 yield grossly incorrect pKa values. The calculated pKa values can be improved by instead distributing the unit charge over several atoms of each ionizable side chain.15–17 Another alternative to improve calculations with ein ¼ 4 is to use the PARSE atomic charge set,24 which was parameterized to reproduce solvation energies of small molecules using FDPB theory. Another more recent device to improve the agreement between calculated and experimental pKa values is to use a small probe radius, smaller than the radius of a water molecule, to define the molecular surface of the protein.25 This helps because the dielectric constant of water will be weighted more heavily if the protein surface is described with a very small probe (i.e., more volume is treated with eH2O). Yet another way of improving the performance of the FDPB method is to treat explicitly the structural waters bound at specific sites that are seen crystallographically rather than subsuming their effect into a dielectric constant.26 The second trend in the empirical strategies to improve the performance of pKa values with the FDPB method is to arbitrarily increase the value of ein used in the calculations. FDPB calculations with static structures, using a single-site charge method, can give very reasonable results and reproduce the properties of surface residues if ein ¼ 20 is used.20 A virtue of the use of ein ¼ 20 is that it renders the calculations less sensitive to the details of parameters, structures, and charge sets used. In contrast, calculations with ein ¼ 4 tend to amplify uncertainties and errors. They are also highly dependent on the specific conformation of the structure used, requiring conformational averaging to improve the agreement between calculated and measured pKa values.16,17,20,27 With ein ¼ 20 the discrepancies between calculations with slightly different structures of the same protein are diminished.20 Figure 3 shows the rank-ordered pKa values of acidic residues in staphylococcal nuclease calculated with a static structure using these different implementations of the FDPB algorithm. The pKa values calculated with the SATK algorithm are also included for comparison. Note that the FDPB-calculated pKa values are systematically more depressed than the values calculated with the Tanford–Kirkwood algorithm, suggesting that the FDPB-calculated electrostatic energies are still exaggerated, no 23
A. Warshel, S. T. Russell, and A. K. Churg, Proc. Natl. Acad. Sci. USA 81, 4785 (1984). D. Sitkoff, K. A. Sharp, and B. Honig, J. Phys. Chem. 98, 1978 (1994). 25 H.-X. Zhou and M. Vijayakumar, J. Mol. Biol. 267, 1002 (1997). 26 H. Trylska, J. Antosiewicz, M. Geller, C. N. Hodge, R. M. Klabe, M. S. Head, and M. K. Gilson, Protein Sci. 8, 180 (1999). 27 D. Bashford, D. Case, C. Dalvit, L. Tennant, and P. Wright, Biochemistry 32, 8045 (1993). 24
[2]
electrostatic calculations with proteins
35
Fig. 3. Rank order of pKa values of Glu and Asp residues in staphylococcal nuclease calculated with the solvent accessibility modified Tanford–Kirkwood method (thick solid line) or with different implementations of the FDPB method. The symbols refer to FDPB calculations as follows: (&) ein ¼ 20, 100 mM KC1; (d) ein ¼ 40, 100 mM KCl; (m) ein ¼ 80, 100 mM KCl; (4) ein ¼ 80, 500 mM KCl; (!) ein ¼ 80, 1 M KCl; ( ) ein ¼ 20, PARSE charge set; (^) ein ¼ 4, Parse charge set, molecular surface defined with van der Waals radii instead of water-accessible surface; (H) ein ¼ 20, 100 mM KCl, charges arbitrarily placed on atom OD1 or OE1; (t) ein ¼ 20, 100 mM KCl, charges arbitrarily placed on atom OD2 or OE2; (o § ) ein ¼ 20, 100 mM KCl, charges placed as in Tanford–Kirkwood calculation, 100 mM KCl.
matter how the calculations are performed. Note also the large differences between pKa values calculated with slightly different implementations of the same method. Staphylococcal nuclease was selected on purpose to illustrate the dependence of the calculated pKa values on the details of the calculation precisely because in this protein these differences are exaggerated. The calculated pKa values of acidic residues in nuclease are more depressed than they should be because this nuclease is very basic, and substantial positive potentials impinge on the acidic residues in the pH range where they titrate. Under more neutral conditions of pH the FDPB calculations on this same protein can reproduce the pKa values of histidines with remarkable accuracy when ein ¼ 20.28,29 The data in Fig. 3 offer a sobering illustration of the degree to which the calculated pKa value can be affected by nuances and details of the calculations. 28 29
K. K. Lee, C. A. Fitch, J. T. J. Lecomte, and B. Garcı´a-Moreno E., Biochemistry 41, 5656 (2002). K. K. Lee, C. A. Fitch, and B. Garcı´a-Moreno E., Protein Sci. 11, 1004 (2002).
36
allosteric enzymes and receptors
[2]
Why Do pKa Calculations with FDPB Improve When Proteins Are Treated Artificially with High Dielectric Constants? To understand the reasons behind the failure of FDPB calculations with static structures and ein ¼ 4 it is necessary to understand the meaning of the dielectric constants of proteins. According to Schutz and Warshel,12 e ¼ 2 accounts for electronic polarizability and e ¼ 4 accounts for electronic polarizability plus small-scale atomic displacements. Values of ein > 4 are needed when larger-scale fluctuations of proteins contribute to the overall dielectric response. There is very little direct experimental information about the nature of the structural relaxation or flexibility that could affect the magnitudes of electrostatic effects so dramatically. It might involve dipolar movement, charge displacement, or even large-scale motions and fluctuations such as local unfolding or reorganization, and in extreme cases global unfolding.12 The problem with calculations that use static structures and ein ¼ 4 is that they underestimate the natural flexibility of the protein, and especially of surface ionizable side chains. ein ¼ 4 also likely underestimates the substantial structural response to the ionization events. Apparently, this is captured implicitly and nearly quantitatively with ein ¼ 20. The general trend is for the value of the dielectric constants used in the models to increase as microscopic detail is removed from the model and treated implicitly within the dielectric constant of the protein. If the dynamic response of a protein to an ionization event is not treated explicitly in the calculations, it must be subsumed into a dielectric constant, thus the need for dielectric constants greater than 4 to reproduce experimental data in calculations with static structures. Strategies for Handling Conformational Flexibility and Reorganization The recognition that most of the problems with exaggerated electrostatic effects originates with the use of low ein in calculations with static structures has led to yet another trend in modifications to methods for pKa calculations, focused on treating the relationship between electrostatic effects, dynamics, and dielectric relaxation explicitly. The attempts to improve FDPB calculations with explicit consideration of dynamics have involved mainly the use of molecular dynamics (MD) or Monte Carlo (MC) methods to explore side chain flexibility.16,30–33 The most important 30
H. W. T. van Vlijmen, M. Schaefer, and M. Karplus, Proteins Struct. Funct. Genet. 33, 145 (1998). 31 B. Rabenstein and E. W. Knapp, Biophys. J. 80, 1141 (2001). 32 T. You and D. Bashford, Biophys. J. 69, 1721 (1995). 33 P. Beroza and D. A. Case, J. Phys. Chem. 100, 20156 (1996).
[2]
electrostatic calculations with proteins
37
conclusion from the MD studies is that comparable pKa values can be obtained using a static structure and ein ¼ 20, and using ein ¼ 4 and averaging over many conformational states sampled in an MD trajectory.30 There is a disconnection between the time scale of minutes used in the measurement of equilibrium thermodynamic data by NMR or other equilibrium methods, and the time scales sampled by even the longest MD simulation possible. This issue is avoided with the multiple conformation continuum electrostatics (MCCE) methods of Gunner and Alexov, which handles conformational heterogeneity and flexibility using an MC protocol to sample side chain rotamers. This procedure is designed to explore the sensitivity of pKa calculations to local sources of heterogeneity involving rotation of side chains, of hydroxyl- or site-bound water molecules, and also to details of placement of polar H atoms. The MCCE calculations using ein ¼ 4 seem to be remarkably accurate, and they contribute significant insight about how the details of the microenvironments affect pKa values.34–36 Clearly in cases in which backbone fluctuations contribute to the high apparent polarizability of a site, neither the MD nor the MC approaches are appropriate. The vast majority of computational studies on structure-based pKa calculations have focused on the calculation of pKa values of surface residues. Warshel has pointed out previously that surface residues do not offer a stringent test of the ability of any model to reproduce physical reality because their pKa values are too close to the pKa values of model compounds. Any model that uses high effective dielectric constants to describe the interactions between charges at the surface is capable of reproducing the pKa values of surface residues.12 In contrast, the pKa values of internal residues constitute stringent benchmarks useful for identifying the most accurate and physically correct models. As shown later, the pKa values of internal residues can experience enormous shifts owing to the loss of hydration in the protein interior or at interfaces between proteins. Not enough experimental data on the pKa values of internal residues are available to allow calibration of the models. All that is known at present is that the ionization properties of buried groups are reproduced by FDPB calculations that treat proteins empirically with ein 10.37–40 This is problematic because in calculations with ein ¼ 10 the magnitude of surface electrostatic 34
E. Alexov, Proteins Struct. Funct. Genet. 50, 94 (2003). E. G. Alexov and M. R. Gunner, Biophys. J. 74, 2075 (1997). 36 R. E. Georgescu, E. G. Alexov, and M. R. Gunner, Biophys. J. 83, 1731 (2002). 37 K. Langsetmo, J. A. Fuchs, and C. Woodward, Biochemistry 30, 7603 (1991). 38 E. Demchuk and R. C. Wade, J. Phys. Chem. 100, 17373 (1996). 39 X. Raquet, J. Lounnas, J. Lamotte-Brasseur, J. M. Fre`re, and R. C. Wade, Biophys. J. 73, 2416 (1997). 35
38
allosteric enzymes and receptors
[2]
effects is exaggerated, and pKa values of surface ionizable residues are not captured. There is no FDPB-based strategy that we are aware of that can be used to capture the energetics of ionization of surface and internal groups simultaneously and in a self-consistent way, using a single value of ein. The practical solutions that have been implemented recently attempt to solve the problems by parameterization. In some of these methods the microenvironments of internal titrating sites are treated with low dielectric constants or with more atomic detail, and charge–charge interactions are treated with arbitrarily high effective dielectric constants.41–46 Some of these methods, in particular the screened Coulomb potential method of Mehler and co-workers, are extremely promising.44,46 In general, adding microscopic detail to continuum calculations can lead to improvement in reproducing pKa values of buried residues or of strongly interacting titratable groups, but they do so at the expense of generality and simplicity. Advantages of PDLD Methods The use of static structures in FDPB calculations is desirable because it is fast and convenient—it avoids the costly exploration of dynamics to improve the treatment of dielectric relaxation. Unfortunately, the trend is that the most useful strategies that have evolved for improvement of FDPB-based continuum calculations increase the amount of microscopic detail to the calculations. Specifically the most serious problems with FDPB calculations, related to the difficulty in accounting for structural relaxation due to the charging process, has required the use of MD or MC simulations to explore conformational relaxation. In some FDPB calculations separate MD have been done for fully charged and fully neutral protein.16 If conformational change is treated explicitly, separate calculations should be performed for each group in the charged and neutral states. A rigorous approach to the problem is impossible due to the large number of states that would have to be considered; approximations are necessary.18 40
C. A. Fitch, D. A. Karp, K. K. Lee, W. E. Stites, E. E. Lattman, and B. Garcı´a-Moreno E., Biophys. J. 82, 3289 (2002). 41 D. Voges and A. Karshikoff, J. Chem. Phys. 108, 2219 (1999). 42 J. J. Havranek and P. B. Harbury, Proc. Natl. Acad. Sci. USA 96, 11145 (1999). 43 R. A. Dimitrov and R. R. Crichton, Proteins Struct. Funct. Genet. 27, 576 (1997). 44 E. L. Mehler and F. Guarnieri, Biophys. J. 75, 3 (1999). 45 M. S. Wisz and H. W. Hellinga, Proteins Struct. Funct. Genet. 51, 360 (2003). 46 E. I. Mehler, M. Fuxreiter, I. Simon, and B. Garcı´a-Moreno E., Proteins Struct. Funct. Genet. 48, 283 (2002).
[2]
electrostatic calculations with proteins
39
In general, FDPB calculations are evolving toward the semimicroscopic method embodied in Warshel’s PDLD method.12 From birth this method has been inherently better suited for handling the contributions by fluctuations and dynamics to electrostatics. Variations of the PDLD model have been developed that incorporate structural relaxation in the neutral and charged states explicitly within the framework of the linear response approximation.18,47 This is tantamount to adding steps in the thermodynamic cycle in Fig. 1 to treat explicitly the reorganization of the protein concomitant with ionization. The difficulties in modeling the ionization behavior of groups in the interior of proteins self consistently show that the treatment of polarizability in the protein interior with a single macroscopic parameter is fundamentally flawed. This has been pointed out by Warshel, who suggested that in principle the explicit treatment of reorganization should take care of this problem.18,26,35 However, this is a difficult problem, and even in the PDLD/ LRA treatment47 it has been necessary to included screening parameters to improve agreement between calculated and measured energies. These screening parameters are used to attenuate interactions. When carefully calibrated against experimental data, this approach has produced excellent results.12 The PDLD method is the most reliable and promising approach for handling rigorously the calculations of pKa values, especially in cases of groups in environments secluded from solvent, which are the groups that are of greatest biological importance. Physical Properties of Surface Ionizable Groups
It is important to emphasize that none of the available computational methods for pKa calculations are free of deficiencies. No one method is capable of handling all types of calculations, nor free of approximations. Most calculations still overestimate the energies of ion pairs, many overestimate the magnitude of long-range interactions, and still others are not appropriate for estimating the ionic strength dependence of electrostatic energies. None is yet capable of handling calculations of surface and internal residues simultaneously and self-consistently, and with the exception of the PDLD, few are ideally suited to deal with the calculation of pKa values of internal residues. On the other hand, used judiciously and in concert with experimental studies, the available computational methods are reliable and useful for the dissection of pH and salt-sensitive thermodynamics of proteins. In the next two sections we discuss some of the properties of electrostatic effects in proteins that have been elucidated recently 47
Y. Y. Sham, Z. T. Chu, and A. Warshel, J. Phys. Chem. B 101, 4458 (1997).
40
allosteric enzymes and receptors
[2]
with joint application of computational and experimental methods. No attempt is made to review the recent literature comprehensively. The intent is simply to illustrate cases in which the structure-based analysis of experimental data with a computational method has contributed significant novel insight about the physical character of protein electrostatics that was inaccessible by experimentation alone. Accurate Electrostatic Potentials Calculated with FDPB The validity of physical models for calculation of electrostatic energies in proteins is usually established by comparison of measured and calculated pKa values. As shown below, most ionizable groups have net favorable coulombic interactions and unfavorable self-energies; pKa values reflect the balance between these two terms. To understand the molecular determinants of pKa values it is necessary to understand how coulombic and selfenergy contributions are parsed. This information is also necessary to establish that a computational method reproduces experimental pKa values for the right physical reasons. In the case of internal residues self-energies can be evaluated easily because the significant perturbation of their pKa values is dominated by the loss of hydration in the protein interior. For surface residues the experimental dissection of the determinants of pKa values is considerably more difficult because these pKa values are similar to the values in model compounds in water, and the nature of the balance between coulombic and self-energies is never obvious. The relatively unperturbed pKa values of surface residues can be reproduced with very different physical models, even incorrect ones. Therefore, in the case of surface residues, agreement between calculated and measured pKa values is a required but not a sufficient condition to establish that a model reproduces pKa values for the correct physical reasons. To test the validity of the electrostatic potentials calculated with the FDPB method, interaction energies between two charges (Gij) were obtained from the change in pKa that results from charge removal or charge reversal by mutagenesis. That is how the data in Fig. 4 were obtained.29 By measuring the pKa values of surface histidines in many mutants of staphylococcal nuclease in which charge has been either removed or reversed, it was possible to construct a map of the distance and salt dependence of charge–charge interactions. Some of the data in Fig. 4 were measured experimentally; the rest were obtained with FDPB calculations using ein ¼ 20. The curve represents the nonlinear least squares fit of Eq. (10) to the data sets. The important thing to note is that the calculations reproduced the distance dependence and the salt sensitivity (not shown) of pairwise coulombic interactions among surface residues. The solid line
[2]
electrostatic calculations with proteins
41
Fig. 4. Comparison of the distance dependence of calculated (closed squares) and measured (open squares) energies of pairwise coulombic interactions between histidines and other surface charges in staphylococcal nuclease. 29 The lines represent nonlinear least-square fits of the experimental (solid) and calculated (dashed) data with a simple coulombic expression, as previously described. 29 All data at 25 , in 10 mM KCl.
represents the shape of the FDPB-calculated electrostatic potential. Despite the use of ein ¼ 20 the calculated pairwise coulombic energies are slightly larger than the measured values, but overall there is excellent agreement. This is a significant observation. It confirms that the electrostatic potentials that were calculated with the FDPB method are accurate. With the assurance that this aspect of the calculation is correct, the more detailed analysis of the calculated molecular determinants of pKa values becomes meaningful. This entails calculation of the relative contributions to the pKa values by the three types of energies described in Eq. (7). Magnitudes of Coulombic, Background, and Born Contributions to pKa Values The pKa values of histidines in staphylococcal nuclease calculated with FDPB methods using a static structure and ein ¼ 20 are in good agreement with the measured values.28 To determine the molecular determinants of these pKa values the data were dissected into contributions by coulombic, Born, and background energies. The data in Fig. 5 illustrate the magnitude and salt sensitivity of these contributions for His-8, His-121, and Glu-52 in nuclease. Note that in the case of these residues the salt dependence of the calculated pKa value closely mirrors the salt dependence of the coulombic
42 allosteric enzymes and receptors Fig. 5. Representative set of FDPB-calculated pKa values of ionizable residues in staphylococcal nuclease. Ionic strength dependence of pKa values (d) of His-8 (A), His-121 (B), and Glu-52 (C), and contributions from coulombic interactions ( ), from Born energies (4), and from interactions with background polar atoms (!). The contributions from self-energies, calculated as the sum of Born and background contributions, are also shown (). All calculations are with the simplest implementation of FDPB with ein ¼ 20.
[2]
[2]
electrostatic calculations with proteins
43
energy. In contrast, the self-energy is salt insensitive. The magnitude of the calculated coulombic contributions is, in general, greater than the magnitude of the self-energy contributions. This is entirely consistent with what has been determined experimentally for surface residues.29,48,49 The Born contribution to the pKa values of surface residues is always destabilizing because surface residues are always less solvated than the ionizable residues in model compounds in water. Thus the Born term depresses the pKa values of the two histidines (A and B) and it raises the pKa value of the glutamic acid (C). In the case of the two histidines the background energies are also destabilizing—they depress the pKa value. This is not unusual for histidines. In the case of Glu, Asp, Lys, and Arg residues the background energies are usually stabilizing. For these residues the Born and the background energies have approximately the same magnitude but opposite sign—they cancel each other. This is illustrated by the data in Fig. 5C. According to the NMR spectroscopy data the pKa value of His-121 is very depressed and extremely salt sensitive.28 The data in Fig. 5 illustrate how the calculations can help interpret the origins of these experimental observations. The calculated pKa for His-121 in Fig. 5B agrees with the experimental measurement—it is depressed and highly salt sensitive. Dissection of this pKa into the three energy terms suggests that at low ionic strength the self-energy and net repulsive coulombic interaction contribute significantly and equally to the depression of this pKa value. These calculated data also show that the salt sensitivity of the pKa originates entirely with the salt sensitivity of coulombic contributions. This histidine and the other residues described in Fig. 5 are in environments with substantial, net positive potential, thus the pKa values increase as the repulsive coulombic interactions with other basic groups are screened by increasing salt concentration. This is an example of Hþ titration behavior that could not be reproduced accurately with an electrostatic model that does not account for self-energies, such as the modified Tanford–Kirkwood method, or the simple coulombic formula such as Eq. (10).21 Long-Range and Short-Range Contributions to Stability The origins of the Born and background energies can be dissected further to describe the microenvironments responsible for their value. However, in general this type of analysis is not very productive because it 48
D. V. Laurents, B. M. Huyghues-Despointes, M. Bruix, R. L. Thurlkill, D. Schell, S. Newsom, G. R. Grimsley, K. L. Shaw, S. Trevino, M. Rico, J. M. Briggs, J. M. Antosiewicz, J. M. Scholtz, and C. N. Pace, J. Mol. Biol. 325, 1077 (2003). 49 B. M. P. Huyghues-Despointes, R. L. Thurlkill, M. D. Daily, D. Schell, J. M. Briggs, J. M. Antosiewicz, C. N. Pace, and J. M. Scholtz, J. Mol. Biol. 325, 1093 (2003).
44
allosteric enzymes and receptors
[2]
is extremely difficult to test experimentally any hypotheses concerning the molecular origins of Born or background energies, suggested by the calculations. In contrast, the contributions from coulombic interactions to pKa values can be analyzed further in a meaningful way. The effects of the contributions from individual charged groups can be calculated and measured, as shown by the data in Fig. 4. Given the good agreement between these calculated and measured data, further analysis of the character of coulombic interactions is warranted. For example, the distance dependence of pairwise coulombic interactions shown in Fig. 4 suggests that long-range coulombic interactions are very small, but nonzero. Interactions between ˚ are stronger than those separated by charges separated by less than 10 A greater distances. The data in Fig. 6 show the ionic strength sensitivity of the total contributions by coulombic interactions to the pKa of His-121 in staphylococcal nuclease at pH 7, parsed into short-range and long-range, stabilizing and destabilizing contributions. According to these data the at˚ are well balanced and they tractive and repulsive interactions at rij < 10 A ˚ are not balcancel each other. In contrast the interactions at rij > 10 A anced. The long-range repulsive interactions are stronger than the longrange attractive interactions. Thus, the long-range repulsive, coulombic interactions are responsible for the depressed pKa values of these and other histidines in nuclease.28 This type of parsing of coulombic interactions is
Fig. 6. Ionic strength dependence of coulombic interactions that contribute to the pKa of His-121 in staphylococcal nuclease, calculated with the simplest implementation of FDPB calculations with ein ¼ 20. Shown separately are the long-range interactions between charges ˚ (left), and short- and medium-range interactions between separated by more than 10 A ˚ (right). The total coulombic interactions (thick line) were charges separated by less than 10 A parsed into attractive (&) and repulsive (d) interactions. The sum of attractive and repulsive interactions in each of the distance regimes is also shown (.).
[2]
electrostatic calculations with proteins
45
useful because, as can be seen by the data in the left panel of Fig. 6, the data explain the detailed molecular origins of the unusual high salt sensitivity of this histidine at a level that is inaccessible by experimentation. The data show that although long-range electrostatic interactions are, in fact, very weak, they can add up to produce substantial electrostatic effects in situations when positive and negative charges are not balanced. This is a novel view, opposite to the view that has prevailed,50,51 and which was supported by the less physically realistic calculations with the SATK method, which can systematically underestimate the magnitude of medium- and long-range electrostatic interactions. Several groups have demonstrated recently that the significant contributions by medium- and long-range coulombic interactions to stability can be exploited to increase the stability of proteins artificially, by judicious manipulation of the constellation of surface charges.52–54 The Contributions of Ion Pairs to Protein Stability Are Context Dependent The data in Fig. 4 show that the FDPB calculations reproduce quantitatively the magnitude of pairwise coulombic interactions between charges ˚ or more. In this range the distance dependence and salt separated by 8 A sensitivity of coulombic interactions seem to follow general trends. Interactions at short range are considerably more complex and very difficult to reproduce with pKa calculations—no clear trends are obvious. Experimentally it is known that the contributions of ion pairs to the stability of proteins can vary dramatically.55 Not surprisingly, the artificial design of surface ion pairs to enhance the stability of proteins is notoriously difficult, and usually unsuccessful. Apparently other factors besides the distance of separation between charges become critical below a certain distance. These factors are not well understood. In the calculations of short-range interactions the details of the calculations seem to matter greatly.56–58 There are aspects of short-range interactions, for example, the contributions by hydrogen bonding,59 that make them unsuitable for study with calculations using static structures. These 50
D. Sali, M. Bycroft, and A. R. Fersht, J. Mol. Biol. 220, 779 (1991). S. Dao-pin, E. So´ derlind, W. A. Baase, J. A. Wozniak, U. Sauer, and B. W. Matthews, J. Mol. Biol. 221, 873 (1991). 52 K. L. Shaw, G. R. Grimsley, G. I. Yakovlev, A. A. Makarov, and C. N. Pace, Protein Sci. 10, 1206 (2001). 53 V. Loladze, B. Ibarra-Molero, J. Sanchez-Ruiz, and G. Makhatadze, Biochemistry 38, 16419 (1999). 54 S. Spector, M. Wang, S. Carp, J. Robblee, Z. Hendsch, R. Fairman, B. Tidor, and D. Raleigh, Biochemistry 39, 872 (2000). 55 S. Dao-pin, U. Sauer, H. Nicholson, and B. W. Matthews, Biochemistry 30, 7142 (1991). 51
46
allosteric enzymes and receptors
[2]
are problems that are best handled with explicit consideration of flexibility and conformational heterogeneity with methods such as the MCCE.34,35 There are other aspects of short-range interactions, for example, the interactions between ionizable residues and aromatic residues,60 which are not well suited for study with methods that consider only electrostatic factors in the calculation of pKa values. A recent analysis of the contributions of ion pairs to the stability of proteins has contributed an important novel concept that could result in improved calculations in the future. Makhatadze and co-workers demonstrated experimentally that the extent to which an ion pair contributes to the stability of a protein is context dependent.61 Using double mutant cycles they established that the energy of interaction between a Lys and a Glu was identical even when the Lys-Glu pair was reversed to a Glu-Lys pair by mutagenesis. However, the magnitude of the net contribution to the global stability of the protein was highly sensitive to the orientation of the ion pair. This suggested that the contributions to stability are determined not only by the energy of interaction between the elements of the ion pair, but by the medium- and long-range interactions between the charges forming the ion pair and the rest of the charges in the protein. The SATK model, devoid of self-energy terms and of background polar charges, is capable of capturing the energetics of the interaction between the two charges in the ion pair remarkably well. However, the SATK calculations are poor at capturing the contribution of the ion pair to stability because they do not reproduce quantitatively the medium- and long-range electrostatic interactions. The FDPB calculations, on the other hand, reproduce quantitatively the magnitude of medium- and long-range coulombic interactions (Fig. 4). However, they routinely fail to reproduce the magnitude of short-range coulombic interactions because the calculations tend to exaggerate interaction energies and are too sensitive to structural and computational details even with ein ¼ 20. A combination of the best aspects of the two different models should greatly improve our ability to calculate properties of short-range electrostatic interactions.
56
W. R. Forsyth and A. D. Robertson, Biochemistry 39, 8067 (2000). W. R. Forsyth, M. K. Gilson, J. Antosiewicz, O. R. Jaren, and A. D. Robertson, Biochemistry 37, 8643 (1998). 58 Y.-H. Kao, C. A. Fitch, S. Bhattacharya, C. J. Sarkisian, J. T. J. Lecomte, and B. Garcı´aMoreno E., Biophys. J. 79, 1637 (2000). 59 L. Swint-Kruse and A. D. Robertson, Biochemistry 34, 4724 (1995). 60 R. Loewenthal, J. Sancho, and A. R. Fersht, J. Mol. Biol. 224, 759 (1992). 61 G. I. Makhatadze, V. V. Loladze, D. N. Ermolenko, X. Chen, and S. T. Thomas, J. Mol. Biol. 327, 1135 (2003). 57
[2]
electrostatic calculations with proteins
47
Origins of the Salt Sensitivity of Electrostatic Effects Among biochemists, the dominant ideas concerning the molecular origins of the salt sensitivity of equilibrium processes of proteins are still rooted in predictions with the original Debye–Hu¨ ckel model. According to this model the energy of a pair of interacting charges is given by Gij ¼
332Zi Zj rij erij
(10)
¼ 50.29 (I/ e H2OT)1/2 with the ionic strength, I, in moles/liter, and T in K. This function predicts a dramatic decay in Gij with increasing ionic strength when rij is comparable to the distance between the charges in an ion pair. This has led to the idea that salt sensitivity of an equilibrium process is diagnostic of energetic contributions by ion pairs to that equilibrium. That is not what was found experimentally in NMR studies of the salt sensitivity of pKa values of groups involved in ion pairs. The pKa values of residues in ion pairs in proteins are largely insensitive to the ionic strength.58,62 This is exactly what would be expected with a more sophisticated theory that captured the fact that the volume occupied by the protein is not accessible to ions. The salt insensitivity of pKa values of charges involved in ion pairs is reproduced in pKa calculations with both SATK and FDPB methods.58 The data in Figs. 4, 5, and 6 suggest that the effects of ionic strength on equilibrium processes reflect mostly the attenuation of medium- and long-range coulombic interactions. The unusually high salt sensitivity of pKa values and coulombic interactions in staphylococcal nuclease is the result of its high charge density and of its high isoionic point. Charges are not balanced in nuclease; there are many more basic than acidic residues, and this imbalance is reflected in the salt sensitivity. None of the ionizable groups included in Fig. 5 make short-range coulombic interactions. The salt sensitivity of their pKa values reflects mostly the attenuation of medium- and long-range interactions. As these two histidines have many more repulsive than attractive interactions with the other ionizable residues in nuclease, the net effect of increasing salt concentration is to increase the pKa values. The same is true of Glu-52 shown in Fig. 5C, but in this case the predominant type of medium- and long-range coulombic interactions are attractive; therefore the pKa value increases with increasing salt concentration as these attractive coulombic interactions with basic residues are screened.
62
B. Kuhlman, D. Luisi, P. Young, and D. Raleigh, Biochemistry 38, 4896 (1999).
48
allosteric enzymes and receptors
[2]
The salt sensitivity of pKa values is very different when the number and surface distribution of acidic and basic residues is balanced. In those cases, every attractive interaction is balanced by a repulsive interaction, thus the net screening effect of increasing ionic strength is nullified. The effects of increasing ionic strength are much smaller in these cases, and they are governed by the ionic strength sensitivity of the self-energy.58,62 This effect favors the charged form of the ionizable group at high salt concentration because of the favorable solvation of the charged species relative to the neutral one. Thus, in proteins where positive and negative charges are balanced, increasing ionic strength increases the pKa values of basic residues and decreases those of acidic residues. These effects are captured nearly quantitatively by the FDPB calculations, which include the self-energy term explicitly. They are missed entirely in the SATK calculations, which normally do not include a self-energy term.58 Electrostatic Interactions in the Denatured State Reproducing the pH dependence of stability with structure-based pKa calculations is difficult. As shown in Fig. 1, this requires knowledge of the pKa values of the protein in the native and in the denatured states. In the calculations based on the thermodynamic cycle in Fig. 2 the pKa values of model compounds in water are used to represent the pKa values of the denatured state. This assumes the absence of any electrostatic effects in the denatured state. This has been shown to be an incorrect approximation in some cases,62,63 and an appropriate one in others.64 This is noteworthy in the context of this chapter primarily because it illustrates another reason that structure-based pKa calculations can fail to reproduce experimental thermodynamic quantities. In this case, the difficulties in capturing the pH dependence of stability of proteins are not related to the problems associated with computation of the electrostatic potential in the macromolecular milieu, or with the quantitative treatment of dielectric relaxation effects of proteins. They are related to the set of model compound pKa values used in the calculations. More experimental studies of the sequence dependence of pKa values in peptides, and new computational methods to reproduce the electrostatic properties of denatured states, will be necessary to overcome these problems.
63 64
M. Oliveberg, V. L. Arcus, and A. R. Fersht, Biochemistry 34, 9424 (1995). M. Tollinger, K. A. Crowhurst, L. E. Kay, and J. D. Forman-Kay, Proc. Natl. Acad. Sci. USA 100, 4545 (2003).
[2]
electrostatic calculations with proteins
49
Physical Properties of Internal Ionizable Residues
Nowhere are the inherent limitations of structure-based pKa calculations with continuum methods more apparent than in the calculations of pKa values of internal residues. The molecular determinants of the pKa values of residues buried in the interior of proteins or at interfaces between macromolecules are drastically different from those of surface residues. Lys-66 in staphylococcal nuclease is useful to illustrate this. This residue was introduced by substitution of the naturally occurring Val-66 with site-directed mutagenesis. Lys-66 is buried in the hydrophobic core of nuclease, surrounded by nonpolar atoms.40,65–67 The ionizable moiety is ˚ from the protein–water interface. Figure 7 describes approximately 12 A the dependence of the calculated pKa value of Lys-66 on the value of ein used in an FDPB calculation with a static structure. The contributions by coulombic, Born, and background energies are also shown. When ein ¼ 80 the calculated pKa value of Lys-66 is higher than the pKa of 10.4 for Lys in a model compound. At this value of ein the contributions by the Born and background terms to the pKa are zero and the slight shift in pKa reflects the effects of long-range attractive interactions with acidic
Fig. 7. Dependence of the calculated pKa value of the internal Lys-66 in staphylococcal nuclease calculated as a function of ein with the simplest implementation of FDPB. Also shown are the contributions by the Born energy () by the background term (!), and by coulombic interactions ( ). The dashed solid line represents the experimental pKa value of 5.7. 40 Note that it takes ein 10 to reproduce the experimental pKa value. 65
W. E. Stites, A. G. Gittis, E. E. Lattman, and D. Shortle, J. Mol. Biol. 221, 7 (1991). B. Garcı´a-Moreno E., J. Dwyer, A. Gittis, E. Lattman, D. Spencer, and W. Stites, Biophys. Chem. 64, 211 (1997). 67 J. Dwyer, A. Gittis, D. Karp, E. Lattman, D. Spencer, W. Stites, and B. Garcı´a-Moreno E., Biophys. J. 79, 1610 (2000). 66
50
allosteric enzymes and receptors
[2]
residues elsewhere on the protein. As the value of ein decreases the pKa value of Lys-66 also decreases. When a critical value of ein 10 is reached the dependence of pKa on ein becomes very steep. The source of the depression of the pKa is the destabilizing Born contribution. The removal of the Lys from water is costly because the protein cannot compensate for the loss of hydration; therefore the equilibrium between the neutral and the charged form is shifted in favor of the neutral form. As the dielectric constant used to treat the interior of the protein decreases the charged form of Lys-66 becomes destabilized relative to its state in water. The dependences of the pKa and of the Born contribution to the pKa on ein are almost parallel when ein < 25. At values of ein < 10 the contributions by coulombic interactions also become significant. They are also destabilizing; thus they also promote the neutral state of Lys-66 and depress its pKa. The coulombic contribution to the pKa of Lys-66 is much smaller than the magnitude of the contributions related to the Born energy. Notice also that the background contribution is very small, as expected for an amino group entirely surrounded by nonpolar groups. However, at very low values of ein, even the background energy, reflecting interactions with polar groups at medium-range becomes significant. The dramatic dependence of pKa values on the value of ein used to treat the protein is not unique to Lys66. Similar behavior has been observed with other internal residues in nuclease and in other proteins.12,68 Notice in Fig. 7 that it takes a value of ein 10 in an FDPB calculation with a static structure to capture the experimental pKa value of 5.7 for the internal Lys-66. The need for such a high value of ein to capture the pKa of this internal group suggests that the protein is undergoing some substantial structural relaxation concomitant with the ionization of the internal Lys-66. This is what ein ¼ 10 captures implicitly. It is noteworthy that according to the intrinsic fluorescence and CD signals, the protein is folded and nativelike after ionization of the internal Lys-66. Further experimental studies will be needed to elucidate the nature of the conformational relaxation induced by the ionization of this internal residue. In contrast to the FDPB calculation, the PDLD method with the linear response approximation reproduces the pKa value of Lys-66 and of Glu-66 when the protein is treated with ein ¼ 6.12 This represents a remarkable improvement over the FDPB calculation—the energy difference between energies calculated with ein ¼ 10 and ein ¼ 6 is very large (see Fig. 7). In principle the PDLD-LRA approximation should have captured the pKa of Lys-66 with ein ¼ 2 because all relaxation processes except induced electronic polarization are treated explicitly in this calculation. The reason that 68
S. Dao-pin, D. E. Anderson, W. A. Baase, F. W. Dahlquist, and B. W. Matthews, Biochemistry 30, 11521 (1991).
[2]
electrostatic calculations with proteins
51
ein > 2 was needed to reproduce the pKa values of residues is probably related to limitations inherent to the simulation times that are used to obtain the trajectories used in the LRA calculations. The calculations could also be underestimating the contributions by water penetration, which has been observed crystallographically.67 Concluding Remarks
The computational approaches for structure-based calculation of pKa values and electrostatic energies in proteins have improved dramatically. The wealth of experimental data on the physical character of surface ionizable groups that has accumulated has allowed rigorous testing, calibration, and modification of continuum methods. Calculations with the method based on the finite difference solution of the Poisson–Boltzmann equation are already useful to analyze a variety of electrostatic contributions to stability and function of proteins governed by surface ionizable groups. These methods capture quantitatively the ionic strength dependence of surface electrostatic effects, and, in general, are useful to estimate pKa values of all surface groups except those involved in strong, short-range interactions. Empirical approaches such as the modified Tanford–Kirkwood method are capable of reliably estimating pKa values of ion pairs on the protein surface. Calculation of pKa values and electrostatic energies in the protein interior or at interfaces between proteins remains very challenging. Not enough experimental data are available to guide the calibration and modifications of existing methods. Our ability to calculate pKa values of internal groups will not improve until we learn how to capture dielectric properties of proteins quantitatively. The most advanced computational method for calculation of pKa values in environments secluded from solvent is the PDLD-LRA, which is in principle equipped to calculate explicitly all contributions to dielectric relaxation other than the contributions from induced dipoles reflected in ein ¼ 2. More experimental data on energetics of ionization of internal residues are needed in order to continue to improve the PDLD-LRA methods. There is urgency in this matter. Without an improved ability to reproduce quantitatively the physical properties of internal ionizable groups, we will remain unable to understand the structural and physical basis of the biological function of most proteins. Acknowledgments Supported by grants from the National Science Foundation (MCB-0212414) and the National Institutes of Health (GM061597). The University of Houston Brownian Dynamics software was used to calculate the data shown in Fig. 3–7.
52
[3]
allosteric enzymes and receptors
[3] Electrostatic Basis for Bioenergetics By Avital Shurki, Marek Sˇtrajbl, Claudia N. Schutz, and Arieh Warshel Introduction
Understanding the molecular basis of biological energy transduction and storage is a problem of fundamental importance. Although different aspects of this problem have been elucidated,1–4 we still lack a detailed description of the relationship between the structure of biological systems and the way they store and utilize their energy. A detailed understanding should cover the action of molecular machines, proton pumps, electron pumps, and enzymes as well as the coupling between these systems. Our early experience has indicated that the best correlation between the structure and function of biological molecules is provided by the corresponding electrostatic energies.5,6 In this chapter we reevaluate the previous proposal considering the progress done in the past 22 years. We will focus on several key systems and show that the corresponding energetics is best described in terms of the corresponding electrostatic energy. Enzyme Catalysis
Enzymes play a pivotal role in biochemistry in controlling the rate of energy transduction. An example is the ATPase reaction in F1-ATPase.4,7 Thus it is important to explore the relationship between the structures of enzymes and the way they catalyze their reactions. Here we will illustrate that the best structure–function correlation in enzymes is obtained by evaluating the corresponding electrostatic energy. Since the subject of enzyme catalysis has been reviewed by us extensively,8 we will consider only several examples including some nontrivial cases. We will also use the discussion of enzyme catalysis as an opportunity 1
P. Mitchel, Nature 191, 144 (1961). W. P. Jencks, ‘‘Catalysis in Chemistry and Enzymology.’’ Dover, New York, 1987. 3 H. Michel et al., Annu. Rev. Biophys. Biomol. Struct. 27, 329 (1998). 4 P. D. Boyer, Biochim. Biophys. Acta 1140, 215 (1993). 5 A. Warshel, Acc. Chem. Res. 14, 284 (1981). 6 A. Warshel, ‘‘Computer Modeling of Chemical Reactions in Enzymes and Solutions.’’ John Wiley & Sons, New York, 1991. 7 H. Wang and G. Oster, Nature 396, 279 (1998). 8 A. Warshel, Annu. Rev. Biophys. Biomol. Struct. 32, 425 (2003). 2
METHODS IN ENZYMOLOGY, VOL. 380
Copyright 2004, Elsevier Inc. All rights reserved. 0076-6879/04 $35.00
[3]
electrostatic basis for bioenergetics
53
to emphasize the importance of proper energy-based analysis, which is an essential requirement in proper analysis of bioenergetics. Defining the Problem in Enzyme Catalysis To clarify the issue of enzyme catalysis we will consider a generic enzymatic reaction using the equation K cat EþS! ES k! ES{ ! EP ! E þ P
(1)
where E, S, and P are the enzyme substrate and product, respectively, ES, EP, and ES{ are the enzyme–substrate complex, enzyme product complex, and transition state, respectively, and K ¼ k1 =k1 . As was shown so eloquently by Wolfenden and Snider,9 many enzymes evolved by optimizing kcat =KM , where KM ¼ (k1 þ kcat )/k1 and can be approximated as KM k1 =k1 . However, this and related findings did not identify the factors responsible for the catalytic effect. As will be shown below, the key question is related to the reduction of the activation barrier in the chemical step. What is needed here is a quantitative tool for structure– function correlation and the ability to determine the individual contributions to the overall catalytic effect. It is gradually becoming clear that this requirement can best be accomplished by computer simulation approaches. Analysis of enzyme catalysis requires proper definition of the relevant questions. First, when talking about catalysis it is essential to ask ‘‘catalysis relative to what?’’ Here we must define a reference reaction and the most obvious reference is the uncatalyzed reaction in water (Fig. 1). Thus elucidation of the origin of enzyme catalysis involves understanding the origin of the difference between the activation barrier in water (g{w ) and the activation barrier in the protein (g{p ¼ g{enz ). However, the enzyme can reduce g{p by both binding the substrate with an equal strength in the reactant state (RS) and the transition state (TS) (in which case g{p g{w ¼ Gbind) and/or by reducing the activation barrier g{cat for the chemical step. Since the factors that control the binding step are well understood, the real puzzle is related to the factors that govern the reduction of the activation barrier of the chemical step (g{cat ). This is, of course, a question of energetics. Experimentally, even the question of whether the enzyme works by stabilizing the RS or TS is not easily resolved, although the type of mutational analysis, which was introduced in Warshel10 (see also Kienhofer et al.11), can help in this respect. In view of the above discussion we should focus 9
R. Wolfenden and M. J. Snider, Acc. Chem. Res. 34, 938 (2001). A. Warshel, J. Biol. Chem. 273, 27035 (1998). 11 A. Kienhofer, P. Kast, and D. Hilvert, J. Am. Chem. Soc. 125(11), 3206 (2003). 10
54
allosteric enzymes and receptors
[3]
Fig. 1. Comparing the activation free energy profile for a reference reaction in water and the corresponding reaction in an enzyme active site. The figure illustrates the relationship between g{cat , g{cage , and g{w .
on two questions: (1) What are the contributions responsible for the difference between (g{cat ) and (g{cage ) and (2) how do these contributions operate (i.e., do they destabilize the RS or stabilize the TS)? Many proposals (see Villa and Warshel12 for a partial list) have attempted to address the above questions in either direct or indirect ways. However, most of the proposals have not been defined in a clear logical way or properly analyzed by their proponents. This, in part, is due to the difficulty of performing such an analysis before the emergence of computer simulations. Moreover, some proposals have not considered a proper thermodynamic cycle (see below). In fact, a major problem in the field is the use of soft definitions, which cannot be examined conceptually or computationally. As will be shown below, with a clear definition of the problem and with a combination of experimental and computational studies it is possible to explore and quantify the origin of the catalytic power of enzymes. Electrostatic Basis for Structure–Function Correlation in Enzymes The field of computer simulations of chemical reactions in enzymes started in 1976.13 This field expanded rapidly in recent years8 and reached a stage where it is possible to reproduce the observed catalytic effect, while 12 13
J. Villa and A. Warshel, J. Phys. Chem. B 105, 7887 (2001). A. Warshel and M. Levitt, J. Mol. Biol. 103, 227 (1976).
[3]
electrostatic basis for bioenergetics
55
calibrating the energy of the reference reaction on the corresponding observed energy (in this way the calculations focus on the difference between the reaction in water and in the enzyme active site). Properly calibrated studies have found that the difference between g{cat and g{cage is mainly due to electrostatic effects. The calculations indicated that enzymes ‘‘solvate’’ their TSs more than the corresponding TSs in the reference solution reactions.14 The nature of this ‘‘solvation’’ effect appeared to be far from obvious. That is, the calculated interaction energy between the TS charges of the reacting atoms and the enzyme was found to be similar to the corresponding interaction energies in solution. This finding indicated that the entire electrostatic energy associated with the formation of the TS must be examined, rather than only the interaction energy at the TS.6 This includes the penalty for the reorganization of the environment upon ‘‘charging’’ the TS. To quantify this catalytic effect it is useful to express the electrostatic free energy of the TS charges by the linear response approximation (LRA) using15 GðQ{ Þ ¼ 0:5 hUðQ ¼ Q{ Þ UðQ ¼ OÞiQ¼Q{ þ hUðQ ¼ Q{ Þ UðQ ¼ OÞiQ¼0 ¼ 0:5 hUiQ{ þ hUi0 (2)
where U is the solute–solvent interaction potential, Q designates the residual charges of the solute atoms with Q{ indicating the TS charges, and < U >Q designating an average over configurations obtained from an MD run with the given solute charge distribution. The first term in Eq. (2) is the above-mentioned interaction energy at the TS, where Q ¼ Q{ , which is similar in the enzyme and in solution. The second term expresses the effect of the preorganization of the environment. If the environment is randomly oriented toward the TS in the absence of charge (as is the case in water), then the second term is zero and we obtain GðQ{ Þw ¼
1 hUiQ{ 2
(3)
where the electrostatic free energy is half of the average electrostatic potential.16 However, in the preorganized environment of an enzyme we obtain a significant contribution from the second term and the overall GðQ{ ) is more negative than in water. This extra stabilization is the catalytic effect of the enzyme. Another way to see this effect is to realize that in water, where the solvent dipoles are randomly oriented around the uncharged 14
A. Warshel, Proc. Natl. Acad. Sci. USA 75, 5250 (1978). F. S. Lee et al., Protein Eng. 5, 215 (1992). 16 A. Warshel and S. T. Russell, Q. Rev. Biophys. 17, 283 (1984). 15
56
allosteric enzymes and receptors
[3]
form of the TS, the activation free energy includes the free energy needed to reorganize the solvent dipoles toward the changed TS. On the other hand, the reaction in the protein costs less reorganization energy since the active site dipoles (associated with polar groups, charged groups, and water molecules) are already partially preorganized toward the TS charges.6,14 The reorganization energy is related to the well-known Marcus reorganization energy, but it is not equal to it. More specifically, the Marcus reorganization energy17 is related to the transfer from the reactant to the product state while here we deal with charging the TS.12 Nevertheless, calculations of the Marcus reorganization energy in enzyme (p) and in solution (w) are also consistent with the above idea, and it has been repeatedly found that p is smaller than w.10,12,18,19 Now, the finding that electrostatic free energies are the key element in structure–catalysis correlation may seem to be inconsistent with many available alternative proposals. The problems with these proposals have been clarified recently.12 Thus we will focus only on some key alternative proposals and demonstrate that they are valid only when they reflect electrostatic effects. Steric Confinements Effect Are Significant Only When They Reflect Electrostatic TSS: The NAC and Related Proposals Several proposals for the origin of enzyme catalysis involve ground state steric strain.20–22 The original strain hypothesis of Phillips and coworkers20 and related subsequent works22 invoked the idea of ‘‘molding’’ the substrate toward the TS by strong steric forces. This idea was inconsistent with simulation studies, which demonstrated that enzymes are flexible and do not apply strong steric forces.6,13 A refined proposal, which is related to the strain hypothesis, has been put forward by Bruice and coworkers (e.g. ref. 23), who suggested that the confinement of the enzyme active site brings the substrate to a so-called near attack conformation (NAC) which is closer to the corresponding TS than in the reference reaction in water. However, the definition of this proposal was based on selecting critical distance and angle, where the NAC is supposed to occur, rather than on free energy surfaces that could be related directly to the difference 17
R. A. Marcus, J. Chem. Phys. 24, 966 (1956). A. Yadav et al., J. Am. Chem. Soc. 113, 4800 (1991). 19 ˚ qvist and M. Fothergill, J. Biol. Chem. 271, 10010 (1996). J. A 20 L. O. Ford et al., J. Mol. Biol. 88, 349 (1974). 21 N. A. Khanjin, J. P. Snyder, and F. M. Menger, J. Am. Chem. Soc. 121, 11831 (1999). 22 O. Tapia, J. Andres, and V. S. Safront, J. Chem. Soc. Faraday Trans. 1 90, 2365 (1994). 23 T. C. Bruice, Acc. Chem. Res. 35(3), 139 (2002). 18
[3]
electrostatic basis for bioenergetics
57
between g{cage and g{cat . That is, the activation free energy can be defined only by the difference between the free energy at the TS and the lowest point at the RS minima, or by the difference between the free energy in the TS and the overall free energy of the RS.24 Thus, selecting an arbitrary point along the reaction coordinate as a reference for the evaluation of the activation energy cannot give unique results. There are clear cases in which it is easy to show that the NAC effect does not contribute significantly to catalysis.25 However, to clarify our perspective we will intentionally take the chorismate mutase (CM) case in which the NAC effect might seem to be very significant. The catalytic reaction of this enzyme (i.e., the Claisen rearrangement of chorismate to prephenate26; see Fig. 2) has been the subject of a large number of theoretical studies. (e.g. refs. 21, 27, and 28). A superficial examination of the results of different studies may suggest that we have here a clear case of reactant state destabilization (RSD). In particular, we can focus on recent MD studies of Hur and Bruice.29,30a This study indicated that the enzyme helps in bringing the reacting atoms of the substrate to a typical distance that they defined as NAC, a distance that is rarely attained in water. Thus they considered this NAC effect as the major reason for the catalytic power of CM. As clarified in our previous work25 the NAC effect and the NAC distance are poorly defined and cannot be uniquely related to the catalytic effect of the given enzyme (see also below). Nevertheless, the MD studies of Hur and Bruice29,30a indicate that the C9 . . . C1 distance of the substrate ˚ for very little free energy, while according to (Fig. 2) can reach about 3.7 A their estimate, it costs 8 kcal/mol in water.30a The question that we would like to address concerns the meaning of this apparent NAC effect. In other words, we would like to find out whether the NAC represent a genuine reason for catalysis or merely reflects the result of electrostatic transition state stabilization (TSS). These two options are described in Fig. 3. According to Fig. 3 in the case of RSD if the enzyme pushes the reacting fragments in the RS toward the TS direction the average distance along the reaction coordinate in the RS (h R iRS in Fig. 3) is shorter in the protein than in water. The second option is the TSS mechanism, which stabilizes both the RS and the TS in 24
A. Warshel and W. W. Parson, Q. Rev. Biophys. 34, 563 (2001). A. Shurki et al., J. Am. Chem. Soc. 124, 4097 (2002). 26 E. Haslam, ‘‘Shikimic Acid: Metabolism and Metabolites.’’ John Wiley & Sons, New York, 1993. 27 S. Martı´ et al., J. Phys. Chem. B 104, 11308 (2000). 28 H. Guo et al., Proc. Natl. Acad. Sci. USA 98, 9032 (2001). 29 S. Hur and T. C. Bruice, Proc. Natl. Acad. Sci. USA 99, 1176 (2002). 30a S. Hur and T. C. Bruice, J. Am. Chem. Soc. 125, 1472 (2003). 25
58
allosteric enzymes and receptors
[3]
Fig. 2. The rearrangement of chorismic acid (1) to prephenic acid (3). The presumed transition state is shown (2). This [3,3]-pericyclic process is formally analogous to a Claisen rearrangement.
Fig. 3. Describing the two possible definitions of the NAC effect in terms of the free energy profile of the reacting fragments along the reaction coordinate. (A) The NAC effect is associated with ground state steric destabilization. That is, the free energy surface of the reacting fragments is pushed up in the RS and, thus, leads to small g{cat . The modification of the water free energy surface by the enzyme is presumably due to the binding of the nonreactive parts of the substrate (this energy is not included in the figure). (B) The enzyme stabilizes the TS by electrostatic effects and in doing so pushes the RS minimum closer to the TS position. This option is the regular TSS proposal, which has nothing to do with the implications of the NAC proposal.
[3]
electrostatic basis for bioenergetics
59
the protein more than in water. However, the stabilization is larger in the w!p w!p TS than in the RS, so that GTS is larger than GRS (where w and p designate water and protein, respectively). The two options in Fig. 3 correspond to two very different limits and to completely different proposals. Bruice and co-workers suggested that CM catalyzes its reaction by ˚ ), which is hard to reach in helping C9–C1 reach a NAC distance (3.7 A water. Now, from a rigorous point of view, the NAC concept is arbitrary since one can choose any distance on the way to the TS (including the TS). Nevertheless, as explained before,25 it is possible to formulate what is probably meant by the NAC concept in a relatively clear way by the restraint release approach of Shurki et al.25 Similar results can be obtained p by a simpler approach focusing on hRiRS and hRiw RS where R is the solute p contribution to the reaction coordinate. That is, if we evaluate hRiRS p we may ask how much it would cost to reach hRiRS in water. We may approximate the NAC free energy by p GNAC G R ¼ hRiRS w G R ¼ hRiw (4) RS w where GðRÞw is the value of the free energy profile in water at the indip cated R. In the above approximation hRiRS provides a proper definition for the NAC distance. However, this analysis does not reveal the origin of the NAC effect. Here we can move again to Fig. 3. In the RSD case (Fig. 3A) we have a real confinement effect where the enzyme pushes the reactants toward the TS and this leads to a reduction of g{cat . Now in the TSS case (Fig. 3B) we also have a ‘‘compression’’ effect p where hRiRS is smaller than hRiw RS . However, this is simply a reflection of the fact that the TSS flattens the potential surface in the enzyme and p p thus hRiRS move closer to hRiTS (Fig. 3B). Obviously, we need to conduct a careful analysis to explore whether the catalytic effect of CM reflects RSD or TSS. In a recent study31 we examined the reaction of CM by the empirical valence bond (EVB) method.6 Our simulations reproduced quantitatively the catalytic effect of CM, thus establishing the reliability of our analysis. After validating the quantitative nature of our free energy calculations we analyzed the NAC effect. As a first step of this analysis we performed LRA calculations of the binding free energy of the RS and TS. The results combined with the EVB free energy profiles are summarized in Fig. 4. Using the binding free energies established that the correct version of Fig. 4 corresponds to TSS. Thus, the apparent NAC is not the reason for the catalysis, but the result of TSS. With this in mind, we tried to find the exact reason for the apparent NAC effect. This was done by performing two sets of calculations: one set with the full EVB, and the other in which
60
allosteric enzymes and receptors
[3]
Fig. 4. Finding the relative positions of the EVB free energy surfaces of CM and the corresponding reaction in water. Using the LRA analysis to obtain the binding free energy we are able to show that the protein curve corresponds to TSS.
Fig. 5. The free energy surfaces for the reaction in water and in CM for calculations that include the complete system (dark lines) and calculations that omit charges of the carboxylate groups.
we omitted the electrostatic interaction between the two carboxylates and between the carboxylates and their surroundings environment. The results of our analysis are shown in Fig. 5. As seen from the figure the omission of the electrostatic contribution from the carboxylates leads to the disappearance of most of the catalytic effect and the rest disappears when all residual charges of the substrate are set to zero. Thus, the main difference between the reaction in CM and in water is due to TSS electrostatic effects.
[3]
electrostatic basis for bioenergetics
61
Now, the reacting system (Fig. 2) involves two negative charges, which are covalently linked to the atoms involved in the bond making process. Thus, a major part of the electrostatic TSS involves stabilizing the two carboxylates at close proximity to each other. This electrostatic stabilization leads to a reduction in the average C9–C1 distance relative to the corresponding distance in water. Although this change in equilibrium distance can be called an NAC effect, it is simply the result of rather than the reason for the catalytic effect. That is, in analyzing enzyme catalysis it is very important to determine what factors actually lead to the overall catalytic effect and to distinguish these factors from other effects that are by-products of the catalytic factors. For example, if an enzyme operates by electrostatic stabilization and the electrostatic effect also leads to a change in the color of the substrate, we will have to recognize that the change in color is a result and not a reason. A recent work of Hur and Bruice30b presented a good correlation between the calculated NAC energies and the increase in activation barrier for different mutants of CM. The correlation was brought as a proves that the catalytic effect of CM is not associated with TS stabilization. Unfortunately, there are several major problems with the above assertion. First, any explicit energy diagram, used by Bruice and coworkers to present their NAC proposal in CM, corresponds to a very clear TSS situation and not to RSD or any other mechanism (see also analysis in Fig. 3 of Sˇ trajbl et al.31 Second, calculated NAC energies seem to represent significant overestimates. For example the calculated NAC energy for the water reaction is much larger than the value obtained by other workers including Strajbel et al.31 Similarly, the values for some mutants are likely to present an overestimate (they reflect an upper limit with some arbitrary definitions). This means that the correlation is not so impressive. Third, and most importantly, a much better correlation is obtained between the changes in the TS energies and the activation free energy. This is also an established experimental fact since KM is similar for the native enzyme and the most important mutant.11 Of course, in cases where the NAC effect is correlated with the TSS we will also have a correlation between the NAC effect and the catalytic effect. Finally, we would like to make a general point. At present all consistent studies indicate that enzymes do not work by RSD but by TSS.32 Now, since enzyme catalysis involves TSS and since this TSS is due to electrostatic preorganization, it is preferable to calculate the electrostatic stabilization 30b
S. Hur and T. C. Bruice, J. Am. Chem. Soc., 125, 10540 (2003). M. Sˇ trajbl et al., J. Am. Chem. Soc. 125, 10228 (2003). 32 A. Warshel et al., Biochemistry 39, 14728 (2000). 31
62
allosteric enzymes and receptors
[3]
effect and to obtain a clear estimate of the catalytic effect than to evaluate the NAC effect, which might or might not help in predicting the catalytic effect.6 It is important to note that the fact that CM works by electrostatic TSS was recently established experimentally in the work of Hilvert and co-workers.11 Most Reactant State Destabilization Proposals Reflect Incorrect Thermodynamic Cycles Many catalytic proposals involve the idea of RSD. These proposals involve the above-mentioned strain proposal, the entropy proposals,2,33,34 and the popular concept that enzymes provide a nonpolar (sometimes described as gas phase–like) environment that destabilizes highly charged ground states.32,35–37 All of these proposals were considered elsewhere,12,24 but in the general contest of bioenergetics it is very useful to consider the desolvation and related proposals. The validity of the desolvation idea has been examined carefully6 and was shown to reflect improper thermodynamic cycles that do not use a proper reference state. This amounts to ignoring the desolvation energy associated with taking the RS from water to a hypothetical nonpolar enzyme site. With a proper reference state, one finds6 that a polar TS is less stable in nonpolar sites than in water and that the RSD does not help in increasing kcat =KM . Thus, there is no evolutionary pressure for this mechanism. In fact, many desolvation models (e.g. refs. 36 and 38) involve ionized residues in a nonpolar environment. Such residues would not be ionized in nonpolar sites. Moreover, in any specific case, when the structure of the active site is known, one finds by current electrostatic models a very polar (rather than nonpolar) active site environment near the chemically active part of the substrate. A case in point is pyrovatedecarboxylase, which was put forward as a classic case of RSD by desolvation.35 However, the structure of this enzyme39 appeared to be very polar. In this respect we would also like to clarify a point of confusion in Jordan et al.,40 who assume that our opinion on polarity reflects a ‘‘simple inspection.’’ In fact, many of our studies that identify protein polarity as their most important feature are based on careful conversion of 33
P. A. Kollman et al., Acc. Chem. Res. 34, 72 (2001). D. Blow, Structure 8, R77 (2000). 35 J. Crosby, R. Stone, and G. B. Lienhard, J. Am. Chem. Soc. 92, 2891 (1970). 36 J. K. Lee and K. N. Houk, Science 276, 942 (1997). 37 M. J. S. Dewar and D. M. Storch, Proc. Natl. Acad. Sci. USA 82, 2225 (1985). 38 F. C. Lightstone et al., Proc. Natl. Acad. Sci. USA 94, 8417 (1997). 39 P. Arjunan et al., J. Mol. Biol. 256, 590 (1996). 40 F. Jordan, H. Li, and A. Brown, Biochemistry 38(20), 6369 (1999). 34
[3]
electrostatic basis for bioenergetics
63
X-ray structures to energetics.16,41,42 At any rate, despite the obvious fact that groups near charges were in a polar rather than nonpolar environment, it is still assumed40 that ion pairs are stabilized in a nonpolar environment and that this is the way pyrovatedecarboxylase catalyzes its reaction. However, as clarified in many of our papers, ion pairs are destabilized (relative to water) rather than stabilized (e.g. ref. 43). Failing to realize this rigorous but seemingly counterintuitive point is one of the obstacles to the progress of modern bioenergetics. A detailed illustration of the problem with the RSD proposal has been given in the case of orotidine 50 -monophosphate decarboxylase (ODCase).32 The catalytic action of this enzyme was first proposed to involve the desolvation effect.36 This was shown to involve an incorrect thermodynamic cycle.44 The elucidation of the structure of this enzyme showed that its active site is extremely polar (highly charged), but this led to a new RSD proposal in which the negatively charged groups of the protein destabilize the carboxylate of the orotate substrate.45 This proposal was shown to be inconsistent with the nature of the system, since a destabilized orotate will accept a proton and become stable.32 Furthermore, careful computational study illustrates that the protein works by TSS and not by RSD.32 This was shown first by including correctly the proton donor (Lys-72) in the reaction system and also by using the same reaction system as used by Wu et al.45 This fact was apparently overlooked in a recent review,46 in which it was suggested that the calculations of Warshel et al.32 involved only a specially selected reaction system. Finally, the fact that the system works by TSS was established experimentally in the mutational studies of Wolfenden and co-workers.47 In discussing the proper use of thermodynamic cycles in bioenergetics in general and in analyzing the desolvation hypothesis in particular, it is useful to consider a recent paper by Devi-Kasavan and Gao.48 They examined the origin of the catalytic power of haloalkane dehalogenase (DhlA) by a QM/MM approach. The calculations reproduced the correct trend of the catalytic effect indicating that it is due to electrostatic effects. It was also found that the activation barrier is higher in water than in the enzyme and that the reaction in water involves loss of solvation energy (the 41
A. Warshel, Nature 333, 15 (1987). A. Warshel and A. Papazyan, Curr. Opin. Struct. Biol. 8, 211 (1998). 43 A. Warshel, S. T. Russell, and A. K. Churg, Proc. Natl. Acad. Sci. USA 81, 4785 (1984). 44 A. Warshel and J. Florian, Proc. Natl. Acad. Sci. USA 95, 5950 (1998). 45 N. Wu et al., Proc. Natl. Acad. Sci. USA 97(5), 2017 (2000). 46 J. Gao and D. G. Truhlar, Annu. Rev. Phys. Chem. 53, 467 (2002). 47 B. Miller and R. Wolfenden, Annu. Rev. Biochem. 71, 847 (2002). 48 L. S. Devi-Kesavan and J. Gao, J. Am. Chem. Soc. 125(6), 1532 (2003). 42
64
allosteric enzymes and receptors
[3]
Fig. 6. Examining the desolvation hypothesis in haloalkane dehalogenase. The figure presents schematically the solvation free energies of the RS and TS, both in water and in the enzyme. It is shown clearly that the solvation effect stabilizes rather than destabilizes the RS in the enzyme (relative to water) but it stabilizes the enzyme TS by a larger extent. This establishes that the enzyme works by solvation rather than desolvation mechanism.
corresponding solvation analysis is not done in the enzyme). However, these findings were confused with the desolvation proposal. That is, the desolvation proposal states very clearly and unambiguously that the enzyme solvates the RS less than water does, regardless of the difference between the solvation energy of the RS and the TS in water.2–3,6 Thus, examination of the origin of the catalytic effect should involve comparison of the absolute solvation energy of the RS in both the enzyme and water systems, as well as a study of the solvation of the TS in the enzyme and in water (rather than a study of the solvation only in water). Consistent studies25 (see also Fig. 6) have found that DhlA stabilizes (solvates) its RS somewhat more than water does, while solvating the TS much more than water. The above considerations are illustrated schematically and unambiguously in Fig. 6 and can be used as an instructive exercise in bioenergetics. Electrostatic Stabilization by Hydrogen Bonds versus the LBHB Proposal Hydrogen bonds (HBs) provide an excellent example of preorganized dipoles that should contribute to catalysis.14 Nevertheless, the catalytic effect of HBs has been the subject of significant controversy and in some cases led to proposals that overlooked key requirements of proper
[3]
electrostatic basis for bioenergetics
65
energy-based analysis. Thus, we will consider the catalytic contribution of HBs as an excellent example for the need of clear energy considerations in bioenergetics. The first concrete support to the idea that HBs contribute to enzyme catalysis can be traced to the identification of the oxyanion hole in subtilisin.49 This structural observation did not involve, however, any estimate of the relevant catalytic energy. Subsequent theoretical studies14,50,51 have established the idea that the overall electrostatic effect of preorganized hydrogen bonds contributes in a major way to enzyme catalysis. These theoretical predictions were confirmed by mutation experiments, showing clearly that a single hydrogen bond can contribute around 5 kcal/ mol to an ionic transition state.52,53 The results of some specific mutation experiments were subsequently reproduced by FEP/US calculations.50 After the experimental demonstration of TS stabilization by hydrogen bonds it was proposed that HBs stabilize TSs in a special nonelectrostatic way, which was termed low-barrier hydrogen bond (LBHB).54–56 The LBHB proposal54–56 suggested that catalytic HBs involve a single (or a flat ground state) rather than a double minimum. Unfortunately, this suggestion (which is sometimes true) does not allow one to distinguish the LBHB proposal from the previous electrostatic proposal of ionic HBs (and thus, does not provide a relevant definition). To distinguish between ionic HBs and LBHB, it is essential to first define the LBHB proposal in a clear way, which reflects the energetics of the system and can be related to enzyme catalysis. At present the best (and in some respects the only) way to define the LBHB proposal is to use the valence-bond (VB) representation. This representation can be treated in a simplified two-state version of the three-state model of Coulson and Danielsson,57,58 augmented by the EVB solvent effect.6 In this representation (Fig. 7) one sees how the pure zero-order states 1 ¼ ½X H Y , 2 ¼ ½X H Y are mixed by an offdiagonal term H12 (resonance term). When the energy gap (g2 g1 ) at r10 is similar in magnitude to H12 we have a single minimum with large covalent character, which is qualified to be defined as LBHB. The transition 49
R. A. Alden et al., Biochem. Biophys. Res. Commun. 45, 337 (1971). A. Warshel, F. Sussman, and J.-K. Hwang, J. Mol. Biol. 201, 139 (1988). 51 S. N. Rao et al., Nature 328, 551 (1987). 52 R. J. Leatherbarrow, A. R. Fersht, and G. Winter, Proc. Natl. Acad. Sci. USA 82, 7840 (1985). 53 P. Carter and J. A. Wells, Proteins Struct. Funct. Genet. 6, 240 (1990). 54 W. W. Cleland and M. M. Kreevoy, Science 264, 1887 (1994). 55 P. A. Frey, S. A. Whitt, and J. B. Tobin, Science 264, 1927 (1994). 56 W. W. Cleland, P. A. Frey, and J. A. Gerlt, J. Biol. Chem. 273, 22529 (1998). 57 C. A. Coulson and U. Danielsson, Arkiv Fys. 8, 239 (1954). 58 C. A. Coulson and U. Danielsson, Arkiv Fys. 8, 245 (1954). 50
66
allosteric enzymes and receptors
[3]
Fig. 7. (A) A two-state VB model for an ionic hydrogen bonded system.59 The free energies g1 and g2 correspond to the states (X H Y ) and (X H–Y). The ground state surface Eg (with a corresponding free energy surface g) is obtained from the mixing of the two states. The donor and the acceptor are held at a distance R. The equilibrium distances for isolated X–H and H–Y fragments are designated by r10 and r20 . and GPT designate the reorganization energy and proton transfer energies, respectively. (B) The LBHB limit occurs when jH12 j > þ GPT , and also when |H12| ’ þ Gpt.
between an ionic HB and LBHB can be quantified by considering the reorganization energy, , the mixing term H12 , and the proton transfer free energy, GPT .59 In the LBHB limit, the electrostatic contribution is larger than the covalent contribution. In other words we are dealing here with a competition between the localized [X H Y], [X H Y ] picture and the delocalized [X1=2 . . . H . . . Y1=2 ] picture. In the gas phase the delocalized picture tends to dominate while in solution the localized is more important. With these limiting cases in mind we can ask what is new in the LBHB proposal. Obviously the idea that HBs, which are preorganized to stabilize ionic TSs, contribute to catalysis is not new (see above). Thus, the only new element in the LBHB proposal is the idea that the covalent delocalized character, which leads to the single energy minimum (or a flat ground state), is the origin of the catalytic effect. In this respect, it should be clear that HBs in solution have a significant covalent character (see early works60). Furthermore, for the LBHB proposal to be valid the covalent character must be larger in the enzyme than in solution, and the corresponding difference must be the source of the HB catalytic effect.59 Obviously, these issues cannot be examined without evaluating the relevant energies. All current attempts to define the LBHB prposal in terms of experimental observations appeared to be circular and logically flowed (e.g. 59). The problem is that any experimental ‘‘proof’’ requires a theoretical interpretation and all current experimental observations are equally 59 60
A. Warshel and A. Papazyan, Proc. Natl. Acad. Sci. USA 93, 13665 (1996). A. Warshel and R. M. Weiss, J. Am. Chem. Soc. 102(20), 6218 (1980).
[3]
electrostatic basis for bioenergetics
67
consistent with the time HB model (see discussion in ref. 65, except pKa measurements, which are simply inconsistent with the LBHB proposal (see later). The entire issue of the validity of the LBHB proposal is related to the interaction between the environment and the VB states of the given ionic HB. The LBHB proponents (who originally assigned to LBHBs in enzymes the enormous energy, 20 kcal=mol, of gas phase LBHB54) argued that the enzyme environment is nonpolar. Obviously, such desolvation arguments are not useful without actual calculations of the relevant polarity and the corresponding solvation effect. Performing such calculations in a reliable way is the best way to examine the LBHB proposal. An excellent case for the analysis of the LBHB proposal is offered by the catalytic triad of serine proteases. Frey and co-workers55 put forward this system as a prime example of LBHB catalysis. They basically proposed that the proton of His-57 is shared between this residue and Asp-102 forming a O1/2 . . . H . . . Nþ1=2 system at the TS of the hydrolytic reaction; this assertion is established by the definition of the LBHB as a system where pKa ¼ 0 and by all the drawings presented by the LBHB proponents. (see Warshel et al.61 for the definition of the relevant system). Warshel and co-workers argued, in turn (based on early calculations61,62), that the pKa of Asp-102 is lower than that of His-57 in the protein, and, thus, the proton must be on His-57. This argument was supported by nuclear magnetic resonance (NMR) studies,63 which were ignored by the LBHB proponents. Now, instead of addressing the well-defined pKa issue, a new argument has been put forward by Cassidy et al.64 They considered the highly relevant system of chymotrypsin with a TS analogue (which will be referred to here as I) where the pKa of His-57 is shifted from 7 to 11. They then argued that the pKa shift is due to a binding-induced steric strain between Asp-102 and His-57, whose release supposedly leads to LBHB. The logical flaws of this proposal are quite significant,65 but here we will simply examine its validity. First, there is no obvious reason (or evidence) for bindinginduced steric strain between Asp-102 and His-57. It is very likely that a negatively charged TS analogue should increase the pKa of the His-57, and, thus, increase pKa between Asp-102 and His-57 and reduce, rather than increase, the LBHB contribution. Although we believe that the trend expected from the I . . . Hisþ interaction based on simple electrostatic considerations should have excluded 61
A. Warshel et al., Biochemistry 28, 3629 (1989). A. Warshel and S. Russell, J. Am. Chem. Soc. 108, 6569 (1986). 63 E. L. Ash et al., Science 278, 1128 (1997). 64 C. S. Cassidy, J. Lin, and P. A. Frey, Biochemistry 36, 4576 (1997). 65 C. N. Schutz and A. Warshel, Proteins Struct. Func. Genetics (in press 2004). 62
68
allosteric enzymes and receptors
[3]
Fig. 8. A schematic description of two thermodynamic cycles describing the different charging states of the intermediate structure with (A) and without (B) the negatively charged inhibitor for examining the LBHB proposal.64 The circles (from the left) designate Asp-102, His-57, and the inhibitor. The energy difference between the different states is given in kcal/mol.
the proposal of Cassidy et al.64 as a valid illustration of the LBHB catalytic effect, we found it useful to examine the actual energetics of the system. The detailed analysis, which will be reported elsewhere,65 is based on the semimacroscopic version of the protein dipole Langivin dipole (PDLD) model) the PDLD/S-LRA method,66 which is one of the most reliable ways of evaluating pKa s in proteins and on EVB calculations.6 The results of this analysis are summarized in Fig. 8. As seen from Fig. 8, the ion pair state is more stable than the nonpolar pair state by 68 kcal/mol in the presence of the TS analogue and about 5–7 kcal/mol in the absence of the TS analogue. The same calculations reproduced the observed change in the pKa of His-57 (12 and 6.5 with and without the TS analogue) and other observables such as the pKa of Asp-102 in the absence of the 66
F. S. Lee, Z. T. Chu, and A. Warshel, J. Comp. Chem. 14, 161 (1993).
[3]
electrostatic basis for bioenergetics
69
TS analogue (pKa ¼ 3 as compared to observed pKa of 2). Furthermore, direct EVB calculations gave free energies of 8 and 6 kcal/mol, respectively, for the PT from His-57 to Asp-102 with and without the TS analogue. Thus, the pKa shift is quantitatively consistent with a model in which there is no LBHB in the free enzyme and even less LBHB in the enzyme with the TS analogue. In addition, it is clear from the enormous contribution of the calculated solvation energy (very similar to those in Warshel and Russell62) that the environment here is very polar, and does not resemble the nonpolar environment envisioned by the LBHB proponents. Note, in this respect, that the arguments of Frey and co-workers64 do not involve any valid energy consideration. Furthermore, it is simply impossible to perform the analysis of Fig. 8 by any current experimental approach. On the other hand, the analysis of Fig. 8 is consistent with the available experimental information and involves reliable and well-tested electrostatic calculations. We consider our analysis to be valid due to its ability to reproduce the observed pKa s using a realistic model of the protein inhibitor system. Detailed examination of the LBHB proposal for the HBs in the oxyanion hole of subtilisin was already presented by Warshel and Papazyan.59 Here again, it was found that the catalysis is due to the preoriented [t . . . H N] system and not to the [t1=2 . . . H . . . N1=2 ] of LBHB (t designates the oxyanion TS). Recent EVB analysis67 examined the LBHB proposal in ketosteroid isomerase. It was found that the HB between Tyr-16 and the substrate enolate has a double minimum and that the charge transfer contribution is similar in the protein and in water. The Energetics of ATP Synthase and Related Systems
The nature of energy transduction in biology has been one of the central issues of molecular biology and bioenergetics. The relationship between protomotive force1 and the action of molecular machines4,68 is a prominent example of the apparent complexity of bioenergetics. In some systems it is more or less clear that the useful energy is transformed in a form of charge separation and charge formation. In others and in particular in molecular machines, it is customary to talk about the conversion of energy to conformational changes. The elucidation of the structure of this system68 confirmed an early hypothesis4 and provides a detailed molecular picture of a remarkable molecular machine structure. Yet, the understanding of the relevant energetics is incomplete. Here we will demonstrate that the relevant energetics is best described as electrostatic energy. 67 68
˚ qvist, Theor. Chem. Acc. 108, 71 (2002). I. Feierberg and J. A J. P. Abrahams et al., Nature 370, 621 (1994).
70
allosteric enzymes and receptors
[3]
Fig. 9. A generic model of the accepted mechanism for the activation of ATP synthase.
Defining the Problem The accepted mechanism of the activation of ATP synthase4,68,69 is described by Fig. 9. Although some modifications of this scheme are available, we can use Fig. 9 as a starting canonical model. In this figure we consider the conventional notation of the three subunits (each composed of and chains), i.e., the structures E, T, and DP, which correspond to the structures of a relaxed empty subunit, a relaxed adenosine triphosphate (ATP) bound structure, and a relaxed adenosine diphosphate (ADP) þ Pi bound structure, respectively. We also use the shorthand notation t, d, and e for ATP þ water, ADP þ Pi, and no ligand, respectively. The steps described in Fig. 9 start with a 120 rotation of the -subunit, which forces the subunits to change their structure and to change the binding energies of the ligands leading to binding of ADP and release of ATP (step A ! B). Next, the ‘‘strained’’ ADP, is formed as a result of step A ! B, is converted to ATP (step B ! C). Significant progress has been achieved in recent years in providing a mechanical picture of the action of ATP synthase.7,70,71 However, the current description is based on macroscopic concepts whose exact relationship to the actual molecular details is not fully understood. The instructive simulation72 showed that the system could be driven from one state to another by exerting a large force. However, a direct simulation of a process that occurs at a millisecond time scale (the time of the first step is 0.2 ms) by a nanosecond process might miss key relaxation processes. It is also hard to obtain reliable conclusions about the energetics of the system by such brute force molecular dynamics (MD) simulations. 69
A. Fersht, ‘‘Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding.’’ W. H. Freeman and Company, New York, 1999. 70 T. Elston, H. Y. Wang, and G. Oster, Nature 391, 510 (1998). 71 D. A. Cherepanov, A. Y. Mulkidjanian, and W. Junge, FEBS Lett. 449(1), 1 (1999). 72 R. A. Bo¨ ckmann and H. Grubmtiller, Nat. Struct. Biol. 9, 198 (2002).
[3]
electrostatic basis for bioenergetics
71
Fig. 10. A schematic description for the energetics of the mechanism for the activation of ATP synthase described with the three zero order (diabetic) states in a curve-crossing diagram. The energies of the different states are displayed along the rotation of the -stalk. A hypothetical adiabetic surface (which describes the fully relaxed system as a function of ) is also given. Note that G2 is actually close to .
Here we would like to convert the structural information about F1-ATPase to a clear structure–energy correlation. As a starting point we convert Fig. 9 to a schematic energy diagram (Fig. 10). In this diagram we consider the three states of Fig. 9 (A, B, and C) as a function of a rotation of the -stalk. In the zero-order picture the structure and ligation state of the subunits are kept fixed (or allowed a limited relaxation) while the -subunit performs a 120 rotation. Thus, the free energy barrier obtained from the energy diagram provides an upper limit for the actual barrier of -rotation. Consideration of Fig. 10 can be useful as a conceptual framework. For example, GA!B ( 0 ) is the free energy of binding ADP þ Pi by E1 and releasing ATP from T2 at ¼ 0. Some of the points on Fig. 10 can be elucidated by using experimental information. However, the construction of the actual free energy curves cannot be accomplished without some form of free energy calculations. Here the selection of the most effective formulation and computational strategy is extremely important. That is, brute force approaches, such as calculations of potential of mean force (PMF), are not likely to give reliable results due to the convergence problems.73 Macroscopic calculations of the direct interaction between the -stalk and its surrounding subunits might also be problematic since the reorganization of the system should have a large effect, which is hard to model by a uniform dielectric constant.74 Thus, we will try to place special emphasis on the selection of the proper simulation approach and will also try to establish the error range on the calculated results. 73 74
A. Burykin et al., Proteins Struct. Funct. Genet. 47, 265 (2002). C. N. Schutz and A. Warshel, Proteins Struct. Funct. Genet. 44, 400 (2001).
72
allosteric enzymes and receptors
[3]
Simplifying the Problem Analyzing the energetics of Fig. 10 by reliable calculations might look hopelessly complicated. Not only do we have to deal with a complex system, but we also have to consider the interaction between different subunits in different conformational states. In addition, we must consider the interactions between the subunits and their ligands. Here the task of obtaining stable and meaningful energy can be overwhelming. Fortunately, it is possible to simplify the problem enormously by using the LRA approach. That is, within LRA it is enough to look on the change in ligand–protein interaction upon a conformational change and to obtain a reasonable approximation for the corresponding change in the interaction between the subunits. This is based on the fact that the change in the interaction between the subunits and within the subunits is about half of the change in the interaction between the subunits and the ligands [note that Eq. (2) does not include the interaction between the environment and itself]. The LRA approach can be used for transformations between different states in the system and for the binding process. To illustrate our LRA approach we will start with the ‘‘simplest’’ case of moving from state B to state C in Fig. 9. Here we will not try to follow the reaction along the coordinate of Fig. 10 but along the conformational change coordinate of Fig. 11A. In other words, we will try to use the LRA to evaluate G(B ! CÞ ¼ 1 (G2 in Fig. 10), by considering the free energy surfaces for the ligand’s configurational states (L ¼ I; II; and III). This is done by using the Marcus-type parabola of Fig. 11A and obtaining
Fig. 11. A schematic energy description of the different diabatic states, shown in Fig. 9, along the conformational changes rather than the rotation of the -stalk in Fig. 10. (A) The second step (B ! C); (B) the first step (A ! B).
[3]
electrostatic basis for bioenergetics
73
1 GII!III ¼ ½hVIII VII iIII þ hVIII VII iII 2 1 II!III ¼ ½hVIII VII iII hVIII VII iIII 2
(5)
where the Vs are the potential surfaces of the indicated states and h iL designates an average over the potential surface VL ðL ¼ I; II; III). It is also understood that the average is performed near the equilibrium configuration of each designated subunit so that hðd; e; tÞ ðd; e; dÞiII is done with the potential surface Vðd1 ; e2 ; d3 ) where the -subunits are constrained by week constraints to be near their observed structure at (DP1 ; E2 ; T3 ). Also, note that at least formally the states I, II, and III are defined only by the ligands A, B, and C. However, the minima of states I, II, and III correspond to the minima of A, B, and C. Now, we can further simplify the nature of Eq. (5) using the explicit nature of the subsystems. For example, we can express 1h GII!III ¼ h½1 ðdÞ2 ðeÞ3 ðtÞ ½1 ðdÞ2 ðeÞ3 ðdÞiDP1 ðdÞE2 ðeÞT3 ðtÞ 2 i þh½1 ðdÞ2 ðeÞ3 ðtÞ ½1 ðdÞ2 ðeÞ3 ðdÞiDP1 ðdÞE2 ðeÞT3 ðdÞ (6) where i ðxÞ designates that the ligand x is bound to the ith subunit. Thus, for example, h½1 ðdÞ2 ðeÞ3 ðtÞ ½1 ðdÞ2 ðeÞ3 ðdÞiDP1 ðdÞE2 ðeÞT3 ðtÞ designates an average over the interaction between d, e, and t and their surroundings when 1 ; 2 , and 3 are held (by the fixed ) near the DP, E, and T configurations, respectively. Now we may simplify our expression by writing 0
0
0
h1 ðdÞ2 ðeÞ3 ðtÞiDP1 ðdÞE2 ðeÞT3 ðtÞ ffi h1 ðdÞiDP 0 ðdÞ þ h2 ðeÞiE0 ðeÞ þ h3 ðtÞiT0 ðtÞ 1
2
3
(7)
where i0 ðxÞ designates the interaction between the ligand x (at the site ) and the entire system. The index III indicates that the subunits are near the configurational state III. Note that we exploit the fact that the LRA approach gives additive contributions. With the help of Eq. (7) we obtain i 1h 0 0 0 0 GII!III ’ hT3 ðtÞ T3 ðdÞiT 0 ðtÞ þ hT3 ðtÞ T3 ðdÞiT 0 ðdÞIII II 3 3 2h (8) i 1 0 0 0 0 II!III ’ hT3 ðtÞ T3 ðdÞiT 0 ðtÞ hT3 ðtÞ T3 ðdÞiT 0 ðdÞ III III 3 3 2 Here the simplified notation h ii ðxÞL means that the average is over the configuration generated with ligand x where the system is kept near the specified structure of i . Equation (8) contains contributions from the chemical part (the ADP!ATP reaction). Following the EVB and our approach for pKa calculations75 we can use the reaction in water as a reference and write
74
allosteric enzymes and receptors
[3]
GII!III ¼ ðGII!III Þw!p þ Gw II!III
(9)
where w and p designate water and protein, respectively. Thus, we have GII!III ¼ ðGII!III Þw!p þ Gðd ! tÞw
(10)
The first term can be evaluated conveniently by the semimacroscopic PDLD/S-LRA approach and the second then is 7.3 kcal/mol in standard conditions where the concentration effect is easily treated.76 The reorganization energy term can also be divided by the solute contribution (inner shell contribution) and the rest of the system (outer shell). Here we can also write II!III ¼ ðII!III Þw!p þ w II!III
(11)
An estimate for the activation barrier can be obtained now from the modified Marcus theory6 g{II!III ¼ ðII!III þ GII!III Þ2 =4II!III HII!III
(12)
where Hij is the mixing between the corresponding states. Because in our case G we have 1 1 1 g{II!III II!III HII!III ¼ ðII!III Þw!p þ (13) II!III HII!III 4 4 4 Here again the expression for can be obtained from the PDLD/ S-LRA approach and the second term is obtained conveniently from the EVB calculation. Trying to use the direct LRA configuration exchange approach for step A!B is more complicated since this step involves binding processes that complicate the use of the configurational exchange approach. One can still try to use such an approach and the diagram of Fig. 11 and obtain the following approximated expression GI!II ffi
1h 0 0 0 0 hE1 ðdÞ E1 ðeÞiE 0 ðeÞ þ hT2 ðeÞ T2 ðtÞiT 0 ðtÞ I I 2 1 2 0
0
0
0
hDP1 ðeÞ DP1 ðdÞiDP 0 ðdÞ þ hE2 ðtÞ E2 ðeÞiE 0 ðeÞ 1
II
2
II
i
þ Gðd ! tÞw
0
¼ GI!II þ Gðd ! tÞw
(14)
where e designates the nonpolar and uncharged form of the ligand x in the expression hðxÞ ðeÞi. Equation (14) can also be expressed as 75 76
A. Warshel, Biochemistry 20, 3167 (1981). M. Sˇ trajbl, J. Florian, and A. Warshel, J. Phys. Chem. B 105, 4471 (2001).
[3]
75
electrostatic basis for bioenergetics 0
0
GI!II ¼ ðGI!II Þw!p þ Gðt ! dÞw þ Gðd ! tÞw ¼ ðGI!II Þw!p
(15)
Equation (15) is, however, a rather rough approximation, since step A!B really involves at least two steps77 that can be modeled as binding processes.77 By the electrostatic contribution to the binding processes by the LRA approximation15 we can obtain 0 0 GI!II ffi GðdÞbind GðtÞbind T T 3
2
(16)
Here we used the cycle introduced in our binding studies15,78,79 where we consider an electrostatic cycle in which the ligand moves from its fully nonpolar and uncharged form to its actual charged configuration in both the solution and the protein environments. The actual electrostatic calculations involved the use of the PDLD/S-LRA approach. This analysis involved a careful evaluation of the binding entropies (by a restraint release approach) and the free energy associated with assembling the ligand components in water.77 The same type of binding cycle allows us to evaluate GII!III . Finally, we can even estimate the activation barrier for the rotation of the -stalk by using the LRA approach. Here, we have to use a nonstandard trick since the corresponding step 1 ! 2 does not involve any change of the ligand charges. However, we can generate a hypothetical process whose reorganization energy corresponds to the free energy of rotation. Doing so77 we obtain i 1h 0 0 0 0 hDP3 ðtÞ DP3 ðdÞiDP0 hT3 ðtÞ T3 ðdÞiT0 ðtÞ 1!2 ¼ (17) 3 3 2 Converting Conformational Energy to Electrostatic Energy The above formulation and the EVB approach allowed us to explore the energetics of the F1-ATPase.77 The first and the conceptually simplest study from our perspective involved the EVB study of the catalytic reaction in step B!C of Fig. 9. These EVB calculations77 reproduced significant catalysis as well as the correct trend in reaction free energy p Gðd ! tÞT ffi 0 kcal/mol. The same study reproduces the large catalytic effect of the enzyme. Similar results were obtained by the PDLD/S-LRA binding calculations. The use of the LRA approach allows us to demonstrate that the energy needed to convert ADP to ATP is supplied by the change of the protein–substrate electrostatic energy upon change of the protein structure from DP to T. M. Sˇ trajbl, A. Shurki, and A. Warshel, Proc. Natl. Acad. Sci. USA (in press 2003). Y. Y. Sham, I. Muegge, and A. Warshel, Proteins 36, 484 (1999). 79 Y. Y. Sham et al., Proteins Struct. Funct. Genet. 39, 393 (2000). 77 78
76
allosteric enzymes and receptors
[3]
The use of the PDLD/S-LRA binding calculations and Eq. (16) also allow us to estimate GI!II . This free energy was also found to reflect electrostatic effects. Although more qualitative studies are obviously needed it is clear that all or most of the conformational effects are converted to changes in electrostatic energies. It is interesting to note in this respect that a significant part of the difference between the energies of the ATP þ H2O and ADP þ Pi states is associated with the electrostatic repulsion between the ADP and Pi fragments. Thus a significant part of the I ! II process can be viewed as a step where the electrostatic energy of assembling the ADP þ Pi system is already paid by the binding process.77 Related Systems Phosphate hydrolysis is used in controlling many other biological processes in addition to the above-mentioned energy transduction processes.80 One of the most important cases is the control of biological signal transduction by G-proteins.81–83 Our extensive studies of the RasGAP switch84–89a have established the mechanism of the guanidine triphosphate (GTP) hydrolysis reaction showing that the GTP substrate itself is the general base. Furthermore, we were able to show how GAP catalyzes the Ras reaction.89b We were also able to quantify the action of Arg-789 (the arginine finger) and Gln-61. While the arginine finger acts by direct electrostatic TS stabilization, the effect of Gln-61 appeared to involve indirect electrostatic effects by changing the local environment of the GTP. Most significantly, from the perspective of the present review, we were able to show that control of GTP hydrolysis is mainly associated with electrostatic effects. Proton Translocation and Electron Transport
The transfer of protons and electrons and the coupling between these processes play a central role in bioenergetics.1,3 Recent progress in the elucidation of the structures of proton transport90,91 and electron transfer 80
F. H. Westheimer, Science 235, 1173 (1987). S. R. Sprang, Curr. Opin. Struct. Biol. 7(6), 849 (1997). 82 I. R. Vetter and A. Wittinghofer, Q. Rev. Biophys. 32(1), 1 (1999). 83 L. Wiesmuller and A. Wittinghofer, Cell. Signal. 6, 247 (1995). 84 R. Langen, T. Schweins, and A. Warshel, Biochemistry 31, 8691 (1992). 85 T. Schweins, R. Langen, and A. Warshel, Nat. Struct. Biol. 1(7), 476 (1994). 86 I. Muegge et al., Structure 4, 475 (1996). 87 T. Schweins and A. Warshel, Biochemistry 35, 14232 (1996). 88 T. Schweins et al., Biochemistry 35, 14225 (1996). 89a T. M. Glennon, J. Villa, and A. Warshel, Biochemistry 39, 9641 (2000). 89b A. Shurk and A. Warshel, Proteins Struc. Func. Genetics (in press 2004). 90 U. Ermler et al., Structure 2, 925 (1994). 91 M. Y. Okamura and G. Feher, Annu. Rev. Biochem. 61, 861 (1992). 81
[3]
electrostatic basis for bioenergetics
77
proteins (see refs. in Warshel and Parson24) has led to major advances in the understanding of such systems. Yet, converting the available structural information to clear energy-based concepts is far from obvious. Here again, we contend that the best way to correlate the structure of the relevant proteins to the corresponding functional properties, the best structure– energy–function correlation, is obtained by evaluating the relevant electrostatic energies. We will demonstrate this point by considering both proton transport and electron transfer. Electrostatic Control of Proton Translocation Processes To quantify the energetics of proton translocation in proteins, we have to consider the feasible proton conduction pathways in the given protein (e.g., the pathway presented in Fig. 12 for the bacterial reaction center of R. sphaeroides) and to evaluate the corresponding energetics and kinetics. This can be done by the approach formulated in Warshel92 and implemented in Sham et al.78 This approach considers the energetics of any relevant charge configuration, G(m), relative to the energy of a state in which all the residues are uncharged. This free energy is related directly to the pKa of each proton donor/acceptor at their sites in the protein and is given by92–94 ( ) h i 1X X ðmÞ ðmÞ ðmÞ p GðmÞ ¼ 2:3RTqi pKint;i pH þ Wij qi qj (18) 2 i6¼j i where m designates the vector of the charge states of the given configurðmÞ ðmÞ ðmÞ ðmÞ ation, i.e., m ¼ ðq1 , q2 ; . . . ; qn ). Here qi is the actual charge of the ith group at the mth configuration. This can be 0 or 1 for acids and 0 or 1 for bases (where we restrict our formulation to mono ions, although the extension to jqj > 1 is trivial). The Wij qi qj term represents the charge– charge interaction term. The intrinsic pKa (pKint ) is the pKa that the given ionizable group would have if all other ionizable groups were kept at their neutral state (the evaluation of this term is described in Sham et al.94). Equation (18) can also be expressed in terms of the energy of forming the given configuration in a reference state (in this case in aqueous solution) at infinite separation of the ions and then transforming it into the protein. This gives75,95
92
A. Warshel, Photochem. Photobiol. 30, 285 (1979). A. Warshel, Methods Enzymol. 127, 578 (1986). 94 Y. Y. Sham, Z. T. Chu, and A. Warshel, J. Phys. Chem. B 101, 4458 (1997). 95 S. H. Chung et al., Biophys. J. 77, 2517 (1999). 93
78 allosteric enzymes and receptors
[3]
[3]
G
79
electrostatic basis for bioenergetics
ðmÞ
ðmÞ w
¼ G
þ
X
( ðmÞ 2:3RTqi
h
p pKint;i
i
¼
X
(
ðmÞ
2:3RTqi
i
þ
1X ðmÞ ðmÞ Wij qi qj 2 j6¼i
w pKa;i
i
1X ðmÞ ðmÞ Wij qi qj þ 2 j6¼i
h i
ðmÞ ðmÞ w!p pKaw pH þ jqi j Gsol qi
)
0
)
(19)
w!p
where ½Gsol ðqi Þ0 represents formally the energy of moving qi from water to its actual protein site when all other ionizable groups are neutral. In the actual calculation we also include in Gsol the solvation of the uncharged form of the given group.94 ðGðmÞ Þw is the free energy of Eq. (18) when all the residues are in water at infinite separation. Now we have to convert the GðmÞ s to the corresponding energy of protonating the different sites. This can be obtained by92 X X ðmÞ ðm;iÞ GHþ ¼ GHþ ¼ W i qm (20) i i
i
where GHþ is the free energy of the given proton configuration and ðmÞ Wi qm i is the contribution to Eq. (19) from its ith term. In more explicit form we can write i w
h ðm;iÞ ðmÞ w!p GHþ ðA ! AHÞ ¼ 2:3RT pK ðA HÞ pH G q i i a i sol 0
X
ðmÞ Wij qi
ðmÞ h qj
i
(21) i
ðm;iÞ ðmÞ w!p GHþ ðBi ! Bi Hþ Þ ¼ 2:3RT pKaw ðBi Hþ Þ pH þ Gsol qi j6¼i
h
0
þ
X
ðmÞ Wij qi
ðmÞ h qj
i
j6¼i
where instead of using the expression for the specific configuration of the qjs we consider now the average charge, h qj i, at the given pH (see discussion below). Applying this approach to H3 Oþ gives
Fig. 12. Schematic description of the groups that can be involved in a proton conductance ˚ . The to QB. The numbers near the dotted lines give the corresponding distances in A sequential numbers of the residues are given according to the Protein Data Bank (PDB) notation of the structure (1PCR) of Ermler et al.90
80
[3]
allosteric enzymes and receptors ðm;iÞ
GHþ
H2 Oi ! H3 Oþ ¼ 2:3RT pKaw H3 Oþ pH i n h io ðmÞ w!p Gsol qi H3 Oþ
þ qi H3 O
þ
X
< qj > Wij
j6¼i
0
(22)
The most significant point from the perspective of the present work is that we have a general expression for the total electrostatic energy of the system including the external pH. This point, which was recognized and formulated in 1979,92 is basically a general formulation of the role of protons in bioenergetics. That is, the pKa s and the corresponding electrostatic energies reflect the total energy of the system, including conformational rearrangements in response to change in charge states as well as the effect of the external proton concentration. The advances in calculations of electrostatic energies in general74 and pKa s in particular94 allow us to use the LRA approach in its semimacroscopic version66,94 and to calculate the energy of all the protonation configurations involved in the proton translocation process. A typical calculation for the proton translocation in the RC of R. sphaeroides, which considered the pathway of Fig. 12, gave the free energy diagram of Fig. 13. The activation barriers g{i!j for a proton translocation between state i and j can be estimated by a simplified ðmÞ modified Marcus relationship6,78 and the Gs of Eq. (19). Thus, we can have all the relevant rate constants (using the g{i!j and transition state theory). With the rate constants it is possible to describe the overall time dependence of the proton transport or proton pumping process by a master equation78 or more reliably by Brownian dynamics (as was done for ion transport73,95). Such studies can provide a direct connection between structural information to energetics and kinetics, thus allowing quantification of the chemiosmotic theory. Electrostatic Control of Light-Induced Electron Transfer Photosynthesis is the most efficient known process for conversion and storage of light energy. Photosynthetic systems operate by light-induced charge separation across a membrane where the electrostatic energy of the charge-separated state is stored in the form of a pH gradient accompanied by conversion of ADP to ATP.96 Now, the previous section considered the relationship between pH gradient and electrostatic energy as well as
96
P. L. Dutton and R. C. Prince, in ‘‘The Photosynthetic Bacteria’’ (R. K. Clayton and W. R. Sistrom, eds.), p. 525. Plenum, New York, 1987.
[3]
electrostatic basis for bioenergetics
81
Fig. 13. A free energy profile for a proton conductance that involves both water molecules and protein residues. This profile includes the effect of the interaction between ionized residues. An alternative profile that keeps some sites is also indicated.
the electrostatic basis of ATP synthesis. In this section we will consider briefly the electrostatic basis of the electron transport process. General considerations of the energetics and efficiency of light-induced electron transport across membranes were introduced in our early work.97 This work considered formally a chain of donors and acceptors that spans the width of the membrane (Fig. 14). It was shown that the entire energetics of the system is determined by electrostatic energy associated with the formation of charges in different sites along the donor and acceptor chain. It was also shown that the only way to control an efficient charge separation process is to control the energetics of the donors and acceptors as well as the reorganization energy in sequential charge transfer steps.97 A proper control can best be obtained by placing the donors and acceptors in the protein sites that will establish the proper electrostatic energy. In particular, it was suggested that fast ET steps should satisfy the relationship shown below (see also Fig. 15): Gij ffi ij
97
A. Warshel and D. W. Schlosser, Proc. Natl. Acad. Sci. USA 78, 5564 (1981).
(23)
82
allosteric enzymes and receptors
[3]
Fig. 14. A schematic model of a conduction chain for light-induced charge separation across a membrane. The chain is composed of a donor (D1) and acceptors (Ai) that span the width of the membrane.
Fig. 15. Energetics and dynamics of conduction chains in several limiting cases. (A) A conduction chain of identical acceptors in a low dielectric membrane. This system cannot give an efficient charge separation because of the large energy of transferring the charge through the membrane. (B) A conduction chain of identical acceptors in aqueous solution. This is an inefficient system because of the high-activation barriers in the individual i ! i þ 1 steps. (C) A conduction chain that combines dielectric stabilization, redox gradient, and optimal relaxation ½ðeÞ ¼ Gi!iþ1 . This provides an optimal downhill charge-separation process.
Our 1981 works,97,98 however, could not provide quantitative proof of the reliability of its concepts in the absence of relevant structural information. 98
A. Warshel, Isr. J. Chem. 21, 341 (1981).
[3]
electrostatic basis for bioenergetics
83
Fig. 16. Structure of the photosynthetic RC of R. sphaeroides.90 The protein is shown in green blue; the ‘‘special pair’’ of BChls (P) in red; the ‘‘accessory’’ BChls (BL and BM) in cyan; the BPhs (HL and HM) in green; quinines (QA and QB) in yellow; the carotenoid (car) in orange; and the nonheme Fe in orange red.
The elucidation of the structure of bacterial reaction centers (RCs)24,99 offered the opportunity to explore quantitatively the principle of lightinduced charge separation in photosynthetic systems. Of particular interest 99
J. Deisenhofer et al., Nature 318, 618 (1985).
84
allosteric enzymes and receptors
[3]
was the relationship between the protein structure and the control of the charge separation process. It was not clear whether the process of moving from the primary acceptor (P in Fig. 16) to the bacteriopheophytin (H in Fig. 16) obeys the electrostatic principles of Eq. (23) and moves through the accessory bacteriochlorophyl (B in Fig. 16), or whether it involves the so-called superexchange mechanism (B participates only as a virtual state). Our electrostatic calculations100 were able to determine for the first time that the system involves a direct hoping mechanism with downhill energetics and very small reorganization energy. This was found at a time at which most experimental studies supported the superexchange proposal. Subsequently, experimental studies have confirmed our prediction.24 More importantly, from the perspective of the present work, it was established that electrostatic calculations provide the ultimate tool for converting structure to energetics and to functions in charge separation processes.5,16,101 This was also found to be true with regard to the directionality of the ET in the two alternative branches in RCs101,102 and in regard to general questions about redox potentials and proteins.103,104 Concluding Remarks
This work considered the structure–correlation aspects of bioenergetics focusing on key processes that are involved in energy transduction and utilization. It was demonstrated that all of these processes can be described quantitatively by considering the corresponding electrostatic energy. Thus, we believe that bioenergetics can be formulated by considering all processes as charge formation, charge distribution, and charge transport. Doing so relative to the corresponding energetics in water provides what is probably the best way of quantifying bioenergetics. Acknowledgments This work was supported by NIH Grant GM 24492 GM 40283 and NSF Grant MCB-0003872.
100
S. Creighton et al., Biochemistry 27, 774 (1988). ˚ qvist, Chem. Scripta 29A, 75 (1989). A. Warshel and J. A 102 W. W. Parson et al., in ‘‘Reaction Centers of Photosynthetic Bacteria’’ (M.-E. MichelBeyerle, ed.), p. 239. Springer-Verlag, Berlin, 1991. 103 P. J. Stephens, D. R. Jollie, and A. Warshel, Chem. Rev. 96, 2491 (1996). 104 A. Warshel, A. Papazyan, and I. Muegge, J. Biol. Inorg. Chem. 2, 143 (1997). 101
[4]
85
control mechanisms in allosteric TD
[4] Local and Global Control Mechanisms in Allosteric Threonine Deaminase By D. Travis Gallagher, Diana Chinchilla, Heidi Lau, and Edward Eisenstein Introduction
Control of enzyme activity through cooperative interactions in multisubunit proteins is a fundamental mechanism for cellular regulation. Decades of biochemical and enzymological research have revealed a host of allosteric systems that exhibit a sigmoidal dependence of ligand binding on concentration.1–5 Additionally, many allosteric enzymes regulate complex metabolic pathways by binding effector ligands at distinct sites that are remote from active sites, in a process referred to as control by feedback inhibition.6,7 Feedback modifiers are often the end products of pathways. Feedback inhibitors, or negative allosteric effectors, typically decrease the activity of the first enzyme in a metabolic pathway. On the other hand, positive allosteric effectors increase the activity of allosteric enzymes at moderate substrate concentrations and are usually products of parallel pathways. The net effect of allosteric interactions is to balance metabolite pools, to increase the efficiency of flux though pathways, and to achieve cellular homeostasis. Despite their widespread importance in metabolic regulation, and although the control of metabolism by allosteric enzymes and their interactions has been well characterized physiologically, there is still much to learn about the molecular basis of this control. The allosteric enzyme threonine deaminase in part controls the biosynthesis of branched-chain amino acids in plants and microorganisms (and it has therefore been referred to as biosynthetic threonine deaminase).8–10 1
H. K. Schachman, J. Biol. Chem. 263, 18583 (1988). J.-P. Changeux, BioEssays 15, 625 (1993). 3 W. N. Lipscomb, Chemtracts-Biochemi. Mol. Biol. 2, 1 (1991). 4 P. R. Evans, Curr. Opin. Struct. Biol. 1, 773 (1991). 5 A. Mattevi, M. Rizzi, and M. Bolognesi, Curr. Opin. Struct. Biol. 6, 824 (1996). 6 H. E. Umbarger, Science 123, 848 (1956). 7 J. C. Gerhart and A. B. Pardee, J. Biol. Chem. 237, 891 (1962). 8 H. E. Umbarger, Adv. Enzymol. 37, 349 (1973). 9 H. E. Umbarger, Annu. Rev. Biochem. 47, 533 (1978). 10 H. E. Umbarger, ‘‘The Biosynthesis of Isoleucine and Valine and Its Regulation.’’ AddisonWesley, Reading, MA, 1983. 2
METHODS IN ENZYMOLOGY, VOL. 380
Copyright 2004, Elsevier Inc. All rights reserved. 0076-6879/04 $35.00
86
allosteric enzymes and receptors
[4]
Threonine deaminase [threonine dehydratase; l-threonine hydrolyase (deaminating); EC 4.2.1.16; TD1] catalyzes the pyridoxal 50 -phosphate (PLP)-dependent conversion of threonine to 2-ketobutyrate in a sigmoidal manner.11 Additionally, enzyme activity is decreased by isoleucine, the end product of the pathway, whereas valine, the product of a parallel pathway, increases activity. The assay and purification of threonine deaminase from several sources have been described previously in these volumes.12–15 Our aim in this contribution is to describe thermodynamic and kinetic approaches that have led to new insights into the molecular basis for allosteric control of threonine deaminase. A key asset to the implementation of these approaches was elucidation of the three-dimensional structure of the enzyme.16 Detailed structural knowledge of the tetrameric enzyme was essential for guiding site-directed mutagenesis to construct enzyme variants with useful properties for a study of the allosteric transition. First we introduce the allosteric and structural properties of threonine deaminase in order to provide a simple description of the promiscuous ligand-binding properties of the enzyme that complicated previous quantitative analyses of valine activation and isoleucine inhibition. Then, we show how the oligomeric structure of the enzyme was altered by a single amino acid substitution at a subunit interface that disrupted the tetrameric quaternary structure, yielding active dimers. The dimeric variant of threonine deaminase we describe shows an increased tendency to assemble to the native tetrameric structure in the presence of active site ligands, and therefore has been useful in providing estimates for the free energies for changes in the subunit interactions that give rise to cooperative active site ligand binding. Finally, we describe the use of chaotropic agents for the generation of hybrid tetramers containing two different dimeric protomers that have specific arrangements of native active sites or regulatory sites. These enzymelike molecules were used to determine whether effector binding to sites on one dimer affects the active sites in an apposing dimer. By extending these classic approaches to the study of threonine deaminase, we have gained significant insight into the nature of allosteric communication that gives rise to metabolic regulation. We believe that adaptation of these approaches to other complex regulatory proteins may also prove valuable in a study of protein interactions linked to biological regulation. 11
E. Eisenstein, J. Biol. Chem. 266, 5801 (1991). R. O. Burns, Methods Enzymol. 17B (1971). 13 P. Datta, Methods Enzymol. 17B, 566 (1971). 14 G. W. Hatfield and H. E. Umbarger, Methods Enzymol. 17B, 561 (1971). 15 Y. Shizuta and M. Tokushige, Methods Enzymol. 17B, 575 (1971). 16 D. T. Gallagher, G. L. Gilliland, G. Xiao, J. Zondlo, E. E. Fisher, D. Chinchilla, and E. Eisenstein, Structure 6, 465 (1998). 12
[4]
control mechanisms in allosteric TD
87
An Expanded Two-State Model for Homotropic Cooperativity in Threonine Deaminase
Historically, investigators have attempted to describe the sigmoidal enzyme kinetics, as well as the effect of isoleucine inhibition and valine activation of threonine deaminase, in terms of the classic two-state model of Monod et al.17 In its simplest form, this model assumes that the enzyme exists in two global forms, known as the T state and the R state (or lowand high-activity/affinity forms), that are in equilibrium in the absence of any ligands. Sigmoidal binding is manifested when the equilibrium distribution of these global conformations or energy states of the enzyme is shifted in the presence of substrates or effectors. Hence, one can determine the applicability of the two-state model by determining the well-known parameters for the allosteric equilibrium constant, L, the [T]/[R] ratio, the dissociation constant for ligands to the R state of the enzyme, KR, and c, the ratio of KR/KT, where KT is the dissociation constant for ligands to the T state. However, early analyses of steady-state kinetic data with threonine18,19 and more recent analyses of the cooperative binding of inhibitors to the active site of the enzyme20,21 were problematic. One issue that has long been considered a complication to the development of a quantitative description of regulation is the structural similarity of threonine, valine, and isoleucine and their potential promiscuous binding to the enzyme.19,22,23 Because the binding isotherms for these ligands to the wild-type enzyme led to conflicting estimates for the allosteric parameters, it was unclear whether the simple two-state model provided a reasonable description of the allosteric transition of threonine deaminase. Can the sigmoidal enzyme kinetics, the activation by valine and the inhibition by isoleucine, be explained by a simple mechanism whereby an equilibrium between global conformations of the enzyme is shifted by the binding of ligands? Or is another mechanism needed to explain the sigmoidal kinetics of threonine deaminase and its allosteric control by feedback modifiers? An important milestone in the attempt to describe the allosteric mechanism of threonine deaminase was the development of an expanded twostate model in which the substrate threonine acts as both a homotropic and heterotropic effector for the allosteric transition by binding not only 17
J. Monod, J. Wyman, and J.-P. Changeux, J. Mol. Biol. 12, 88 (1965). C. J. Decedue, J. G. Hofler, and R. O. Burns, J. Biol. Chem. 250, 1563 (1975). 19 J. G. Hofler and R. O. Burns, J. Biol. Chem. 253, 1245 (1978). 20 E. Eisenstein, H. D. Yu, and F. P. Schwarz, J. Biol. Chem. 269, 29423 (1994). 21 E. Eisenstein, J. Biol. Chem. 269, 29416 (1994). 22 J.-P. Changeux, J. Mol. Biol. 4, 220 (1962). 23 J.-P. Changeux, Cold Spring Harbor Symp. Quant. Biol. 28, 497 (1963). 18
88
allosteric enzymes and receptors
[4]
to the active sites, but also to the four regulatory sites on the tetrameric enzyme.24 Experimental data in support of this model have come from studies of the kinetic and ligand-binding properties of two mutants that are altered in catalysis or regulation. An analysis of the biochemical properties of the feedback-resistant mutant TDL447F revealed that it was insensitive to isoleucine because it was stabilized in the R state. This variant exhibited hyperbolic kinetics using either threonine or serine as substrates, and bound the allosteric activator valine hyperbolically with higher average affinity than that seen for the wild-type enzyme. Moreover, the inhibitors 2-aminobutyrate and alanine bound hyperbolically to the active sites of TDL447F, consistent with the enzyme adopting an R conformation. Another useful variant was an inactive mutant enzyme in which a lysine residue that is essential for catalysis and that forms the Schiff base with PLP in the active site was replaced with alanine (K62A). Several separate preparations of this enzyme variant revealed that it purified with threonine bound covalently to the pyridoxal phosphate cofactor in the active site, thereby stabilizing it in the R state. Additional support for the interpretation that these two enzyme variants were stabilized in the R state conformation came from binding studies that revealed that the parameters determined for isoleucine and valine binding to the TDK62A-Thr complex were identical with those obtained with TDL447F. Importantly, because the active sites of TDK62A were already completely occupied with threonine as a covalent complex with the PLP cofactor, it was possible to assess whether threonine possessed measurable affinity for the regulatory sites on the enzyme. Interestingly, threonine binding to the regulatory sites of the TDK62A-Thr complex revealed a binding constant of 0.8–1.1 mM, at least five-fold stronger than that to the active sites of wild-type enzyme (5–8 mM). Thus, threonine shows stronger affinity for the regulatory sites than it does for the active sites of threonine deaminase. This was seen even more strikingly for 2-aminobutyrate, which binds to the regulatory sites of TDK62A with a binding constant of 110 M, roughly 100-fold more tightly than to the active sites (8–12 mM). An expanded form of the two-state model was used to describe the cooperative binding data of substrate analogs not only to the active sites, but also to the effector sites, to synergistically promote the allosteric transition. This model accounts for the effects of regulatory site saturation in a manner analogous to that proposed by Rubin and Changeux for nonexclusive ligand binding to either the T or the R states in allosteric systems.25 24
E. Eisenstein, H. D. Yu, K. E. Fisher, D. A. Iacuzio, K. R. Ducote, and F. P. Schwarz, Biochemistry 34, 9403 (1995). 25 M. M. Rubin and J.-P. Changeux, J. Mol. Biol. 21, 265 (1966).
[4]
89
control mechanisms in allosteric TD
This expanded form of the two-state model for cooperativity has the following functional form Fractional saturation ¼
ð1 þ Þ3 4 C ½X 1þ½X ð1 þ Þ4 þ L 1 þ Kact;X KRact;X Ract;X
where L is the allosteric equilibrium constant ([T]/[R]) in the absence of ligands, cact,X is the ratio of dissociation constants, KRact,X/KTact,X, for the association of ligand X with the regulatory sites when the enzyme is in either the R or the T conformation, KRact,X is the dissociation constant for ligand X binding to the regulatory sites when the enzyme is in the R conformation, ¼ [X]/KR where [X] is the particular ligand concentration, and KR is the dissociation constant for the ligand for the active sites in the R conformation. The parameter c, or the ratio KR/KT, was fixed at zero because numerical analyses indicated that this value tended to be exceedingly small, reflecting the exclusive binding limit for active site ligands.20 As can be seen in Table I, not only is there excellent agreement in the
TABLE I Allosteric Parameters for Homotropic Cooperativity in Threonine Deaminasea Parameterb
Threoninec
2-Aminobutyrate
L KR c KRact,X cact,X
1450 3.42 mM 0 1.0 mM 0.15
1125 10.9 mM 0 105 M 0.15
a
The allosteric parameters are reported for binding experiments and steady-state kinetics that were conducted in 50 mM potassium phosphate, pH 7.50, at 25 . The fractional saturation for active site ligand binding was measured from the large change in PLP fluorescence upon formation of the external aldimine with an amino acid substrate or inhibitor.21 b The allosteric parameters were determined using nonlinear least-squares analysis methods,26 with the error on the parameters corresponding to 65% confidence intervals. This usually resulted in confidence intervals of about 10–20% of the parameter value for binding constants, and between about 20 and 40% of the value for the allosteric equilibrium constants.20,21,24,27 When binding constants were fixed to the independently determined values, the error on the allosteric equilibrium constants improved substantially to about 10% of the parameter value. c The parameters for threonine are derived from analysis of steady-state kinetics experiments in which it is assumed that fractional saturation is directly proportional to maximal velocity.
90
allosteric enzymes and receptors
[4]
analyses for the allosteric parameters for threonine and 2-aminobutyrate binding to threonine deaminase, but the returned values for the binding constants for these ligands to the effector sites are in accord with those determined separately for TDL447F and the TDK62A-Thr complex. Although the expanded model provided a good description of the regulatory properties of threonine deaminase, it cannot explain in molecular terms a mechanism for how ligands exert their effect on the activity of the enzyme, and to probe these issues, structural information for the enzyme was needed. Structure and Control of Threonine Deaminase
˚ resolution crystal structure of unliganded threonine deamiThe 2.8-A nase (pdb code 1 tdj) reveals that the four subunits of the tetramer appear loosely assembled and are related by three molecular two-fold axes, designated x, y, and z. There is no contact between subunits along the y-axis, and only limited interaction between the N-terminal catalytic domains along the x-axis. In contrast, there is extensive contact between adjacent subunits along the z-axis. The organization of the four chains in the tetramer can be seen in Fig. 1, where each chain is shown in a different color. Each polypeptide chain adopts two roughly equal-sized domains that relate to the mutually perpendicular two-fold symmetry axes determining the tetramer structure. The larger, N-terminal domain contains the PLPcontaining active site and is composed of two / folding units. Each of these two folding units consists essentially of four parallel -strands, with helices on either side of the sheet. Between these two folding units is the PLP cofactor. The N-domain is nearest the center of the molecule and contacts two of its three symmetry mates in the tetramer, at the x- and z-directed symmetry axes. Interestingly, the N-domain shows a striking similarity to the -subunit of the tryptophan synthase complex, in agreement with previous predictions based on sequence analysis and genetic selections for inactive variants.28,29 The active site can clearly be identified, and various residues stabilizing the PLP cofactor are evident. The C-terminal domain is only slightly smaller in size and provides extensive contact with its symmetry mate around the z-axis. The C-domain also has an / organization, with three helices flanking eight antiparallel -strands, which surround a stretch of irregular structure at the subunit 26
M. L. Johnson and S. G. Fraser, Methods Enzymol. 117, 301 (1985). E. Eisenstein, Arch. Biochem. Biophys. 316, 311 (1995). 28 B. E. Taillon, R. Little, and R. P. Lawther, Gene 63, 245 (1988). 29 K. E. Fisher and E. Eisenstein, J. Bacteriol. 175, 6605 (1993). 27
[4]
control mechanisms in allosteric TD
91
Fig. 1. Tertiary and quaternary structure of the threonine deaminase tetramer. Each of the four chains is shown in a different color. Shown in yellow are the pyridoxal 50 -phosphate cofactors that are embedded in the N-terminal catalytic domains. The C-terminal regulatory domains are at the top and bottom in this view. Also shown are the locations of the two symmetry axes that are involved in intersubunit contacts (the y-axis is perpendicular to the plane of the figure). Each subunit contacts two others in the tetramer, e.g., the magenta chain contacts both the green chain and the blue chain. The contacts along the x-axis are relatively few; they include the emphasized key residue glutamine 175 (see also Fig. 2). Contacts along the z-axis include both catalytic and regulatory domains; the regulatory domain contacts are the most extensive in the tetramer, giving the paired regulatory domains the appearance of a single dimeric globular unit. The asterisk indicates the helix in the green chain’s regulatory domain that contains leucine 447, leucine 451, and leucine 454 and is probably near to this chain’s regulatory site. Note that due to the twist in the ‘‘neck’’ between the N and C domains, this green chain regulatory helix is nearer to the magenta chain’s active site than it is to the active site in its own chain.
92
allosteric enzymes and receptors
[4]
interface along the z-axis. The location of the effector binding site in the TD regulatory domain has not been determined crystallographically, but both mutational evidence and alignment with the homologous phosphoglycerate dehydrogenase structure point to the same regions (the helix consisting of residues 446–454, see Fig. 1). A narrow necklike region formed by a single helix (residues 323–334) and its symmetry mate connects the catalytic and regulatory domains. Interestingly, due to the twist in this neck, the putative regulatory helix in one chain is closer to the active site in a different chain than to the active site in its own chain. The structure determination for unligated threonine deaminase provides only a starting point for analyzing the regulation of binding and catalysis. A detailed, molecular explanation for the allosteric transition of the enzyme will remain elusive without additional architectural information. However, the structure in hand has guided the engineering of several variants that have proven useful for a dissection of the allosteric properties of threonine deaminase and has enabled the construction of variants with useful, defined molecular attributes. Active Dimeric Variants Enable an Estimation of the Coupling Free Energy for Cooperative Active Site Ligand Binding
Tetrameric threonine deaminase can be considered a ‘‘dimer of dimers’’ since the crystal structure revealed significant differences in the extent and the nature of the quaternary interactions along the x- and zaxes. Moreover, the structure suggested that it might be possible to alter the smaller of the two quaternary interfaces (the x-interface) so as to promote dissociation of tetramers into component dimers. As can be seen in Fig. 2, a key target for site-specific mutagenesis was glutamine 175 since it forms the central interaction of the x-interface, a bidentate hydrogen bond with the same residue on a symmetrically related monomer. Replacement of the glutamine with glutamate results in a dramatic destabilization of the tetrameric quaternary structure of the enzyme, likely attributable to the significant potential for charge repulsion in the variant. Indeed, the TDQ175E variant is a stable, active dimer, with many functional properties nearly indistinguishable from wild-type threonine deaminase. The ability to construct stable dimers that retain wild-type functional properties provides a significant advantage in dissecting the regulatory energetics of the tetrameric enzyme. Because cooperative ligand binding in allosteric systems is coupled to changes in the intersubunit bonding energy,30 a useful approach for understanding this coupling is to combine 30
R. W. Noble, J. Mol. Biol. 39, 479 (1969).
[4]
control mechanisms in allosteric TD
93
Fig. 2. Quaternary interactions along the x-axis. The view is along the x-axis, which is at the center. The symmetry-related glutamine 175 side chains, interacting through bidentate hydrogen bonds, are emphasized. About six other side chains from each subunit, mostly hydrophobics, are involved in this contact.
ligand-binding studies with subunit association studies.31–33 In this way it is possible to correlate the changes in subunit interaction energies with changes in ligand affinity and thus the regulatory properties of a protein. Several lines of evidence suggest that the TDQ175E variant possessed native-like functional properties. First, an analysis of the kinetic parameters for TDQ175E using the Hill equation yields a K0.5 for threonine of 11 mM, which is increased by about a factor of two from the wild-type value of 5–8 mM, and a Hill coefficient, nH, of 2.0, which is similar to wild-type TD, reflecting a sigmoidal saturation curve. In the presence of 0.5 mM valine, the K0.5 for threonine of 10 mM is virtually unchanged, although nH is lowered to 1.2. On the other hand, in the presence of 50 M isoleucine, the K0.5 increases to 88 mM and the value for nH is 2.4. Second, using changes in tryptophan fluorescence to measure the binding of isoleucine and valine to the regulatory sites of TDQ175E suggests that the variant possesses nativelike functional properties.11,21 Analysis of the binding isotherm for isoleucine using the Hill equation reveals a K0.5 of 5.5 M and a 31
G. K. Ackers and H. R. Halvorson, Proc. Natl. Acad. Sci. USA 71, 4312 (1974). G. K. Ackers, M. L. Johnson, F. C. Mills, and S. H. C. Ip, Biochem. Biophys. Res. Commun. 69, 135 (1976). 33 G. K. Ackers, M. L. Doyle, D. Myers, and M. A. Daugherty, Science 255, 54 (1992). 32
94
allosteric enzymes and receptors
[4]
Fig. 3. Sedimentation equilibrium of TDQ175E. Sedimentation equilibrium was performed with a Beckman XL-A analytical ultracentrifuge. 21 Because of the relatively weak association of dimeric TDQ175E, concentration profiles were obtained from absorbance scans of the PLP cofactor of threonine deaminase at 412 nm, which is reduced by a factor of about six relative to protein absorbance at 280 nm. Scans were performed after equilibrium was attained
[4]
control mechanisms in allosteric TD
95
Hill coefficient, nH, of 1.5, whereas analysis of the valine isotherm yields a K0.5 of 146 M and an nH value of 1.3. Both of these sets of parameters are quite similar to those obtained for the wild-type enzyme.20 Third, at relatively low (mg/ml) concentrations the circular dichroism spectrum of TDQ175E is virtually identical to wild-type threonine deaminase, both in the near- and far-UV regions, as well as in the visible region near 410 nm, indicative of a nativelike environment for the pyridoxal phosphate cofactor. And fourth, at high concentrations (20 mg/ml) the mutant enzyme crystallizes in the same space group as the wild-type enzyme. Despite the similarity of the functional properties of TDQ175E to the wild-type enzyme, sedimentation equilibrium showed conclusively that the mutational alteration indeed resulted in a dimeric quaternary structure. Under native buffer conditions, the tetrameric wild-type enzyme does not show any tendency either to aggregate at high concentration or to dissociate at lower concentration, yielding a molecular weight of 220,000.21 However, as can be seen in Fig. 3A, analysis of sedimentation equilibrium data for TDQ175E reveals that the substitution results in the formation of a dimeric enzyme with a molecular weight of 105,000. Interestingly, sedimentation experiments performed in the presence of isoleucine and valine yielded similar values for the molecular weight, (between 18 and 24 h for 3-mm column heights). Typically, data for TDQ175E were taken at 11,000 rpm at two different protein concentrations at 25 . The molecular weight of dimeric TDQ175E was determined by nonlinear least-squares analysis26 in terms of a single species according to 2 Þ=2RT cr ¼ B þ cm exp Mð1 vÞ!2 ðr2 rm where cr is the concentration of the protein at a given radial position, cm is the concentration of the protein at some reference position (e.g., the meniscus), M is the molecular weight, v is the partial specific volume, is the solvent density, ! is the angular velocity, r is the radial position in centimeters from the center of rotation, rm is the distance in centimeters from the center of rotation to the meniscus, R is the gas constant, T is the absolute (Kelvin) temperature, and B is a correction term for a nonzero baseline. A partial specific volume of 0.738 ml/g was estimated from the predicted amino acid sequence of the threonine deaminase, and the solvent density was determined pychnometrically. In the presence of d-threonine where an analysis of the molecular weight distribution did not conform to that for a single species, data were fit to 2 Þ=2RT cr ¼ B hþ cm;D exp MDið1 vÞ!2 ðr2 rm 2 4 2 þ ðcm;D Þ = KDT exp MT ð1 vÞ!2 ðr2 rm Þ=2RT where MD and MT are the dimer and tetramer molecular weights, and 4KDT is the dimer– tetramer dissociation constant in the presence of saturating d-threonine. (A) Sedimentation equilibrium of TDQ175E in 50 mM potassium phosphate, pH 7.5, with no additional ligands. (B) Sedimentation equilibrium of TDQ175E in 50 mM potassium phosphate, pH 7.5, in the presence of 0.3 M d-threonine.
96
allosteric enzymes and receptors
[4]
indicating that neither of the regulatory ligands has a measurable effect on the quaternary structure of TDQ175E. However, the active site ligands d-threonine and 2-aminobutyrate have a striking effect on the molecular weight distribution of TDQ175E as seen in sedimentation equilibrium experiments. Both of these ligands, which form stable complexes with pyridoxal phosphate in the active site, increase the tendency of the dimeric TDQ175E variant to assemble into tetramers. As can be seen in Fig. 3B, the average molecular weight for TDQ175E obtained in the presence of saturating concentrations of d-threonine is increased relative to the unligated variant. Analysis of the sedimentation equilibrium data presented in Fig. 3B yields a dissociation constant (4KDT) of 11.25 M for the dimer–tetramer equilibrium of the ligated TDQ175E variant. Thus, in the presence of high concentrations of d-threonine sufficient to saturate the active site, the free energy for assembling fully liganded tetramers from liganded dimers, 4 GDT, is 6.75 kcal/mol. Since the sedimentation equilibrium results indicate that active site ligands stabilize the tetrameric form of TDQ175E, simple thermodynamic linkage relationships predict that d-threonine should bind more strongly to tetrameric relative to dimeric forms of the enzyme. This was verified by measuring the binding of d-threonine to TDQ175E at various enzyme concentrations. As can be seen in Fig. 4, representative isotherms for d-threonine binding to TDQ175E shift to the left, indicative of stronger average binding as the enzyme concentration is increased. Because of the limitations of the fluorescence assay for active site ligand binding,21,27 only a 20-fold range in active site concentration could be compared in d-threonine binding studies. At the lowest protein concentration of the assay, corresponding to 1.45 M sites, the average binding constant was estimated to be 49 mM, which corresponds to a free energy for ligand binding to a single site on a dimer, GDX, of 1.8 kcal/mol. At the highest protein concentrations examined, 28.3 M sites, the average binding constant is reduced to 29.7 mM. Thus, on a qualitative basis, the interaction energy at the glutamine 175 interface increases as ligands bind to the active site of threonine deaminase. Except for its quaternary structure, dimeric TDQ175E is so similar to the wild-type enzyme in its structural and functional properties that it is useful to consider the consequences of these energetic binding patterns by making two assumptions. The first assumption is that at high enough TDQ175E concentrations, beyond those amenable to the fluorescence assay for active site ligand binding, the saturation curve for d-threonine will approach that seen for wild-type threonine deaminase, characterized by an average binding constant of 19.8 mM. The second assumption is that at the lowest concentrations of TDQ175E used in the binding assay, the protein
[4]
control mechanisms in allosteric TD
97
Fig. 4. Protein concentration-dependent d-threonine binding to TDQ175E. Saturation curves for d-threonine binding to various concentrations of TDQ175E were measured from the change in PLP fluorescence upon titration with d-threonine, which binds only to the active site of threonine deaminase.21 Binding experiments were performed in 50 mM potassium phosphate, pH 7.5, at 25 . Saturation curves were analyzed in terms of an average binding constant, equivalent to the median ligand activity, for each protein concentration.20,21,24,27 Three of the isotherms shown represent the following (site) concentrations of TDQ175E: (d) 1.45 M sites, yielding a Kav of 49 mM and a GDXav of 1.8 kcal/mol; (h) 6.0 M sites, yielding a Kav of 42.7 mM; (m) 17.7 M sites, yielding a Kav of 34.2 mM. Also shown is a reference curve for d-threonine binding to tetrameric, wild-type threonine deaminase (m) at a concentration of 1.76 M sites, yielding a Kav of 19.8 mM and a GTXav of 2.32 kcal/mol.
concentration is sufficiently below the dimer–tetramer equilibrium constant that the average binding energy for d-threonine reflects binding solely to the dimeric species. Employing these assumptions enables an evaluation of the total energies for ligand binding to dimeric and tetrameric forms of threonine deaminase, and along with the experimentally determined dimer–tetramer equilibrium constant, enables the estimation of the free energy for unliganded dimers associating to tetramers, and to evaluate the coupling free energy for cooperative active site ligand binding to the enzyme. A linkage scheme for d-threonine binding to dimers and tetramers of threonine deaminase and for the dimer–tetramer equilibrium in the absence and presence of ligand is presented in Fig. 5. The total binding energy for d-threonine saturation of two (TDQ175E) dimers is 7.2 kcal/mol. Since 4 GDT, the dimer–tetramer equilibrium constant in the presence of saturating concentrations of d-threonine, was determined to be 6.75 kcal/mol, then the total energy in assembling unliganded dimers to liganded tetramers is 13.95 kcal/mol. Because the total free energy for binding
98
allosteric enzymes and receptors
[4]
Fig. 5. Thermodynamic linkage scheme for cooperative d-threonine binding and dimer– tetramer assembly in threonine deaminase. The total energy for four ligands binding to two dimers was estimated from the average energy obtained for d-threonine binding to TDQ175E at a concentration (1.45 M sites) well below the dimer–tetramer dissociation constant. The total energy for binding 4 mol of d-threonine to tetrameric threonine deaminase is estimated from ligand binding to the wild-type enzyme. The free energy for the dimer–tetramer equilibrium of TDQ175E in the presence of saturating d-threonine was obtained from sedimentation equilibrium experiments. With these three quantities it is straightforward to estimate the free energy for the dimer–tetramer equilibrium of TDQ175E in the absence of ligands. A cooperative free energy of 2.08 kcal for active site ligand binding in this system can be estimated either from the difference in assembly free energy in the presence and absence of ligands or from the difference in the total ligand binding free energy for tetramers and dimers. d-Threonine is indicated by an X in the scheme, dimeric TDQ175E by D, and tetrameric threonine deaminase by T.
d-threonine to the (wild-type) tetramer is 9.28 kcal/mol, then it is possible to estimate an assembly free energy, 0GDT, of 4.67 kcal/mol for the association of two unliganded dimers to form an unliganded tetramer, which corresponds to a binding constant of about 375 M. Thus, the coupling or cooperative free energy for cooperative d-threonine binding to TDQ175E, and by analogy, to the wild-type enzyme, can be estimated either from the difference between the total energy of ligation for tetramers versus dimers, or the difference in assembly free energy between fully liganded dimers forming tetramers versus unliganded dimers forming tetramers. Either of these approaches yields an estimate for the coupling free energy for cooperative d-threonine binding to threonine deaminase of 2.08 kcal, a small, negative number. The importance of estimating a value for the cooperative free energy for threonine deaminase is that this is the energy that the molecule releases in undergoing the allosteric transition from a low-affinity to a high-affinity
[4]
control mechanisms in allosteric TD
99
form. Interestingly, this value is negative, which reflects the tightening of intersubunit bonding energies in the presence of active site ligands as seen by sedimentation equilibrium. The fact that this value is rather small may simply reflect the relatively limited surface area at the glutamine 175 inter˚ 2). Strikingly, the temperature dependence of the dimer– face (only 730 A tetramer equilibrium constant for d-threonine–ligated TDQ175E yields a positive enthalpy change of þ6.6 kcal/mol, indicating that the association reaction is entropy driven, possibly due to solvent release from the vicinity of glutamate 175 as the interface is buried. Although both isoleucine and valine showed significant effects on the d-threonine binding isotherms for TDQ175E, it was unexpected that they had no effect on the subunit association energies. The most obvious interpretation of this result is that the regulatory information stemming from isoleucine and valine binding to the effector sites is not communicated from one dimer to another across the x-axis, which raises the question of whether regulatory ligands act by a local or global mechanism. Hybrid, Enzyme-Like Tetramers Support a Local Model for Feedback Regulation of Threonine Deaminase
Despite the pronounced inhibition and activation of threonine deaminase that isoleucine and valine show in kinetics assays, the molecular basis for these effects, and the similar effects seen for many allosteric enzymes, is unknown. Do isoleucine and valine act globally to propagate their effects to all of the active sites of the tetrameric enzyme, or do heterotropic ligands exert local changes in the activity of only those active sites in the proximity of their binding? A classic approach to address these issues is to construct hybrid enzymes with distinct arrangements of native and defective catalytic and regulatory sites and to characterize them with respect to their allosteric properties.33,34–39 Based on the striking changes in quaternary structure of threonine deaminase upon the introduction of single amino acid substitution at the x-axis of the tetramer, the effect of low levels of chaotropic agents such as NaSCN to promote dissociation was evaluated. Sedimentation equilibrium 34
F. R. Smith and G. K. Ackers, Proc. Natl. Acad. Sci. USA 82, 5347 (1985). Y. R. Yang and H. K. Schachman, Anal. Biochem. 163, 188 (1987). 36 S. R. Wente and H. K. Schachman, Proc. Natl. Acad. Sci. USA 84, (1987). 37 E. Eisenstein and H. K. Schachman, in ‘‘Protein Function: A Practical Approach’’ (T. Creighton, ed.), p. 135. IRL Press, Oxford, 1989. 38 E. Eisenstein, M. S. Han, T. S. Woo, J. M. Ritchey, I. Gibbons, Y. R. Yang, and H. K. Schachman, J. Biol. Chem. 267, 22148 (1992). 39 G. K. Ackers, Adv. Protein Chem. 51, 185 (1998). 35
100
allosteric enzymes and receptors
[4]
indicated that the addition of as little as 0.125 M NaSCN increased the tendency of wild-type threonine deaminase to dissociate from tetramers into dimers, yielding an equilibrium constant for dissociation of about 0.1 M under these conditions, consistent with the limited contact between the dimers at the x-axis interface of the enzyme. Because of the relative ease of dissociating native enzyme, the ability of limited NaSCN treatment to construct hybrid tetramers containing dimers from different parents was evaluated using two chromatographically distinguishable variants of threonine deaminase. This approach utilized a purified enzyme variant expressed from pET-15b (Novagen) with a 20-residue, thrombin-cleavable, His6 sequence that requires higher salt concentrations to elute from an anion-exchange column relative to wild-type threonine deaminase. After addition of 0.125 M NaSCN to an equal mixture of wild-type and Histagged threonine deaminase (at mg/ml levels), overnight incubation, and dilution of NaSCN to minimize effects on chromatography, three species elute from an anion-exchange resin in a roughly binomial (1:2:1) distribution. These results are consistent with the formation of hybrid tetramers composed of two different homodimeric protomers. However, because His-tagged threonine deaminase exhibits a marked reduction in activity relative to native enzyme, analyses of the catalytic and allosteric properties of hybrids were performed on mixtures of hybrids and their parents to shed light on a mechanism for feedback regulation. The experimental strategy was to mix equal amounts of a catalytically deficient variant of threonine deaminase with another variant that was altered in binding feedback modifiers. In this way it was possible to generate a hybrid that contained one dimer with a pair of native catalytic sites but inactive regulatory sites apposed to another dimer with a pair of inactive catalytic sites but native regulatory sites. These hybrids were used to assess the effect of binding feedback modifiers on one dimer on the activity of the other dimer in a tetramer. The compartmentalized, twodomain structure for threonine deaminase readily enabled the construction of inactive variants with native regulatory binding properties29 and fully active variants that were unable to bind isoleucine and valine.40 The first hybridization experiment presented in Fig. 6 illustrates the predicted and observed properties of hybrid tetramers composed of one catalytically defective dimer and one regulatory site defective dimer. The catalytically inactive parent in this experiment contains the active site S86G substitution, resulting in the complete loss of enzyme activity and isoleucine auxotrophy.29 The parent defective in regulatory ligand binding is a triple mutant of threonine deaminase in which leucine residues at 40
D. Chinchilla, F. P. Schwarz, and E. Eisenstein, J. Biol. Chem. 273, 23219 (1998).
[4]
control mechanisms in allosteric TD
101
Fig. 6. Experimental strategy and results for the hybridization of catalytically inactive and regulatory site-deficient variants of threonine deaminase. The top panel is a schematic of the hybridization of a parental variant of threonine deaminase with no catalytic activity, TDS86G (shaded catalytic domains) and another parental species that cannot bind ligands at the effector sites, TDL447,451,454A (shaded regulatory domains) to yield hybrid tetramers with defined arrangements of native active and regulatory sites. (The catalytic and regulatory domains of each chain are presented in the same orientation as Fig. 1, with the small, central circles representing active sites and the small peripheral rectangles representing regulatory sites.) The expected hybrid possesses native regulatory sites adjacent to inactive catalytic sites in one dimer, and competent catalytic sites adjacent to impaired regulatory sites in the other dimer. The bottom panel shows the specific activities of the various components in the hybridization mixture. Control experiments (d) show no activity of the active site variant either in the absence or presence of isoleucine (50 M). Alternatively, the activity of the regulatory site variant (&) is unchanged in the presence of isoleucine. The mixture (m) exhibits half of the specific activity of the active parent because only half of the active sites are functional. However, there is no effect of isoleucine on the activity of the mixture. This result is consistent with a local mechanism for regulation by feedback modifiers and is in contrast to that expected for a global effect for feedback regulation (shown as a dotted line). The production of 2-ketobutyrate was assayed continuously at 230 nm in 50 mM potassium phosphate, pH 7.5, at 25 , containing 10 mM l-threonine. Reactions were initiated by 500-fold dilution of enzyme mixtures that were incubated in the presence or absence of 0.125 M NaSCN into substrate solutions. There was no effect of up to 25 mM NaSCN on the activity or regulation of wild-type threonine deaminase. Because there was virtually no difference between the specific activities seen for the mixtures either in the absence or presence of feedback modifiers, only one set of data points is presented for each experimental condition to simplify the presentation of the data. The predicted effects for local and global mechanisms of regulation are shown parenthetically, adjacent to the relevant curves in the bottom panel.
102
allosteric enzymes and receptors
[4]
positions 447, 451, and 454 are replaced by alanine, resulting in a dramatic loss in affinity for isoleucine and valine.40 According to this rationale, dissociation of these two parents to dimers followed by random reassembly should yield hybrid tetramers with a distinct arrangement of native active sites and native regulatory sites (Fig. 6, top panel). If isoleucine (and valine) regulated the enzyme through a local mechanism in which they affected only the active sites within a dimer that were adjacent to competent regulatory binding sites, then no change would be expected in the level of activity of the mixture in the presence of heterotropic ligands. On the other hand, if feedback ligands altered enzyme activity in a global manner that was communicated across the x–interface, then a gradual decrease in the activity for a hybrid mixture would be expected in the presence of isoleucine, reflecting the time course for hybridization. Representative results can be seen in the bottom panel of Fig. 6 for the hybridization of inactive TDS86G with a regulatory site triple mutant deficient in isoleucine and valine binding. At 0.125 M NaSCN, which is sufficient to promote the complete hybridization at the dimer level for these two parents, there is no effect of isoleucine or valine on the mixture relative to controls incubated in the absence of chaotropic agent. These results are consistent with the interpretation that heterotropic ligand binding affects only those catalytic sites within the same dimer of a hybrid tetramer, and is in sharp contrast to that expected if the binding of feedback modifiers resulted in a global effect that altered activity throughout the tetramer. A second experiment performed using another catalytically inactive TD variant, the TDK62A-Thr complex, which is stabilized in the high-affinity, R state24 and the regulatory site triple mutant, yielded surprising results. As can be seen in Fig. 7, this hybridization mixture displayed an increase in activity with time, rather than a fixed level based on the concentration of native active sites in the mixture. However, because there was no effect of isoleucine (or valine) on the activity of this mixture, similar to the results for TDS86G, they provide additional support for a local mechanism for feedback regulation in threonine deaminase. The simplest interpretation for the increase in activity seen for this mixture is that the R form of the TDK62A-Thr complex was able to convert the unliganded active sites in the apposing dimer of the hybrid tetramers from the T into the R state, thereby increasing the activity of the mixture relative to control or predicted values (Fig. 7, bottom panel). Support for this interpretation comes from additional binding and enzyme kinetic measurements. Threonine saturation curves of the mixture treated with NaSCN relative to controls in the absence of chaotropic salt reveal that the hybrid mixture exhibits nearly hyperbolic kinetics, consistent with its
[4]
control mechanisms in allosteric TD
103
Fig. 7. Activation of unliganded active sites by inactive, R state dimers in a hybrid tetramer of threonine deaminase. The top panel shows the specific activities of the various components in a hybridization mixture containing the TDK62A-Thr complex, which is stabilized in the R state, and TDL447,451,454A, which is in the T state and cannot bind regulatory ligands. Control experiments show no activity for the inactive parent, TDK62A-Thr, (bottom curve, d), and no change in activity for the regulatory site parent, TDL447,451,454A (top curve, d), either in the absence or presence of NaSCN and isoleucine. Also, a mixture of these enzymes in the absence of NaSCN (&) exhibited half of the specific activity of the active parent. In the presence of NaSCN, however, the hybrid mixture (m) exhibited an increase in activity, reflecting an activation of the hybrid enzyme during the time course. The bottom panel shows a schematic representation of a possible mechanism for activation of the native catalytic domains in one dimer by the liganded, but inactive catalytic domains in an apposing dimer. Inactive domains are shaded gray, and liganded active sites are shown as small filled circles. Because there was virtually no difference between the specific activities seen for the mixtures either in the absence or presence of feedback modifiers, or in relevant cases, in the absence or presence of sodium thiocyanate, only one set of data points is presented for each experimental condition to simplify the presentation of the data.
conversion to the R state. Additionally, valine-binding experiments provide an estimate for an average dissociation constant of roughly 25 M, similar to that seen for the R state variant TDL447F, and vastly reduced from the value of roughly 140 M for control reactions of the parent tetramers mixed in the absence of NaSCN. Thus, these hybridization experiments suggest that it is possible to stabilize the activated R form of threonine deaminase when two catalytic sites within one dimer are
104
allosteric enzymes and receptors
[4]
occupied with substrate. This interpretation has significant implications for identifying important intermediates that populate the T and R states in the course of cooperative ligand binding to the active sites of the enzyme. The binding of a second substrate within the same dimer of threonine deaminase may therefore be sufficient to promote the allosteric transition by converting the entire enzyme population from the T to the R form. Although the previous two approaches do not support the notion of a global mechanism for feedback regulation in threonine deaminase, and they are also consistent with the finding that neither isoleucine nor valine showed an effect on the dimer–tetramer dissociation constant of TDQ175E, more direct evidence could be obtained for a local mechanism in a third hybridization experiment illustrated in Fig. 8. This strategy consisted of
Fig. 8. Isoleucine inhibition within an active dimer of hybrid tetramers supports a local model for feedback regulation. The top panel illustrates the hybridization strategy for the inactive, R state–like TDK62A-Thr complex that also contains alanine substitutions for leucines 447, 451, and 454, and wild-type threonine deaminase. The bottom panel shows the effect of isoleucine (50 M) on the steady-state kinetics of the hybrid mixture using threonine as a substrate. In the absence of isoleucine (d), the saturation curve is virtually hyperbolic, consistent with the fact that the majority of the active sites have been converted to the R state. The addition of isoleucine (&) results in a marked decrease in the activity of the hybrid mixture, indicating that feedback regulation occurs within a dimeric protomer of threonine deaminase.
[4]
control mechanisms in allosteric TD
105
combining in a single threonine deaminase variant the K62A mutation along with the three regulatory site mutations to produce an inactive enzyme that was unable to bind effector ligands. Once again, because the TDK62A-Thr complex is stabilized in the R state, hybridization experiments between this variant and with wild-type threonine deaminase resulted in a mixture that exhibited an increase in activity with time. However, in this case, there was a (slight) effect of isoleucine on reducing the increase in activity during the time course. This can be seen more clearly in the bottom panel of Fig. 8, which shows that a hybrid tetramer containing inactive catalytic and regulatory sites in one dimer and native catalytic and regulatory sites in another dimer exhibits hyperbolic kinetics, indicating that the hybrid is stabilized in the R state. However, in this case, the hybrid enzyme shows a significant decrease in activity in the presence of isoleucine. This experiment provides important, additional support for the idea that feedback modifiers act on catalytic sites that are adjacent to local regulatory sites, and that these ligands do not have a substantial effect on the global properties of the enzyme. Conclusions
The strategy of combining structural, thermodynamic, and kinetic approaches to a study of allosteric enzymes can yield important insights into the molecular mechanisms for their regulation. Here we have illustrated how the three-dimensional structure of threonine deaminase guided mutagenesis efforts to enable the construction of a number of enzymes that proved useful for biochemical studies. Experimental results on these variants have led to an interesting, yet complex picture for threonine deaminase regulation. Substrates bind not only to active sites, but also to regulatory sites to activate the enzyme. Thus, substrates can synergistically promote the allosteric transition, which can be explained quantitatively by an expansion of the classic two-state model to incorporate promiscuous ligand binding. Cooperative active-site ligand binding to the tetramer strengthens intersubunit interactions, and the relatively small coupling free energy that can be estimated suggests that subtle changes at subunit interfaces may significantly influence homotropic cooperativity. Indeed, analyses of hybrid tetramers composed of two different parental dimers that exhibit altered kinetics and effector-binding properties suggest that once two substrates are bound to the active sites within one dimer, the entire tetrameric enzyme converts to the high-activity conformation. Thus, full dimer ligation is an important switch for a global transition that leads to homotropic cooperativity in active site ligand binding. On the other hand, feedback modifiers appear to regulate only the active sites within
106
[5]
allosteric enzymes and receptors
the dimer to which they are bound. Since they do not have an effect on the catalytic activity of the apposing dimer within tetramers, feedback modifiers regulate threonine deaminase by a local mechanism that may involve intra- or interchain interactions that are communicated only within a dimeric protomer of enzyme.
[5] Methods for Analyzing Cooperativity in Phosphoglycerate Dehydrogenase By Gregory A. Grant Introduction
d-3-Phosphoglycerate dehydrogenase (PDGH) from Escherichia coli exhibits multiple cooperative processes. These include positive and negative cooperativity in effector binding,1 positive cooperativity in catalytic inhibition by the effector that reaches a maximum at less than full occupancy of effector binding sites,1 and negative cooperativity in cofactor binding.2 Thus, this enzyme provides a relatively unique and very interesting system for studying the structural basis of cooperativity. d-3-Phosphoglycerate dehydrogenase (EC 1.1.1.95) catalyzes the first committed step in the biosynthesis of l-serine by converting d-3-phosphoglycerate to hydroxypyruvic acid phosphate utilizing NADþ as a cofactor.3,4 Subsequently, hydroxypyruvic acid phosphate is converted to phosphoserine by phosphoserine transaminase and then to l-serine by phosphoserine phosphatase.3 In some organisms, such as E. coli,5 PGDH is inhibited by l-serine, the end product of the pathway. E. coli PGDH is a V-type enzyme6 that accomplishes its regulation of catalysis by altering the velocity of the reaction rather than the affinity of the substrates. PGDH is found throughout the range of living organisms4,7,8 and is a member of a family of proteins that are classified as 2-hydroxyacid dehydrogenases, which are generally specific for substrates with a d 1
G. A. Grant, X. L. Xu, and Z. Hu, Protein Sci. 8, 2501 (1999). G. A. Grant, Z. Hu, and X. L. Xu, J. Biol. Chem. 277, 39548 (2002). 3 A. Ichihara and D. M. Greenberg, J. Biol. Chem. 224, 331 (1957). 4 D. A. Walsh and H. J. Sallach, J. Biol. Chem. 241, 4068 (1966). 5 L. I. Pizer, J. Biol. Chem. 238, 3934 (1963). 6 E. Sugimoto and L. I. Pizer, J. Biol. Chem. 243, 2081 (1968). 7 J. E. Willis and H. J. Sallach, Biochim. Biophys. Acta 81, 39 (1964). 8 J. C. Slaughter and D. D. Davies, Methods Enzymol. 41, 278 (1975). 2
METHODS IN ENZYMOLOGY, VOL. 380
Copyright 2004, Elsevier Inc. All rights reserved. 0076-6879/04 $35.00
106
[5]
allosteric enzymes and receptors
the dimer to which they are bound. Since they do not have an effect on the catalytic activity of the apposing dimer within tetramers, feedback modifiers regulate threonine deaminase by a local mechanism that may involve intra- or interchain interactions that are communicated only within a dimeric protomer of enzyme.
[5] Methods for Analyzing Cooperativity in Phosphoglycerate Dehydrogenase By Gregory A. Grant Introduction
d-3-Phosphoglycerate dehydrogenase (PDGH) from Escherichia coli exhibits multiple cooperative processes. These include positive and negative cooperativity in effector binding,1 positive cooperativity in catalytic inhibition by the effector that reaches a maximum at less than full occupancy of effector binding sites,1 and negative cooperativity in cofactor binding.2 Thus, this enzyme provides a relatively unique and very interesting system for studying the structural basis of cooperativity. d-3-Phosphoglycerate dehydrogenase (EC 1.1.1.95) catalyzes the first committed step in the biosynthesis of l-serine by converting d-3-phosphoglycerate to hydroxypyruvic acid phosphate utilizing NADþ as a cofactor.3,4 Subsequently, hydroxypyruvic acid phosphate is converted to phosphoserine by phosphoserine transaminase and then to l-serine by phosphoserine phosphatase.3 In some organisms, such as E. coli,5 PGDH is inhibited by l-serine, the end product of the pathway. E. coli PGDH is a V-type enzyme6 that accomplishes its regulation of catalysis by altering the velocity of the reaction rather than the affinity of the substrates. PGDH is found throughout the range of living organisms4,7,8 and is a member of a family of proteins that are classified as 2-hydroxyacid dehydrogenases, which are generally specific for substrates with a d 1
G. A. Grant, X. L. Xu, and Z. Hu, Protein Sci. 8, 2501 (1999). G. A. Grant, Z. Hu, and X. L. Xu, J. Biol. Chem. 277, 39548 (2002). 3 A. Ichihara and D. M. Greenberg, J. Biol. Chem. 224, 331 (1957). 4 D. A. Walsh and H. J. Sallach, J. Biol. Chem. 241, 4068 (1966). 5 L. I. Pizer, J. Biol. Chem. 238, 3934 (1963). 6 E. Sugimoto and L. I. Pizer, J. Biol. Chem. 243, 2081 (1968). 7 J. E. Willis and H. J. Sallach, Biochim. Biophys. Acta 81, 39 (1964). 8 J. C. Slaughter and D. D. Davies, Methods Enzymol. 41, 278 (1975). 2
METHODS IN ENZYMOLOGY, VOL. 380
Copyright 2004, Elsevier Inc. All rights reserved. 0076-6879/04 $35.00
[5]
analyzing cooperativity in PGDH
107
configuration.9 PGDH is the only known member of this family that exists as a tetramer; all other members so far identified are dimeric proteins. It appears that it is the tetrameric structure of E. coli PGDH that is responsible for its ability to be regulated by l-serine (see below). However, even though eukaryotic PGDHs retain a tetrameric structure, no eukaryotes have been shown to contain a PGDH that is inhibited in this manner. PGDH exists in two different structural motifs that do not appear to be strictly specific for organism type.10 The PGDH of some bacteria and some single-cell eukaryotes, such as yeast, are structurally similar to the E. coli enzyme. In addition to the 2-hydroxyacid substrate and nucleotide-binding domains, they possess a C-terminal domain that is involved in effector binding and regulation of activity. This third domain has been called the ACT domain11,12 and consists of a structural motif that has been found in other proteins as well. Other bacteria and higher order eukaryotes, including mammals, possess a large polypeptide insertion in their C-terminal segment between the ACT domain and the 2-hydroxyacid domain. E. coli PGDH (EC 1.1.1.95) is composed of four identical subunits (see Fig. 1) each with three structurally distinct domains, the substrate-binding domain, the nucleotide-binding domain, and the regulatory domain.13 The substrate-binding domain is flanked on either side by the nucleotidebinding domain and the regulatory domain, which binds the effector, l-serine. The catalytic cleft is found between the substrate- and nucleotide-binding domains. In the tetramer, the subunit interfaces are formed by contact between adjacent regulatory domains on the one hand and adjacent nucleotide binding domains on the other, to form a ‘‘dimer of dimers’’ type structure. Two l-serine molecules can bind between each of the two pairs of adjacent regulatory domains forming a hydrogen bond network across the noncovalent interface. Note that each subunit does not contain a complete serine-binding site within its own structure. Rather, binding of effector at two symmetrical interfaces controls the activity of four active sites. The regulatory and substrate-binding domains are linked by only a single strand of polypeptide, which contains a Gly-Gly sequence approximately midway between the two domains. The substrate-binding and the nucleotide-binding domains are connected at one end of the catalytic cleft by only two strands of polypeptide, one of which also contains the only 9
G. A. Grant, Biochem. Biophys. Res. Comm. 165, 1371 (1989). Y. Achouri, M. H. Rider, E. Van Schaftingen, and M. Robbi, Biochem. J. 323, 365 (1997). 11 L. Aravind and E. V. Koonin. J. Mol. Biol. 287, 1023 (1999). 12 D. M. Chipman and B. Shaanan. Curr. Opin. Struct. Biol. 11, 694 (2001). 13 D. Schuller, G. A. Grant, and L. J. Banaszak, Nat. Struct. Biol. 2, 69 (1995). 10
108
allosteric enzymes and receptors
[5]
Fig. 1. Ribbon diagram of the structure of PGDH. The enzyme is a tetramer of identical subunits shown in alternating dark and light gray. The three structural domains in each subunit are labeled for the upper left subunit. The subunit contacts are at the interface of the regulatory domains and the interface of the nucleotide-binding domains. The location of the serine-binding sites are shown and the serines are depicted with space-filling structures. The serine molecules bind at the interfaces and form hydrogen bonds to both subunits. One of the active sites is also labeled. Bound NADH is shown in ball and stick form.
other Gly-Gly sequence found in the enzyme. Site-directed mutagenesis studies14,15 have shown that the properties of these Gly-Gly sequences are consistent with them functioning as flexible hinge regions in PGDH. Thus, catalysis and regulation of PGDH are thought to occur through movement of rigid domains about flexible hinges. As mentioned above, E. coli PGDH is particularly interesting because its regulation by l-serine displays various levels of cooperativity. While the 14 15
G. A. Grant, X. L. Xu, and Z. Hu, Biochemistry 39, 7316 (2000). G. A. Grant, Z. Hu, and X. L. Xu, J. Biol. Chem. 276, 17844 (2001).
[5]
analyzing cooperativity in PGDH
109
catalytic activity of PGDH displays normal Michaelis–Menton kinetics, its inhibition by l-serine behaves in a positively cooperative manner.6,16 Under appropriate conditions, the binding of l-serine to PGDH can display both positive and negative cooperativity in a stepwise manner.1 Furthermore, these two cooperative processes, serine inhibition and serine binding, can be uncoupled by restricting the rotational freedom around one of the Gly-Gly hinges.15 This observation underscores the concept that the two processes occur by distinct pathways that, although initiated by a common event, diverge at some point and proceed by way of unique structural elements. In addition, E. coli PGDH displays negative cooperativity in the binding of NADH.2 Two sites in the enzyme bind NADH very tightly and two sites bind NADH with weaker affinity. A very interesting property of E. coli PGDH is that cofactor binding modulates the degree of cooperativity observed in l-serine binding. The differential binding of NADH provides evidence for at least two additional conformational states that can be directly correlated to altered degrees of cooperativity of serine binding. Somewhat unexpected is the significant effect of cofactor binding on effector binding without a similar effect in the opposite direction. In summary, at least three cooperative processes can be distinguished in PGDH. They are the binding of l-serine, the inhibition of catalytic activity, and the binding of the cofactor, NADH. Investigations of these properties require reliable means to assess the nature of the interaction of the effector molecule with the protein and the modulation of catalytic activity produced, both in the native enzyme and in response to structural mutations introduced into the enzyme. This chapter discusses the methods that have been used to provide this information. None of the methods described here is new or can be attributed as unique to this investigation. However, they have been very productive in providing insight into the structural basis and dynamics of allosteric regulation in an enzyme with multiple dependent sites. Characterizing Cooperative Ligand Binding
Binding to a Single Site or Multiple Independent Sites In the simplest case, one molecule of ligand binds to one binding site on each molecule of protein. As you will see below, this case is relatively straightforward and can be characterized quite easily.
16
E. Sugimoto and L. I. Pizer, J. Biol. Chem. 243, 2090 (1968).
110
allosteric enzymes and receptors
[5]
The binding of a ligand (L) to a protein (P) can be depicted simply as P þ L ! PL and the equilibrium constant, which is equivalent to the association constant, is defined as Keq ¼ Ka ¼ ½PL=½P½L
(1)
Conversely, the process of dissociation of a ligand from a protein is depicted as PL ! P þ L and the dissociation constant, which is the inverse of the association constant, is Kd ¼ ½P½L=½PL
(2)
To determine the magnitude of these binding constants, the concentrations of protein [P], ligand free in solution [L], and ligand bound to protein [PL] must be determined. Note that [L] refers to the free ligand concentration and is not equivalent to the total ligand concentration [Lt] which is actually [L] þ [PL]. The total protein and ligand concentration can be directly measured prior to the start of the binding experiment. The challenge is in distinguishing bound from free ligand (see equilibrium dialysis below). The experimental determination of the binding constants is accomplished by measuring the concentration of [PL] as a function of the concentration of [L]. This is usually expressed in terms of the fractional saturation of P by L. The fractional saturation (Y) is defined as the fraction of available binding sites that are occupied by ligand and ranges from 0 to 1. Thus Y ¼ ½PL=ð½P þ ½PLÞ
(3)
Rearranging Eq. (2) to [PL] ¼ [P] [L] /Kd and substituting into Eq. (3) yields Y ¼ ð½L=Kd Þ=ð1 þ ð½L=Kd ÞÞ ¼ ½L=Kd þ ½L
(4)
For a protein with only a single ligand binding site ‘‘n,’’ Y ¼ n. However, if more than one binding site exists (n > 1), then Y ¼ r=n
(5)
where r is the number of ligands bound per protein molecule. Thus Eq. (4) becomes r ¼ n½L=Kd þ ½L
(6)
[5]
analyzing cooperativity in PGDH
111
This equation works well to define a system in which all of the binding sites are equivalent and independent of each other and produces a hyperbolic binding curve when r is plotted against [L]. Multiple Dependent Sites What if there are more than one binding site for a ligand and what if these binding sites are not equivalent, that is, what if the affinity for the ligand is different for each site and the affinity of the other sites changes as each new ligand binds? This is the situation that one is presented with when dealing with cooperative processes—that is, processes in which the ligand-binding sites are not independent but instead where they interact with each other by virtue of a dynamic structural change in the protein during the successive binding of multiple ligands. A useful equation to deal with this situation was developed by Adair17 in 1925 when it was used to describe the binding of oxygen to hemoglobin. The Adair equation is derived in a manner similar to that above by considering each individual binding event PLn1 þ L ! PLn For instance, the binding events for a protein with four ligand sites are PþL PL þ L PL2 þ L PL3 þ L
! ! ! !
PL PL2 PL3 PL4
The dissociation constant for the binding of the first ligand is expressed by Eq. (2), but for binding of each subsequent ligand it is expressed by Kd;n ¼ ½PLn1 ½L=½PLn
(7)
The fractional saturation, Y, can then be expressed as above by Y ¼ ½PL þ þ n½PLn =nð½P þ þ ½PLn Þ
(8)
Substituting the appropriate terms for [PLn] from Eq. (2) and (7) and dividing both the numerator and denominator by [P] yields the Adair equation for n binding sites. For n ¼ 1: Y ¼ ð½L=K1 Þ=ð1 þ ð½L=K1 ÞÞ
17
G. S. Adair, Proc. R. Soc. Lond. A 109, 292 (1925).
(9)
112
allosteric enzymes and receptors
[5]
For n ¼ 2: n h io Y ¼ ð½L=K1 Þ þ 2½L2 =K1 K2 = 2 1 þ ð½L=K1 Þ þ ½L2 =K1 K2 (10) For n ¼ 3: Y ¼ ð½L=K1 Þ þ 2½L2 =K1 K2 þ 3½L3 =K1 K2 K3 = n h io 3 1 þ ð½L=K1 Þ þ ½L2 =K1 K2 þ ½L3 =K1 K2 K3
(11)
For n ¼ 4: Y ¼ ð½L=K1 Þ þ 2½L2 =K1 K2 þ 3½L3 =K1 K2 K3 þ 4½L4 =K1 K2 K3 K4 = n h 4 1 þ ð½L=K1 Þ þ ½L2 =K1 K2 þ ½L3 =K1 K2 K3 io þ ½L4 =K1 K2 K3 K4 (12)
where Y is the fractional occupancy, [L] is the free ligand concentration, and Ki are the stepwise Adair constants. Note that in the case of n ¼ 1, Eq. (9) is equivalent to Eq. (4). The same equation can also be derived in a more general way using a binding polynomial or binding partition function.18,19 The partition function represents the sum of the concentrations of all of the species present relative to a reference species, which is usually taken to be the unliganded protein. For PGDH, which has four binding sites, its partition function can be represented as Q ¼ ð½P þ ½PL þ ½PL2 þ ½PL3 þ ½PL4 Þ=½P
(13)
First consider the various association constants that can be represented for each binding step,
18
K1 ¼ ½PL=½P½L
(14)
K2 ¼ ½PL2 =½PL½L
(15)
K3 ¼ ½PL3 =½PL2 ½L
(16)
K4 ¼ ½PL4 =½PL3 ½L
(17)
J. Wyman and S. J. Gill, ‘‘Binding and Linkage, Functional Chemistry of Biological Macromolecules.’’ University Science Books, Mill Valley, CA, 1990. 19 M. L. Johnson and M. Straume, Methods Enzymol. 323, 155 (2000).
[5]
analyzing cooperativity in PGDH
113
Solving for [PLn] and putting the equation in the form of just [P] and [L] gives ½PL ¼ K1 ½P½L
(18)
½PL2 ¼ K2 ½PL½L ¼ K1 K2 ½P½L2
(19)
½PL3 ¼ K3 ½PL2 ½L ¼ K1 K2 K3 ½P½L3
(20)
½PL4 ¼ K4 ½PL3 ½L ¼ K1 K2 K3 K4 ½P½L4
(21)
Substituting into Q gives Q ¼ 1 þ K1 ½L þ K1 K2 ½L2 þ K1 K2 K3 ½L3 þ K1 K2 K3 K4 ½L4
(22)
The degree of binding, r, is found by taking the partial derivative of ln Q with respect to ln [L] or @ ln Q=@ ln ½L ¼ ð½L=QÞ@Q=@½L
(23)
which is r ¼ ðK1 ½LÞ þ 2K1 K2 ½L2 þ 3K1 K2 K3 ½L3 þ 4K1 K2 K3 K4 ½L4 = 1 þ ðK1 ½LÞ þ K1 K2 ½L2 þ K1 K2 K3 ½L3 þ K1 K2 K3 K4 ½L4
(24)
And since Y ¼ r=n; and n ¼ 4, Y ¼ ðK1 ½LÞ þ 2K1 K2 ½L2 þ 3K1 K2 K3 ½L3 þ 4K1 K2 K3 K4 ½L4 = n h 4 1 þ ðK1 ½LÞ þ K1 K2 ½L2 þ K1 K2 K3 ½L3 io þ K1 K2 K3 K4 ½L4
(25)
Since the dissociation constant is the inverse of the association constant, Eq. (25) can be expressed as Y ¼ ð½L=K1 Þ þ 2½L2 =K1 K2 þ 3½L3 =K1 K2 K3 þ 4½L4 =K1 K2 K3 K4 = n h i o 4 1 þ ð½L=K1 Þ þ ½L2 =K1 K2 þ ½L3 =K1 K2 K3 þ ½L4 =K1 K2 K3 K4
(26) which is the same as Eq. (12).
114
[5]
allosteric enzymes and receptors
Note that the Adair constants are not equivalent to the intrinsic dissociation constant of each site. This is because as each site becomes occupied, there are fewer sites available for occupancy and more sites from which ligand can dissociate. In other words, for a protein with no bound ligand, there are four sites available for binding. Once the first site binds ligand, only one site can dissociate a ligand and there are now only three sites available for binding. When the second site is occupied, dissociation can occur from two sites but there are also only two sites available for more binding, and so on. Thus there is a statistical relationship between the Adair constant (Ki ) and the intrinsic constant (Ki0 ) for each site. For n ¼ 2 sites: 0
0
K1 ¼ 2K1 ;
K2 ¼ K2 =2
(27)
For n ¼ 3 sites: 0
K1 ¼ 3K1 ;
0
K2 ¼ K2 ;
0
K3 ¼ K3 =3
(28)
For n ¼ 4 sites: 0
K1 ¼ 4K1 ;
0
K2 ¼ 3K2 =2;
0
K3 ¼ 2K3 =3;
0
K4 ¼ K4 =4
(29)
The statistical parameters can be incorporated into the Adair equation to directly yield the intrinsic constants. For n ¼ 2: n h io 0 0 0 0 0 0 Y ¼ 2½L=K1 þ 2½L2 =K1 K2 = 2 1 þ 2½L=K1 þ ½L2 =K1 K2 (30) For n ¼ 3: 0 0 0 0 0 0 Y ¼ 3½L=K1 þ 6½L2 =K1 K2 þ 3½L3 =K1 K2 K3 = n h io 0 0 0 0 0 0 3 1 þ 3½L=K1 þ 3½L2 =K1 K2 þ ½L3 =K1 K2 K3
(31)
For n ¼ 4 : 0 0 0 0 0 0 0 0 0 0 Y ¼ 4½L=K1 þ 12½L2 =K1 K2 þ 12½L3 =K1 K2 K3 þ 4½L4 =K1 K2 K3 K4 n h io 0 0 0 0 0 0 0 0 0 0 4 1 þ 4½L=K1 þ 6½L2 =K1 K2 þ 4½L3 =K1 K2 K3 þ ½L4 =K1 K2 K3 K4
(32)
[5]
115
analyzing cooperativity in PGDH
Thus, the Adair equation can be used to analyze systems in which cooperative behavior is occurring since dissociation constants can be derived for each binding event by fitting the equation to a plot of Y versus [L]. Once the Adair constants are determined, the relative distribution of the bound species as a function of free ligand concentration can be plotted using expressions for each species derived from the Adair equation: n h h i D1 ¼ ð½L=K1 Þ= 1 þ ð½L=K1 Þ þ ½L2 =ðK1 K2 Þ h i h iio þ ½L3 =ðK1 K2 K3 Þ þ ½L4 =ðK1 K2 K3 K4 Þ (33) D2 ¼
D3 ¼
h i n h h i ½L2 =ðK1 K2 Þ = 1 þ ð½L=K1 Þ þ ½L2 =ðK1 K2 Þ h i h iio þ ½L3 =ðK1 K2 K3 Þ þ ½L4 =ðK1 K2 K3 K4 Þ i n h h i ½L3 =ðK1 K2 K3 Þ = 1 þ ð½L=K1 Þ þ ½L2 =ðK1 K2 Þ h i h iio þ ½L3 =ðK1 K2 K3 Þ þ ½L4 =ðK1 K2 K3 K4 Þ
(34)
h
h
i n h h i D4 ¼ ½L4 =ðK1 K2 K3 K4 Þ = 1 þ ð½L=K1 Þ þ ½L2 =ðK1 K2 Þ h i h iio þ ½L3 =ðK1 K2 K3 Þ þ ½L4 =ðK1 K2 K3 K4 Þ
(35)
(36)
where Di indicates the distribution of the species with i bound ligands. For molecules that bind fewer numbers of ligands, the equations can be adjusted by deleting the later terms in the denominator. The change in free energy associated with ligand binding can be expressed as the free energy of dissociation and is given by Gd ¼ RT ln Kd
(37)
Then, the interaction free energy, which reflects the effect of binding of one ligand on another, is the difference in intrinsic free energy expressed as 0
0
0
0
Gint ¼ RT ln K2 RT ln K1 ¼ RT ln ðK2 =K1 Þ
(38)
Note that Gint is negative for a positively cooperative process. Assessing the Cooperativity of Binding A common perception in regard to positive cooperativity is that it produces a binding curve with sigmoidal character. This is generally true, but the sigmoidicity of the curve can be obscured in plots made over the whole range of binding. As the number of binding sites increases and the
116
allosteric enzymes and receptors
[5]
interaction between sites becomes more complex, the idea that cooperativity can necessarily be detected by visual inspection of the Y versus [L] plot is less useful. Even if positive cooperativity is sustained from step to step, the effect cannot always be determined visually. Figure 2 shows theoretical
Fig. 2. Theoretical binding curves. Curves were generated from the Adair equation for four binding sites [Eqs. (12) and (26)] to demonstrate the effect of cooperative binding on the curve shape. Top left: Curves demonstrating increasing positive cooperativity where the 0 0 0 0 dissociation constants differ 10-fold () K1 ¼ 100, K2 ¼ 10, K3 ¼ 1, K4 ¼ 0:1; increasing 0 0 negative cooperativity where the dissociation constants differ 10-fold (r) K1 ¼ 0:1, K2 ¼ 1, 0 0 0 0 0 0 K3 ¼ 10, K4 ¼ 100; and no cooperativity (d) K1 ¼ 10, K2 ¼ 10, K3 ¼ 10, K4 ¼ 10. Bottom left: Expansion of the top left plot at low l-serine concentrations. Top right: Curves demonstrating 0 increasing positive cooperativity where the dissociation constants differ 2-fold () K1 ¼ 10, 0 0 0 K2 ¼ 5, K3 ¼ 2:5, K4 ¼ 1:25; increasing negative cooperativity where the dissociation 0 0 0 0 constants differ 2-fold (r) K1 ¼ 1:25, K2 ¼ 2:5, K3 ¼ 5, K4 ¼ 10; and no cooperativity 0 0 0 0 (d) K1 ¼ 10, K2 ¼ 10, K3 ¼ 10, K4 ¼ 10. Bottom right: Expansion of the top right plot at low l-serine concentrations.
[5]
117
analyzing cooperativity in PGDH
Adair plots for a protein with four dependent binding sites (like PGDH) when the dissociation constants for successive sites differ by either 2- or 10-fold. In no case is a sigmoidal curve shape very evident when the data are plotted over the whole range of ligand concentration. The insets show that at low ligand concentrations, sigmoidal character can be visually detected in the positively cooperative plots, but this does not occur for negative cooperativity. An example of l-serine binding to PGDH that shows both positive and negative cooperativity is given in Fig. 3. Table I shows the dissociation constants determined from fitting the data to the Adair equation for four binding sites as well as the interaction free energy calculated from those constants. Ideally, the values of the dissociation constants determined with the Adair equation will reveal if cooperativity is present. If subsequent dissociation constants decrease in magnitude, the binding is positively cooperative. If they increase in magnitude, the binding is negatively cooperative. The distribution of species calculated from the dissociation constants by Eqs. (33)–(36) is shown in Fig. 4. Note that due to the positive cooperativity of binding the second ligand, the D2 species rises very rapidly and closely follows the occurrence of the D1 species at low serine concentration. As the number of binding sites in a protein increases, the requirement to fit additional variables in the Adair equation can introduce a large degree of uncertainty, which manifests itself as relatively large error factors. Although the fit may look very good visually and the fitting statistics are acceptable, the error for each variable may be so large that they are not statistically different. An example of such a fit to the Adair equation for a mutant of PGDH is presented in Fig. 5. Note that the dissociation constants produced from this fit (see figure legend) are associated with very
TABLE I Parameters Derived from Fitting Equilibrium Dialysis Binding Data to the Adair Equation for Four Sites Adair constant (M) K1 K2 K3 K4 R
¼ ¼ ¼ ¼ ¼
7.8 0.001 2.7 0.004 42.1 0.0002 1026 0.99304
Statistical correction factor 4/1 3/2 2/3 1/4
Intrinsic dissociation constant (M) K10 K20 K30 K40
¼ ¼ ¼ ¼
31.2 4.1 28.1 very large
Interaction free energy (kcal / mol)
Gint Gint Gint
12 23 34
¼ 1.2 ¼ þ1.1 ¼ þ very large
118
allosteric enzymes and receptors
[5]
Fig. 3. Serine binding to PGDH. Analysis of serine binding was performed by equilibrium dialysis under conditions in which both positive and negative cooperativity are seen. The fractional occupancy of l-serine is plotted against the f